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 ABSTRACT 
 
The enteric nervous system (ENS) in vertebrates is derived from neural crest cells 
which emerge during embryogenesis from the hindbrain and, following stereotypical 
migratory pathways, colonize the entire gastrointestinal tract. Assembly of enteric 
ganglia and formation of functional neuronal circuits throughout the gut depends on 
the highly regulated differentiation of enteric neural crest stem cells (eNCSCs) into a 
plethora of neuronal subtypes and glia. The identification of eNCSCs and the 
lineages they generate is fundamental to understand ENS organogenesis. However, 
the study of the properties of eNCSCs has been hindered by the lack of specific 
markers and genetic tools to efficiently identify and follow these cells in vivo. 
Although previous in vitro studies have suggested that Sox10-expressing cells of 
the mammalian gut generate both enteric neurons and glia, the differentiation 
potential of these Sox10
+ cells in vivo is currently unclear. Here, we have developed 
a genetic marking system which allows us to identify Sox10
+ cells and follow their 
fate in vivo. Using this system we demonstrate that Sox10
+ cells of the gut generate 
both enteric neurons and glia in vivo,  thus representing multilineage ENS 
progenitors.  
To examine whether the neurogenic potential of Sox10
+ eNCSCs is temporally 
regulated over the course of gut organogenesis, we generated additional transgenic 
mouse lines expressing a tamoxifen-inducible Cre recombinase (iCreER
T2) under the 
control of the Sox10 locus (Sox10iCreER
T2). Activation of iCreER
T2 in 
Sox10iCreER
T2 transgenic mice at specific developmental stages and analysis of 
enteric ganglia from adult animals showed that the pool of Sox10
+ cells 
progressively lose their neurogenic potential. 
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These findings raise the question of the origin of multilineage ENS progenitors 
isolated from cultures of post-neurogenic gut. By combining genetic fate mapping in 
mice, cultures of enteric ganglia and an ENS injury model, we demonstrate that glial 
cells in the adult ENS retain neurogenic potential which can be activated both in 
vitro and in vivo, in response to injury.  
The signals that lead Sox10
+ progenitor cells to become either neurons or glial 
cells remain unclear. We hypothesized that the receptor tyrosine kinase RET may be 
part of the molecular fate switch between the two lineages being able to divert 
differentiation of eNCSCs away from the glial lineage and towards the neuronal fate.  
Here, we describe a genetic strategy to attain persistent expression of RET in vivo, in 
a temporally and spatially controlled manner. Such a strategy will allow us to assess 
the role of RET in ENS differentiation during development.  
Taken together, our data provide a framework for exploring the molecular 
mechanisms that control enteric neurogenesis in vivo and identify glial cells as a 
potential target for cell replacement therapies in cases associated with congenital 
absence or acquired loss of enteric neurons. TABLE OF CONTENTS 
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Chapter I 
 
 
General Introduction 
 
 General Introduction 
1.1. Enteric Nervous System: structure, organization and function 
The autonomic division of the peripheral nervous system (PNS) consists of three sub-
divisions: the sympathetic, the parasympathetic and the enteric nervous system (ENS). 
The ENS is the largest and most complex sub-division of the PNS. 
 
1.1.1. Structure and organization of the ENS 
The ENS is composed of a vast number of neurons and glial cells clustered into multiple 
interconnected ganglia embedded within the gut wall. Enteric ganglia are organized into 
two major plexi: the myenteric (or Auerbach’s) plexus and the submucosal (or 
Meissner’s) plexus (Fig.1.1). The myenteric plexus is situated between the longitudinal 
and circular smooth muscle layers and it runs along the full length of the gastrointestinal 
tract. The submucosal plexus is closely associated with the connective tissue, between 
the circular muscle and the innermost mucosal tissue. In small mammals, the 
submucosal plexus is restricted to the small and large intestines whereas in large 
mammals, including humans, a few submucosal cell bodies and nerve fibers can be 
found in the stomach. The size of ENS ganglia is variable between myenteric and 
submucosal ganglia, between gut regions and, to a lesser extent, between species. 
Typically, myenteric ganglia are considerably larger than submucosal ganglia in the 
same region (Furness, 2006). 
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Figure 1.1. The enteric nervous system is organized into two ganglionic plexi, the myenteric and the 
submucosal plexus. Schematic representation of a cross-section through the intestinal wall showing its 
general organization. Ganglia of the myenteric plexus are localized between the longitudinal and circular 
muscle layers whereas the submucosal plexus resides within the submucosa (modified from Cabarrocas et 
al., 2003). 
 
 
1.1.2.Functions of the ENS 
Enteric neurons synapse onto other enteric neurons and innervate the muscle, secretory 
epithelium, and blood vessels of the digestive tract; the biliary system and the pancreas. 
In accordance, the ENS is involved in regulating fundamental activities of the gut wall 
such as peristalsis, epithelial secretion, nutrient uptake, blood flow and immune and 
inflammatory processes (Kunze & Furness, 1999). In small mammals, control of gut 
motility is mainly carried out by the myenteric plexus whereas submucosal neurons are 
primarily responsible for the regulation of the secretory, absorptive and vascular 
functions of the gut. In larger mammals, some submucosal neurons participate directly, 
19 
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along with the myenteric plexus, in the control of motility reflexes (Timmermans et al., 
2001). Because of its critical role in fundamental activities of the gastrointestinal tract, 
the ENS is absolutely essential for all stages of postnatal life. Hence, mice lacking ENS 
throughout the gastrointestinal tract (Pattyn et al., 1999; Southard-Smith et al., 1998) or 
from particular regions, such as the esophagus (Guillemot et al., 1993) or small and 
large intestines (de Graaff et al., 2001; Schuchardt et al., 1994), usually die within 24 
hours after birth. 
 
1.1.3.Characteristics of the ENS  
The ENS differs both structurally and functionally from any other component of the 
PNS (Gabella, 1987; Gershon, 1981). Unlike other autonomic ganglia, enteric ganglia 
do not contain blood vessels, connective tissue cells or collagen fibrils. Structural 
support for enteric neurons is not provided by connective tissue or Schwann cells but 
rather by a unique glial cell population, morphologically and phenotypically more 
similar to central nervous system (CNS) astrocytes than to support cells of the 
sympathetic and parasympathetic ganglia (Gershon & Rothman, 1991). The absence of 
connective tissue and the close packing of neurons and glia give enteric ganglia an 
appearance similar to the CNS (Gabella, 1981). In terms of cell numbers, the ENS is the 
largest sub-division of the PNS containing as many neurons as can be found in the 
spinal cord (Gershon, 1993). Moreover, the ENS is, by far, the most complex PNS 
component in terms of the number of different subtypes of neurons and their 
connectivity. Enteric neurons can differ in neurotransmitter expression, morphology, 
electrophysiology and function (Brookes, 2001; Costa et al., 1996; Furness, 2000). 
Although clustered into ganglia, neurons do not form identifiable structural units of 
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morphologically, functionally and biochemically similar neuronal subtypes. In contrast, 
neurons of different subtypes are grouped in each ganglion forming repeating units of 
neuronal circuitry along the length of the gastrointestinal tract. 
The large number of neurons present in the enteric plexi and their phenotypic 
diversity is reflected into highly complex reflex circuits, which function largely 
independent of the CNS. In fact, even though the ENS receives input from the brain and 
spinal cord nuclei via the sympathetic and parasympathetic branches of the autonomic 
nervous system (Luckensmeyer & Keast, 1998; Powley, 2000), the intrinsic innervation 
of the bowel is the only region of the PNS intrinsically capable of mediating reflex 
activity (Furness et al., 1995). Given its autonomy and the structural and neurochemical 
resemblance to the CNS, the ENS has been referred to as the “second brain” (Gershon, 
1998).  
1.2.  Enteric Nervous System: origin and development 
1.2.1.Embryonic origin of the ENS 
As part of the PNS, the ENS is derived from the neural crest, a transient structure that 
extends along the rostro-caudal axis of developing vertebrate embryos (Le Douarin & 
Teillet, 1973; Yntema & Hammond, 1954). Neural crest-derived cells (NCCs) comprise 
a heterogenous population of migratory progenitors that emigrate from the dorsal neural 
tube during embryogenesis. NCCs, which include neural crest stem cells (NCSCs), 
follow stereotypical migratory routes and colonise specific embryonic sites where they 
generate a range of different derivatives, namely neurons and glia of the peripheral 
sensory and autonomic ganglia, Schwann cells, melanocytes, chromaffin cells of the 
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adrenal medulla and much of the skeletal and connective tissue of the craniofacial 
structures (Le Douarin & Dupin, 2003).  
The neural crest origin of the ENS was first suggested by Yntema and Hammond 
(1954). In a series of ablation studies, Yntema and Hammond showed that, in the 
absence of the neural crest, the ENS fails to develop in a histologically normal gut. 
These results were later confirmed by Le Douarin and Teillet (1973) using chick-quail 
interspecies chimaeras. Quail NCCs were grafted into chick embryos prior to the onset 
of migration and this led to the presence of quail neurons and glia in the gut of the 
grafted chick embryos supporting the neural crest origin of the ENS (Le Douarin & 
Teillet, 1973). Cell lineage studies revealed a similar origin for the ENS in mammals 
and zebrafish (Serbedzija et al., 1991; Shepherd et al., 2001). Even though NCCs are 
produced from the entire length of the neural axis, only certain tightly defined regions of 
the neural crest give rise to the ENS, more specifically the vagal and sacral regions 
Fig.1.2). 
.  
Figure 1.2. Enteric neurons and glia arise from neural 
crest-derived cells.  At approximately embryonic day 
(E) 8.5-9 in the mouse, vagal neural crest cells (red 
arrow) invade the foregut and migrating in a 
rostrocaudal direction colonise the entire foregut (FG), 
midgut (MG), caecum and hindgut (HG) giving rise to 
the majority of the enteric nervous system (red dots). 
The sacral level neural crest cells (orange arrow) also 
contribute to the ENS by migrating towards the gut at 
E13.5 and colonising the colon (orange dots) (modified 
from (Heanue & Pachnis, 2007). 
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Contribution of the vagal neural crest to the ENS 
 
The vagal crest is the only axial level that provides precursors to the entire 
gastrointestinal tract (Epstein et al., 1994; Yntema & Hammond, 1954). Located at the 
level of somites 1 to 7, the vagal crest comprises the NCSCs that give rise to the 
majority of enteric neurons and glia as well as to other structures of the PNS like cardiac 
ganglia and sensory ganglia of cranial nerves (Durbec et al., 1996; Le Douarin & 
Teillet, 1973; Newgreen, 1979; Yntema & Hammond, 1954).  
Identification of the vagal neural crest as a major source of the ENS throughout the 
gut was achieved by performing crest ablations in chick embryos at various axial levels 
(Yntema & Hammond, 1954). More recent studies using chick-quail grafts and 
fluorescent dyes to label the neural crest confirmed the contribution of the vagal neural 
axis to the ENS (Le Douarin & Teillet, 1973; Serbedzija et al., 1991).  
Colonisation of the embryonic gut by vagal NCCs has been examined using cellular 
markers and transgenic lines. These studies showed that vagal progenitors of the ENS 
(called pre-enteric neural crest stem cells-peNCSCs) delaminate from the neural tube 
between embryonic days (E) 8.5-9 in mice and start migrating, first ventrally and then 
ventromedially, until they enter the foregut by E9.5. Once within the gut, enteric NCCs 
(eNCCs), which include enteric neural crest stem cells (eNCSCs), migrate in a rostro-
caudal wave to populate the entire gastrointestinal tract (Anderson et al., 2006a; 
Anderson et al., 2006b; Druckenbrod & Epstein, 2005; Kapur et al., 1992; Pachnis et 
al., 1993; Young et al., 1998; Young et al., 1999).  
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Contribution of the sacral neural crest to the ENS 
 
The vagal crest is not the sole source of the ENS. A combination of cell lineage studies 
using chick-quail grafts, DiI and retrovirus showed that some cells that populate the 
chick ENS are derived from the sacral level neural crest (Burns & Douarin, 1998; Le 
Douarin & Teillet, 1973; Pomeranz et al., 1993; Serbedzija et al., 1991). Similarly, 
studies using transgenic markers revealed an additional minor contribution of sacral-
derived NCCs for the mouse ENS (Anderson et al., 2006b; Kapur, 2000). In one of the 
few species differences this source is absent in zebrafish (Elworthy et al., 2005). 
The sacral crest lies caudal to somite 28 in birds and somite 24 in mice and it 
colonises only the post-umbilical gut (Burns & Douarin, 1998; Le Douarin & Teillet, 
1973). The time of arrival of sacral NCCs into the hindgut and the phenotypes of its 
derivatives was examined in both chick and mouse embryos. Sacral NCCs were 
observed to migrate ventrally to populate the pelvic mesenchyme and the nerve of 
Remark (unique to birds) and then pause in their migration outside the hindgut. Upon 
arrival of the vagal eNCCs, sacral progenitors invade the hindgut (at E7.5 in the birds, 
E13.5 in mice) contributing to the colonisation of the distal region of the bowel 
(Anderson et al., 2006b; Burns & Douarin, 1998; Kapur, 2000). Sacral NCCs were 
found to give rise to neurons and glia but the proportion of ENS cells derived from the 
sacral crest level is small and declines rostrally (Burns & Douarin, 1998). 
 
1.2.2.Development of the ENS 
NCCs that form the ENS emigrate from the neural crest and migrate into the foregut 
(vagal NCCs) and hindgut (sacral NCCs) during embryogenesis. These cells then 
migrate along the gut to colonise the entire gastrointestinal tract, which is itself 
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undergoing growth, morphogenesis and differentiation. A number of studies showed 
that, from the foregut, vagal eNCCs migrate in a rostral to caudal direction following a 
specific time course. eNCCs migrate through midgut and approach the ileocaecal 
junction by E10.5 in the mouse. By E11.5, eNCCs have passed the caecal bulge and by 
E12.5 they have entered the hindgut. Colonisation is complete around E14.5 when 
eNCCs reach the end of the hindgut (Anderson et al., 2006a; Druckenbrod & Epstein, 
2005; Kapur et al., 1992; Young et al., 1998; Young et al., 1999). At this point, vagal 
eNCCs mix with cells of sacral origin that are migrating caudorostrally to colonise the 
hindgut (Fig.1.3). During early stages of migration, eNCCs spread through the 
mesenchyme, but shortly after colonising a region, they form a narrow layer between the 
longitudinal and circular muscle. In contrast, eNCCs are found in the submucosal plexus 
only 2-3 days after and it has been suggested that they arise from a secondary centripetal 
migration from local myenteric cells (Gershon et al., 1980; Jiang et al., 2003; Kapur et 
al., 1992).  
As eNCSCs migrate away from the gut entry points and spread uniformly through 
the gut, they respond to strong proliferative signals, which increase their numbers 
dramatically (Gianino et al., 2003). In parallel, subsets of eNCSCs undergo sequential 
lineage restriction before differentiating into neurons and glia. Thus, the development of 
the ENS is a complex, asynchronous process that relies on the control of cell migration, 
proliferation and differentiation of eNCSCs and their progeny in a spatiotemporally 
controlled manner. Appropriate control of these cellular processes is absolutely essential 
for the formation of a functional ENS. 
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Figure 1.3. Temporal and spatial distribution of eNCCs labelled using the bigenic system Wnt1-Cre; 
R26ReYFP. Inverted microscopic confocal images of whole mount gut preparations immunostained for 
YFP. At E10.5 vagal eNCCs have migrated through the stomach (st) and midgut (mg) and approach the 
caecal buldge of the intestine (A; x100 magnification). Between E11.5 and E12.5, eNCCs colonise the 
caecum (B-C; x100 magnification) and, by E14.5, they reach the end of the hindgut (hg) (D; x50 
magnification). At that point, vagal eNCCs mix with cells of sacral origin that are migrating 
caudorostrally to colonise the distal colon.  
 
1.3. Cellular and molecular mechanisms of ENS differentiation 
Some of the migrating NCCs are multipotent (Fraser & Bronner-Fraser, 1991) and 
remain so at the time they reach the foregut mesenchyme (Lo & Anderson, 1995; 
Rothman et al., 1990; Rothman et al., 1993). Once within the gut, these eNCSCs must 
generate a vast array of phenotypically diverse neurons and glial cells. In the ENS, 
unlike some parts of the nervous system, different neuronal subtypes and glia are 
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generated in the same environment. Furthermore, differentiation of eNCSCs is 
asynchronous and so multipotent progenitor cells co-exist with fate-restricted cell types 
(Lo & Anderson, 1995). This raises the question of how and when cell type specification 
is initiated. A number of studies have suggested that self-renewal of eNCSCs and their 
orderly differentiation into distinct lineages is dependent on the interplay between 
extracellular cues and cell-autonomous intracellular signalling (Chalazonitis et al., 1998; 
Gershon et al., 1993; Paratore et al., 2002; Pisano & Birren, 1999; Taraviras et al., 
1999). In the last decades considerable progress has been made in identifying a range of 
transcription factors, signalling receptors and other molecules implicated in ENS 
differentiation.  
 
1.3.1.Molecular control of the generation and maintenance of the pool of eNCSCs 
To form the mature ENS, eNCSCs must generate correct numbers of neurons and glia in 
a spatiotemporal controlled manner. This requires a fine-tuned balance between 
persistence of a pool of eNCSCs and the differentiation of derivatives from this pool. A 
number of molecules have been implicated in the maintenance of the eNCSCs 
population by controlling cell survival and renewal. One such molecule is Sox10, a 
transcription factor of the Sox (SRY-box containing) super-family, identified by a DNA-
binding domain similar to the high-mobility group (HMG) domain of the mammalian 
testis-determining factor Sry (Koopman et al., 1991). During early stages of 
development, Sox10 is specifically expressed in NCCs. Its expression is induced shortly 
before NCCs exit the neural tube and it continues to be expressed as these cells migrate 
(Anderson et al., 2006b; Kuhlbrodt et al., 1998; McKeown et al., 2005). Later, when 
NCCs have reached their final destination and become post-migratory, Sox10 is strongly 
27 
 General Introduction 
expressed in glial cells, but not the neurons that comprise neural crest derivatives, such 
as the dorsal root ganglia (DRG), sympathetic chain and ENS (Britsch et al., 2001; 
Cheng et al., 2000; Cheung & Briscoe, 2003; Kuhlbrodt et al., 1998). Outside the neural 
crest and its derivatives, Sox10 is expressed in the otic epithelium and in the central 
nervous system where it is maintained exclusively in the oligodendrocyte lineage 
(Cheng et al., 2000; Kuhlbrodt et al., 1998; Stolt et al., 2002).  
Consistent with its expression pattern, Sox10 is required for proper development of 
various neural crest-derived cell types. Animals homozygous for a spontaneous 
mutation in the Sox10 locus, the Dominant megacolon (Sox10
Dom), show a severe 
embryonic lethal defect comprising absence of enteric ganglia as well as reduction of 
sympathetic and parasympathetic ganglia, loss of glia, melanocytes and adrenal 
chromaffin cells (Kapur, 1999; Southard-Smith et al., 1998). A similar phenotype is 
exhibited by homozygous mice carrying a targeted Sox10 null mutation (Sox10
LacZ; 
(Britsch et al., 2001). Haploinsufficiency of Sox10 results in distal enteric aganglionosis, 
pigmentation defects and cochlear neurosensory deafness (Britsch et al., 2001; Herbarth 
et al., 1998; Paratore et al., 2002), a phenotype similar to WS4 (Shah-Waardenburg 
syndrome) observed in human patients carrying SOX10 mutations (Pingault et al., 1998; 
Southard-Smith et al., 1998). Studies by Paratore et al. (2001) showed that the cellular 
basis for these phenotypes is the requirement for Sox10 by NCSCs before lineage 
segregation. Sox10 is not required for initial NCSCs specification or migration from the 
neural tube (Britsch et al., 2001; Herbarth et al., 1998; Southard-Smith et al., 1998) but 
it is essential for the survival of undifferentiated post-migratory NCSCs. In accordance, 
in the absence of this transcription factor NCSCs undergo apoptotic cell death before 
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entering the foregut, which leads to the complete elimination of ENS precursors from 
the entire gastrointestinal tract (Kapur, 1999; Southard-Smith et al., 1998).  
A combination of in vivo and cell culture studies has suggested that Sox10 might be 
also implicated in maintaining NCSCs in an undifferentiated state. Paratore et al. (2002) 
reported that decreased levels of Sox10 do not impair survival or migration of eNCSCs 
within the gastrointestinal tract but prevents them from maintaining their progenitor 
state leading to the acquisition of preneuronal traits (Paratore et al., 2002). In contrast, 
Sox10 overexpression in cultured NCSCs inhibits neuronal and glial differentiation 
(Bondurand et al., 2006; Kim et al., 2003).  
Despite its role in the maintenance of the ENS progenitor pool, Sox10 does not 
appear to be sufficient for conferring progenitor character to eNCSCs as it is also 
expressed at high levels in the glial lineage of the ENS. This argues that additional 
factors contribute to the maintenance of the pool of eNCSCs, presumably by interacting 
with Sox10 either directly or indirectly.  One such factor is the transcriptional factor 
Sox8.  Sox8 belongs to group SoxE along with Sox9 and Sox10. Unlike Sox9, Sox8 
exhibits an expression pattern similar to Sox10 with occurrence in peNCSCs, eNCSCs 
and later confinement to enteric glia (Maka et al., 2005). Although single Sox8 mutant 
animals show no defects in ENS development (Sock et al., 2001), Sox8 functions as a 
modifier gene for Sox10-dependent ENS defects as it increases cell death in the 
peNCSC population leading to an increased severity of aganglionosis in Sox10 
heterozygous mice. 
A number of genetic and cell culture studies have highlighted also the interaction 
between Sox10 and the signalling pathways EDNRB/endothelin-3 and RET/GDNF in 
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the regulation of the progenitor pool size. EDNRB is a G protein-coupled receptor for 
the intracellular messengers endothelin-1 (ET-1), ET-2, ET-3 (Inoue et al., 1989). 
Among these peptides ET-3 is the only known ligand of EDNRB in the gut during 
mouse embryogenesis (Gershon, 1999; Leibl et al., 1999). Analysis of spontaneous and 
targeted mutations in the genes encoding ET-3 (Edn3) and EDNRB (Ednrb) established 
the requirement of this signalling pathway in ENS development. In mice and rats 
lacking Edn-3 or Ednrb, enteric ganglia are missing from the distal regions of the GI 
tract (Baynash et al., 1994; Hosoda et al., 1994). Genetic studies showed that the 
EDNRB/ET-3 signalling pathway interacts with Sox10 to promote the survival of 
peNCSCs as loss of Ednrb (Cantrell et al., 2004) or Edn3 (Stanchina et al., 2006) 
increases severity of aganglionosis in Sox10 heterozygous animals due to increased cell 
death of peNCSCs. Consistent with a genetic interaction between Sox10 and Ednrb loci, 
Sox10 binding sites exist in an Ednrb  enhancer region and are required for proper 
spatiotemporal expression of Ednrb in the ENS (Zhu et al., 2004). Moreover, 
EDNRB/ET-3 signalling cooperates with Sox10 to maintain eNCSCs in an 
uncommitted, self-renewing state allowing a larger enteric neural precursor population 
to be built up, for later differentiation (Bondurand et al., 2006; Hearn et al., 1998; Nagy 
& Goldstein, 2006). Experiments performed in mouse and chick showed that via its 
receptor on crest cells, ET-3 produced by the gut mesenchyme, inhibits or retards 
neuronal differentiation (Hearn et al., 1998; Wu et al., 1999). Accordingly, in the 
absence of signalling via this pathway there is premature neuronal differentiation and a 
resultant smaller pool of undifferentiated cells. As a consequence, fewer progenitors are 
available to complete colonisation of the distal gut leading to distal aganglionosis as 
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observed in mice and humans with mutations in the genes encoding either ET-3 or 
EDNRB (Amiel & Lyonnet, 2001; Baynash et al., 1994; Brooks et al., 2005; Hosoda et 
al., 1994).  Furthermore, studies by Barlow et al. (2003) showed that EDNRB/ET-3 
signalling enhances the proliferative response of eNCSCs to RET signalling.  
RET is a transmembrane tyrosine kinase that acts as a receptor for the glial cell line-
derived neurotrophic factor (GDNF) and the other members of the GDNF family of 
ligands (GFLs), neurturin, artemin and persephin (Baloh et al., 2000; Saarma, 2000). 
The interaction between GFLs and RET is mediated by glycosyl-phosphatidyl-inositol 
(GPI)-linked cell-surface glycoproteins (GFR1-4) and these determine RET ligand 
specificity (Airaksinen et al., 1999; Baloh et al., 2000).  
The gene that encodes RET (c-Ret) was originally identified as a transforming gene. 
Dominant, gain-of-function mutations in this locus lead to the familial cancer syndromes 
multiple endocrine neoplasia type 2A (MEN2A) and 2B (MEN2B) and familial 
medullary thyroid carcinoma (FMTC) (Grieco et al., 1990; Mulligan et al., 1993). These 
syndromes are defined by tumors of the endocrine glands arising from neural crest 
derivatives and result from an increased kinase activity and aberrant stimulation of 
downstream pathways. 
Besides its role in oncogenesis, RET is essential for proper development of diverse 
neuronal populations of the PNS, including enteric, sympathetic, parasympathetic and 
sensory neurons (Durbec et al., 1996; Schuchardt et al., 1994).  In the ENS, c-Ret is 
expressed in peNCSCs when they first reach the vicinity of the gut at E9-9.5 and 
continues to be expressed as these cells migrate within the foetal gut (Durbec et al., 
1996; Pachnis et al., 1993; Tsuzuki et al., 1995). In the differentiated lineages of the 
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ENS, Ret expression is maintained exclusively in the neuronal population (Young et al., 
2003). As suggested by this expression pattern, RET is essential for the development of 
the ENS in vertebrates. For instance, humans heterozygous for germline mutations at the 
c-RET locus have increased susceptibility to Hirschsprung’s disease (HSCR), a 
congenital disorder characterized by the absence of enteric ganglia in the distal colon 
(intestinal aganglionosis; (Edery et al., 1994; Romeo et al., 1994). Mice with null 
mutations in this gene (Ret
k-) die soon after birth and display complete intestinal 
aganglionosis (Durbec et al., 1996; Schuchardt et al., 1994). A similar phenotype is 
found in mice deficient for either gdnf or gfr1, highlighting the functional interaction 
between these molecules (Cacalano et al., 1998; Pichel et al., 1996).  
Gene targeting studies in mice have provided valuable insight into the role of RET in 
ENS development. A detailed analysis of the Ret-deficient embryos showed that in the 
absence of RET, eNCSCs undergo apoptosis and fail to enter the midgut suggesting that 
the RET signalling pathway provides survival signals to the majority of the progenitors 
of the ENS (Durbec et al., 1996; Taraviras et al., 1999).  In addition to this early 
function, the RET receptor has also been implicated in eNCSCs proliferation. In vitro 
assays have demonstrated that activation of the RET receptor by exogenous GDNF 
added to the culture medium enhanced cell proliferation and induced an increase in the 
number of neural precursors (Chalazonitis et al., 1998; Hearn et al., 1998; Heuckeroth et 
al., 1998; Taraviras et al., 1999). Furthermore, studies by Gianino et al. (2003) 
suggested that GDNF critically determines the proliferative capacity of eNCSCs and 
that the extent of their proliferation ultimately determines the number of enteric neurons 
in the adult gut. Interestingly, the response of eNCSC to GDNF changes as a function of 
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developmental age. Chalazonitis et al. (1998) reported that even though at E12 GDNF 
has a mitogenic effect on eNCSCs, during the post-migratory stages of enteric 
neurogenesis (in the mouse after E14) GDNF preferentially induces the differentiation 
of these cells into neurons. The EDNRB/ET-3 signalling system seems to be critical in 
the balance between the mitogenic and differentiation effect of RET/GDNF signalling 
by counteracting the differentiation role of GDNF without affecting its effect on 
proliferation (Hearn et al., 1998).  
Maintenance of the eNCSCs population is also dependent on the mitogenic role of 
the epidermal growth factor (EGF) as highlighted in a recent study (Fuchs et al., 2009). 
Fuchs et al. (2009) showed that, once in the gut, eNCSCs acquire responsiveness to EGF 
through upregulation of the EGF receptor (EGFR). This receptor acts through two small 
GTPases, Rac1 and Cdc42. Conditional deletion of Rac1 and Cdc42 in eNCSCs results 
in the reduction of the self-renewal and proliferative abilities of eNCSCs which suggests 
that, acting via Rac1 and Cdc42, EGFR signaling promotes self-renewal and 
proliferation of eNCSCs. 
Another factor involved in maintenance of the progenitor pool is Notch. The Notch 
receptors are transmembrane proteins activated by Delta and Jagged ligands (Yoon & 
Gaiano, 2005). The role of Notch signalling in the CNS and PNS is complex and 
context-dependent. Overexpression of Notch pathway components has been shown to 
either promote the maintenance of undifferentiated progenitor cells or gliogenesis. In the 
CNS, overexpression of Notch1 or its target genes increases the formation of radial glia 
in the telencephalon (Yoon et al., 2004) and instructs adult hippocampus progenitors to 
become astrocytes in culture (Tanigaki et al., 2001). In contrast, the absence of Notch or 
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the Notch transcriptional effectors Hes1 or Hes5 in mice leads to the loss of 
neuroepithelial cells and premature neuronal differentiation due to the upregulation of 
proneural genes such as Mash1 (mammalian achaete-scute homologue 1–Ascl1; 
(Hatakeyama et al., 2004; Hitoshi et al., 2002). Whether Notch acts to maintain 
undifferentiated progenitors and, subsequently to promote gliogenesis, or whether the 
defects in gliogenesis are secondary to a premature depletion of the progenitor pool is 
still under debate. 
Evidence for the role of Notch signalling in the maintenance of eNCSCs in an 
undifferentiated state came from the study of mice exhibiting neural crest-specific 
defects in Notch signalling (Okamura & Saga, 2008; Taylor et al., 2007). Taylor et al. 
(2007) showed that conditional deletion of Rbpsuh, which encodes a DNA binding 
protein (RBP/J) required for canonical signalling by all Notch receptors, results in 
severe deficits in the number of eNCSCs. Consistent with a role for the Notch pathway 
in the maintenance of the progenitor pool, Rbpsuh
-/- eNCSCs exhibited low efficiency in 
colony formation precluding analysis of a potential requirement for Notch signalling in 
ENS gliogenesis (Taylor et al., 2007).  These results were further confirmed by 
Okamura and Saga (2008), who showed that in the absence of Notch signalling there is 
loss of Sox10 expression suggesting that Notch is required for the maintenance of Sox10 
in eNCSCs, maybe by repressing expression of Mash1 (Chen et al., 1997). 
Downregulation of Sox10 is accompanied by reduced proliferation and premature 
neuronal differentiation leading to the depletion of the progenitor pool.  
Another transcription factor essential for the survival of eNCSCs is Phox2b. This 
paired box homeodomain transcription regulator is expressed by autonomic neural crest 
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derivatives (sympathetic, parasympathetic and enteric ganglia) as well as by some 
cranial ganglia and hindbrain nuclei (Pattyn et al., 1999). In the PNS, Phox2b is required 
for the activation of the neuronal programme by inducing expression of proneural genes 
such as Mash1 and also for the early specification of the neuronal phenotype in 
noradrenergic neurons of the PNS (Pattyn et al., 1999; Pattyn et al., 2000). In the ENS, 
peNCSCs induce expression of Phox2b upon arrival to the dorsal aorta and its 
expression is maintained in essentially all differentiated neurons and also a 
subpopulation of glial cells (Corpening et al., 2008; Young et al., 1998; Young et al., 
2003). In the absence of Phox2b, eNCSCs cells arrive at the foregut but fail to migrate 
further and undergo apoptosis, which leads to aganglionosis. Furthermore, eNCSCs fail 
to express the receptor tyrosine kinase RET (Pattyn et al., 1999). This phenotype 
suggests an essential role for Phox2b in the early survival of eNCSCs, probably through 
the regulation of Ret expression.  
 
1.3.2.Molecular regulation of enteric neuronal differentiation 
Mutant mice in which myenteric neuron density is increased (Taketomi et al., 2005) or 
decreased (Roberts et al., 2008) exhibit motility defects, and thus eNCSCs must 
generate correct numbers of enteric neurons for the formation of an intact, functional 
ENS. Studies over the past years showed that the number and type of neurons produced 
by neural stem cells is modulated by changes in the expression of neurogenic signals in 
the environment as well as by cell-intrinsic changes that affect the way stem cells 
respond to these neurogenic factors (Qian et al., 2000; White et al., 2001). Within the 
ENS analogous regulatory mechanisms have been identified. Earlier in vitro studies on 
chick, mouse and rat suggested that the RET/GDNF signalling pathway can stimulate 
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differentiation of eNCSCs into neurons and promote neurite growth (Chalazonitis et al., 
1998; Hearn et al., 1998; Heuckeroth et al., 1998; Taraviras et al., 1999). Interestingly, 
Chalazonitis et al (1998) reported that GDNF inhibits expression of the glial marker 
S100, thus favouring neuronal but not glial differentiation. Despite these studies, the 
role of the RET/GDNF signalling pathway in eNCSCs differentiation in vivo is still 
poorly understood. Conditional ablation of gfrα1 or c-Ret suggested that, at late stages 
of development, RET signalling is required for the survival of enteric neurons in the 
colon (Uesaka et al., 2007; Uesaka et al., 2008). However, the effects of abrogating 
RET signalling pathway in eNCSCs and how that affects cell commitment and 
differentiation was not addressed in this study. Evidence supporting a potential 
association between RET signalling and differentiation of eNCSCs into specific cellular 
phenotypes came from the study of the monoisoformic Ret mutants, which express only 
one of the two RET isoforms, RET9 or RET51 (de Graaff et al., 2001). In contrast to 
RET9, the RET51 isoform is not sufficient to support normal embryonic and postnatal 
development as mutant mice that express only RET51 (Ret
51/51) exhibit distal 
aganglionosis. Further analysis of these mutants revealed a significant reduction in the 
number of enteric neurons (Dipa Natarajan, personal communication), thus suggesting 
that RET signalling is required for the generation of neurons in proper numbers. The 
role of the RET receptor in neuronal differentiation is further supported by the analysis 
of Sprouty2-deficient mice (Taketomi et al., 2005). Sprouty proteins are evolutionary 
conserved inhibitors of tyrosine kinase signalling. Studies by Taketomi et al. (2005) 
showed that Sprouty2 functions as a negative regulator of RET/GDNF signalling as its 
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absence results in hyper-responsiveness to the RET/GDNF system and consequently, 
enteric neuron hyperplasia.  
Neurturin is another functional ligand of the RET receptor important for ENS 
differentiation. The RET/NRTN pathway has a minimal effect on enteric neuron 
survival or proliferation but it is involved in the development of cholinergic neurons, not 
only in the gut but also in parasympathetic ganglia, since neurturin-/- and gfr2-/- mice 
have reduced numbers of cholinergic neurons in the cranial and enteric ganglia 
(Heuckeroth et al., 1999; Rossi et al., 1999). 
Another class of signalling molecules that influence neuronal differentiation is the 
bone morphogenetic proteins (BMPs). The BMPs instruct neuronal differentiation of 
NCSCs by inducing expression of proneural genes, such as Mash1 (Shah et al., 1996; 
Shah & Anderson, 1997). However, the response of NCSCs to these neurogenic signals 
changes over time influencing the number and type of neurons that are generated (White 
et al., 2001). Within the ENS, BMPs are also involved in the regulation of enteric 
neuron number as shown by the study of transgenic mice over expressing the BMP 
inhibitor noggin.  Noggin antagonism of BPM signalling resulted in an increase of the 
total number of enteric neurons, however, enteric neuron subtypes were affected 
differently; the number of early-born neuronal subpopulations increased whereas late-
born neuronal subtypes decreased.  The effects of noggin over expression are, thus, 
correlated with cell cycle exit suggesting that BMP signalling may regulate enteric 
neuronal phenotypic diversity by promoting the exit of precursors from the cell cycle 
(Chalazonitis et al., 2004; Chalazonitis et al., 2008). 
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A number of transcription factors involved in enteric neuronal differentiation have 
also been identified, including Mash1 and Hand2. Mash1 is a transcription factor that 
belongs to the basic helix-loop-helix (bHLH) family. In the CNS, Mash1 is expressed 
transiently during embryogenesis in neuron-committed progenitors and it is involved in 
promoting neurogenesis by activating the expression of a cascade of neuron-specific 
genes as well as inhibiting the expression of glia-specific genes (Guillemot et al., 1993; 
McNay et al., 2006; Nieto et al., 2001; Parras et al., 2002; Tomita et al., 2000). In the 
ENS, Mash1 is also expressed transiently; expression begins in neural precursor cells 
but it is extinguished as they differentiate into neurons. An earlier report on the in vivo 
role of Mash1 in the ENS showed that deletion of this bHLH transcription factor results 
in a transient delay in the migration and differentiation of early neural crest cells. This 
delay is eventually overcome but the selective elimination of the transient 
catecholaminergic-serotonergic neuronal lineage persists suggesting that Mash1 is 
required for the development of this particular subtype of neurons (Blaugrund et al., 
1996).  
More recent studies have identified the transcription factor Hand2 as an important 
player in neuronal differentiation. Hand2 is a member of the twist family of bHLH 
transcription factors (Firulli, 2003) and it is expressed in the peripheral autonomic 
nervous system, including the enteric ganglia (Cserjesi et al., 1995; Dai et al., 2004; 
Morikawa et al., 2005). In the ENS, Hand2 expression is developmentally regulated; it 
peaks at E12.5 and then at E14 declines to a lower level that is maintained throughout 
adulthood. The effect of the conditional deletion of Hand2 in eNCSCs has been 
analysed (D'Autreaux et al., 2007; Hendershot et al., 2007). A study by D'Autreaux et 
38 
 General Introduction 
al. (2007) showed that loss of Hand2 leads to a dramatic reduction in the differentiation 
capacity of eNCSCs without affecting their ability to colonise the gastrointestinal tract 
or differentiate into glial cells. Furthermore, eNCSCs that enter the neuronal lineage are 
unable to complete neuronal differentiation and acquire subtype-specific markers. In a 
similar study, Hendershot et al. (2007) suggested that Hand2 expression is required for 
the differentiation of specific neuronal subtypes, namely TH
+ and VIP
+ neurons. 
 
1.3.3.Molecular control of enteric glia differentiation 
A fundamental question in developmental neurobiology concerns the mechanisms that 
regulate the transition from neurogenesis to gliogenesis in vertebrates. In the ENS, 
neurons appear prior to glial cells as evidenced by the detection of specific markers for 
both cell types (Baetge & Gershon, 1989; Baetge et al., 1990a; Young et al., 2003).  
This suggests that, as in other parts of the nervous system, enteric glial differentiation 
lags behind neural differentiation. However, formation of new neurons persists after the 
appearance of glial cells indicating that neurogenesis and gliogenesis co-exist in the gut 
of mouse embryos. Although substantial progress has been made towards understanding 
environmental and cell intrinsic signals that promote ENS formation in general, very 
little is known about the mechanisms that regulate gliogenesis in the gut.  
The continuous expression of Sox10 in peripheral glia, including enteric glial cells, 
points towards a role for this transcription factor in glial fate specification and 
differentiation. Such function has already been verified in the DRGs. In mice 
homozygous for a targeted mutation in Sox10, neuronal cells are able to form in the 
DRGs but Schwann cells or satellite cells are not generated (Britsch et al., 2001). Also, 
Sox10
-/- NCCs from mouse embryos cultured in gliogenic promoting conditions fail to 
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produce any glia (Paratore et al., 2001). This is thought to involve ErbB3 and Notch1 as 
its expression in glial progenitors is lost in the Sox10 mutant DRGs (Britsch et al., 2001; 
Paratore et al., 2001). Indeed, another important player in glia development is the 
receptor tyrosine kinase ErbB3. This receptor interacts with the neuronal-derived 
neuregulins (NRGs), in particular with the soluble NRG1 isoform, which strongly 
suppresses the neuronal fate while promoting differentiation of peripheral glia 
(Marchionni et al., 1993; Shah et al., 1994).  
Notch is another factor that has been implicated in gliogenesis (Kopan & Ilagan, 
2009). More than just inhibiting neuronal differentiation, Notch signalling has been 
shown to participate in the regulation of binary fate decisions during neural development 
by instructing gliogenesis (Morrison, 2001). Studies by Tanigaki et al. (2001) showed 
that Notch activation in CNS stem cells of the adult hippocampus leads to astrocytic 
differentiation (Tanigaki et al., 2001). Also, overexpression of Notch1 or its target genes 
promotes acquisition of glial fates in vivo in the postnatal retina (Hojo et al., 2000). 
Consistent with the idea that Notch can send a positive signal that promotes glial lineage 
determination in vertebrates, RBP/J (a DNA-binding protein that interacts with the 
intracellular domain of activated Notch to regulate transcription) can directly bind the 
promoters of glial genes and activate transcription (Anthony et al., 2005; Ge et al., 
2002). The role of Notch signalling in gliogenesis has also been examined in the 
peripheral nervous system (Morrison et al., 2000; Taylor et al., 2007). Morrison et al. 
(2000) showed that exposure of NCSCs of the DRG to Notch ligand delta-like1 (Dll1) 
instructs glial differentiation and causes an irreversible loss of neurogenic potential. In 
light of these results, the authors suggested that the transient expression of Notch ligands 
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by nascent autonomic neurons lead NCSCs to loose their neurogenic potential and 
differentiate into glial cells triggering the switch between neurogenesis and gliogenesis 
during development. Also, in vivo studies using mice with neural crest-specific defects 
in the Notch pathway showed that Notch signalling is required for gliogenesis in sensory 
and sympathetic ganglia (Taylor et al., 2007). In the developing ENS, Notch signalling 
was shown to be involved in the maintenance of normal numbers of NCSCs (Okamura 
& Saga, 2008; Taylor et al., 2007) but its role in gliogenesis was not examined.   
1.4.  Lineages of the ENS 
The mature ENS is comprised of a vast number of different neuronal subtypes plus an 
even higher number of enteric glial cells. Generation of specific neuronal subtypes with 
a defined projection pattern and the supporting glial cells is essential for the assembly of 
functioning neural circuits within the ENS.   
 
1.4.1.Phenotype of neural crest-derived cells that form the ENS 
Differentiation of NCSCs into enteric neurons and glia is thought to follow a series of 
cell commitment and differentiation steps orchestrated by a highly regulated pattern of 
gene expression. Thus, after delamination from the neural tube peNCSCs express 
general neural crest cell markers, including the HMG-containing transcriptional 
regulator Sox10 and the low-affinity nerve growth receptor p75 (Anderson et al., 2006b; 
Young et al., 1998; Young et al., 1999). Upon arrival at the dorsal aorta, peNCSCs 
induce expression of the transcription regulator Phox2b and the receptor tyrosine kinase 
RET and invade the foregut mesenchyme (Durbec et al., 1996; Lo & Anderson, 1995; 
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Pattyn et al., 1999).  At this point, a subpopulation of eNCSCs starts to express the 
transcription factor Mash1 (Blaugrund et al., 1996; Lo et al., 1997).  
From the foregut, eNCSCs initiate a well-orchestrated rostro-caudal migration 
culminating in the uniform colonization of the entire gastrointestinal tract (Kapur et al., 
1992; Young & Newgreen, 2001). As eNCSCs migrate through the gut, they proliferate 
extensively, while subsets of eNCSCs initiate neuronal and glial differentiation (Fig.1.4; 
(Heanue & Pachnis, 2007). In a study by Young et al. (2003) the phenotype of eNCSCs 
as they differentiate into neurons and glia was examined (Young et al., 2003). This 
showed that differentiation of eNCSCs into neurons takes place shortly after invasion of 
the foregut and it is accompanied by the expression of pan-neuronal markers (molecular 
characteristics common to all neurons) such as neuron class III β-tubulin (Tuj1) and 
HuC/D  (Marusich et al., 1994; Wakamatsu & Weston, 1997). Along with these 
markers, differentiating neurons express also RET, Phox2b but not Sox10. As for the 
glial precursors, these are firstly identified behind the migratory wave front, at E11.5, by 
the expression of Sox10, p75 and brain-specific fatty acid binding protein 
(BFABP;(Kurtz et al., 1994; Veerkamp & Zimmerman, 2001). Besides Sox10, p75 and 
BFABP, adult glial cells express S100 (Ferri et al., 1982) from E14.5 onwards and 
glial fibrillary acidic protein (GFAP; (Jessen & Mirsky, 1980; Jessen & Mirsky, 1983) 
after E16.5 (Young et al., 2003). 
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Figure 1.4. Differentiation of eNCSCs into neurons and glia follows a highly regulated programme of 
gene expression. eNCSCs that enter the foregut express the transcription factors Sox10 and Phox2b, p75, 
and the receptor tyrosine kinase RET. A fraction of eNCSCs induce expression of Mash1 and these are 
thought to be committed precursors of the neuronal lineage. These cells do not express Sox10 and they 
exhibit low levels of p75. Cells that differentiate into neurons downregulate Mash1 and p75, maintain 
RET expression, and upregulate pan-neuronal markers such as Tuj1 and HuC/D. Similar to eNCSCs, 
gliogenic precursor cells express Sox10 and p75 but they downregulate RET expression and upregulate 
the glial specific marker BFABP. Differentiated glial cells express BFABP and upregulate other glial 
markers such as S100β and GFAP. Adapted from (Heanue & Pachnis, 2007). 
 
 
1.4.2.Enteric neuronal cells 
Neuronal diversity in the adult ENS 
 
Enteric neurons are very diverse in terms of cell morphology, function, type of 
neurotransmitters and neuropeptides produced and patterns of axonal projection. 
Initially, enteric neuron subtypes were classified based on morphological characteristics 
(Furness, 2006). More recently, a combination of morphology, 
neurotransmitter/neuromodulator content, electrophysiology, target tissue and direction 
and length of axon projection have been used to classify enteric neurons. In the small 
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intestine of the guinea pig about 20 distinct subtypes of myenteric neurons and 4-5 
subtypes of submucosal neurons have been identified. These include excitatory and 
inhibitory motor neurons (which target the muscle layers), ascending and descending 
interneurons (that connect enteric neurons in different ganglia), sensory neurons (which 
monitor the state of the lumen and gut wall), secretomotor neurons and vasodilator 
neurons (project to the mucosa and to the local blood vessels) (Brookes, 2001; Costa et 
al., 1996; Furness, 2000). A similar number of enteric neuron subtypes is also present in 
the mouse gut (Qu et al., 2008).  
 
Developmental appearance of enteric neuronal subtypes 
 
During differentiation, enteric neurons first express pan-neuronal markers and then 
acquire markers of terminally differentiated neurons (Baetge & Gershon, 1989; 
Branchek & Gershon, 1989; Rothman & Gershon, 1982; Young et al., 1999). As in most 
parts of the nervous system, different types of enteric neurons (identified by the 
combined expression of specific neurotransmitters and the enzymes responsible for their 
synthesis) develop at different developmental stages (Table1.1; (Epstein et al., 1983; 
Rothman & Gershon, 1982). The first neurons of the developing ENS express the 
cathecolamine synthetic enzyme, tyrosine hydroxylase (TH), and they are found only 
transiently in the mouse gut. TH is expressed by all developing enteric neurons from 
E10 to E15 (Baetge & Gershon, 1989; Baetge et al., 1990a; Young et al., 1999). 
However, expression of this marker is downregulated by immature enteric neurons 
(Pisano & Birren, 1999) and so, in the mature ENS only a small population of neurons 
(less than 0.5% of myenteric neurons) are TH
+ and these do not arise from the 
transiently TH
+ cells that are present early in embryonic development (Li et al., 2004). 
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Table1.1 The earliest detection of subtype-specific markers and birthdates of myenteric 
neurons in the mouse small intestine 
Neuronal 
Subtype 
Developmental 
appearance 
Birthdate 
(myenteric plexus) 
References 
5-HT E12
*  E8-E14  (Pham et al., 1991; Rothman & Gershon, 
1982) 
NOS E12  E12.5-P1  (Branchek & Gershon, 1989; Chalazonitis 
et al., 2008) 
cholinergic E10
δ E8-E15  (Pham et al., 1991; Rothman & Gershon, 
1982) 
NPY E13-E13.5  E10-E18  (Branchek & Gershon, 1989; Pham et al., 
1991) 
VIP E14  E10-P5  (Pham et al., 1991; Rothman et al., 1984) 
CGRP E17  E10-P3  (Branchek & Gershon, 1989; Pham et al., 
1991) 
* Radioactively labeled 5’HT can be detected in the gut at E12 but immunoreactivity to 5’HT is not found 
until E18 
δ Synthesis of radioactively labeled Ach from 
3H-choline is detected from E10 onwards but immunoreactivity 
to acetylcholine transporter (ChAT) cannot be detected until E18.5. 
As neuronal precursors loose their catecholaminergic phenotype they acquire properties 
of cholinergic, serotoninergic, nitregic or peptidergic terminally differentiated neurons. 
This has been suggested to involve changes in the microenvironment as the original 
catecholaminergic phenotype is maintained when the gut is cultured in vitro (Baetge et 
al., 1990b). Terminally differentiated enteric neurons can first be detected in the mouse 
gut on day E12. Among these are the serotoninergic neurons that express 5’-
hydroxytryptamine (5-HT) and nitrergic neurons, identified by the expression of nitric 
oxide synthase (NOS; (Branchek & Gershon, 1989; Rothman & Gershon, 1982). Using 
the synthesis of 
3H-acetylcholine (Ach) as a marker, cholinergic neurons were first 
detected from E10 to E12 (Rothman & Gershon, 1982) although immunoreactivity to 
acetylcholine transporter (vChAT) cannot be detected until E18.5 (Vannucchi & 
Faussone-Pellegrini, 1996). In embryonic mice, expression of neuropeptide Y (NPY) is, 
firstly, found at E13-13.5 (Branchek & Gershon, 1989), vasoactive intestinal peptide 
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(VIP) at E14 (Rothman et al., 1984) and calcitonin gene-related peptide (CGRP) at E17 
(Branchek & Gershon, 1989). 
 
Phenotypic characteristics of enteric neurons in the adult ENS 
 
In adult mice, NOS-immunoreactive neurons are inhibitory motor neurons to the muscle 
or descending interneurons and they represent around 29% of all neurons (Qu et al., 
2008; Sang & Young, 1996). Most NOS
+ neurons express VIP and a subset of these is 
also NPY
+ (Sang & Young, 1997). 5-HT expression is restricted to 1% of all neurons 
and these are descending interneurons that also express acetylcholine (Ach; (Sang & 
Young, 1996; Sang & Young, 1997). Ach is expressed in excitatory motor neurons, 
which comprise approximately 35% of all neurons, and in interneurons. Intrinsic 
sensory neurons represent about 26% of all neurons and express Ach, CGRP and 
calbindin (Furness, 2006; Qu et al., 2008). 
 
1.4.3.Enteric glial cells 
Morphology, localization and quantification of enteric glia 
 
In addition to neurons, the ENS contains a large number of supporting glial cells. These 
are small, star-shaped cells with numerous processes of various length and shape. 
Enteric glial cells are found in both myenteric and submucosal ganglia and in the 
interconnecting nerve strands. In the nerve strands, glial processes ensheat multiaxonal 
bundles whereas in the ganglia, glial cells are in close association with neurons 
(Fig.1.5). Unlike the satellite cells of sympathetic ganglia, enteric glia do not envelop 
neurons completely. Indeed, a characteristic feature of the enteric plexus is that the glial 
sheet that surrounds ENS neurons is incomplete and, as a result, portions of axons or 
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neuronal cell bodies can make direct contact with the extraganglionic connective tissue 
(Gabella, 1972).  
 
Figure 1.5. Ganglia of the myenteric plexus 
from the mouse  small intestine.  
Confocal microscope image (x400 
magnification) of a whole mount preparation 
of the myenteric plexus immunostained for 
the neuronal marker HuC/D (red) and the 
glial marker S100β (green). Glial cells are 
found in close association with neurons and 
in the interconnecting nerve strands between 
ganglia.  
 
Glial cells are more abundant than neurons. Quantification of these cells showed that 
the glia index, which describes the ratio of glial cells to neurons, increases with species 
size from 1.1 or 0.6 in mice to 7 or 1.9 in humans, in the myenteric and submucosal 
ganglia respectively (Gabella & Trigg, 1984; Hoff et al., 2008). The number of enteric 
glia decreases, however, with age. Age-related glial loss is accompanied by a 
proportional loss of enteric neurons but it is unclear whether enteric glia decay precedes 
or follows neuronal loss (Phillips et al., 2004). Changes in glial cell numbers were 
further observed in animal models of inflammation (Bradley et al., 1997; Bush et al., 
1998) as well as in patients with inflammatory bowel disease (Geboes & Collins, 1998; 
Storsteen et al., 1953). 
 
Phenotypic characteristics of enteric glia 
 
Glial precursors are first identified in the developing ENS at E11.5 by the expression of 
BFABP (Veerkamp & Zimmerman, 2001; Young et al., 2003). BFABP is found 
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exclusively in glial cells and its expression starts even before glial differentiation and so 
this is considered as a commitment marker for glial lineage (Young et al., 2003). Other 
markers that identify differentiated enteric glia are S100β (Ferri et al., 1982) and GFAP 
(Jessen & Mirsky, 1980; Jessen & Mirsky, 1983), both of which are typical of CNS 
astrocytes. S100 proteins are small, acidic Ca
2+-binding proteins, localized in the 
cytoplasm of glial cells where they regulate cytoskeletal structure and function as well 
as Ca
2+ homeostasis. In the gut of embryonic mice, S100β expression can be first 
detected at E14.5, exclusively in glial cells (Gershon & Rothman, 1991; Young et al., 
2003). GFAP identifies the intermediate filament found in cells of astroglial lineage.  In 
the gut, GFAP starts to be expressed at E16.5 and it is a specific glial marker. 
 
Physiological roles of enteric glia 
 
For some time, glial cells were seen as mere mechanical support elements, holding the 
various components of the ENS together. Indeed, during the mechanical activity of the 
muscularis externa there are changes in width and thickness of the ganglia as well as 
changes in shape of the individual neurons. Morphological data suggest that, by being 
firmly anchored to the surface of enteric ganglia and nerve strands through GFAP 
filaments, enteric glial cells stabilize the ENS (Gabella, 1981; Gabella, 1990; Hanani & 
Reichenbach, 1994). In addition, enteric glia actively respond to mechanical stimulation 
with enhanced expression of c-fos (Sharkey et al., 1999) and a rise in intracellular Ca
2+ 
levels (Zhang et al., 2003) which suggests that these cells may adjust for structural and 
metabolic changes resulting from mechanical stress in the gut wall. 
Besides providing structural support, increasing evidence suggest that enteric glia 
are actively involved in the control of gastrointestinal functions. The fundamental role 
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of enteric glia in the maintenance of ENS integrity was demonstrated by the study of 
transgenic mouse models in which enteric glial cells were conditionally ablated (Bush et 
al., 1998; Cornet et al., 2001). In these mouse models, ablation of enteric glia led to the 
disruption of the intestinal epithelium and vascular integrity resulting in fulminant 
intestinal inflammation, hemorrhage and necrosis. The breakdown of the intestinal 
epithelial barrier in the absence of enteric glia suggests that these cells are involved in 
maintaining mucosal barrier integrity. Also, the occurrence of early vascular lesions in 
the intestinal mucosa and submucosa following selective depletion of enteric glia 
indicates that these cells may be involved in the regulation of the vascular function of 
the gastrointestinal tract. Indeed, enteric glial processes can be found in the mucosal 
crypts and tips of the villi where they are in close proximity to epithelial cells and blood 
vessels but it is still unclear whether the direct contact between glial cells/processes and 
epithelial cells and blood vessels is required for maintaining epithelial and vascular 
integrity. Besides their role as a potential component of the mucosal defence system 
through the maintenance of the intestinal epithelial barrier, enteric glia have been shown 
to be involved in mucosal immune responses. Studies by Ruhl et al., (2001) showed that 
enteric glia can synthesise cytokines and respond to inflammatory insults (Ruhl et al., 
2001a). In accordance, an enhanced GFAP expression and increased proliferative 
capacity of glial cells was observed in animal models of intestinal inflammation and 
tissue samples from patients with inflammatory bowel disease (Bradley et al., 1997; 
Storsteen et al., 1953). Whether this proliferative response represents a phenomenon 
comparable to the neuroprotective reactive gliosis observed in the CNS is not known.  
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Ablation of enteric glia in genetically modified animals indicates that these cells 
may also be crucial for neuronal maintenance as their absence results in neuronal 
degeneration (Bush et al., 1998) and changes in the neurochemical coding and function 
of enteric neurons (Aube et al., 2006; Nasser et al., 2006). It has been proposed that 
enteric glia may promote neuronal survival by directly regulating substrate supply and 
extracellular homeostasis (Cabarrocas et al., 2003). As for the role of glia in the control 
of neurochemical phenotypes, is still unknown whether the actual presence of glia is 
required or whether enteric glia secrete factors which stabilize the neurochemical 
composition of the ENS but there is some evidence that neurotrophins may be produced 
by enteric glia to modulate neuronal gene expression and, eventually, enteric 
neurophenotypes (Hoehner et al., 1996). The crosstalk between glial cells and neurons is 
further underlined by recent studies demonstrating that glial cells respond to electrical 
stimulation or depolarization of enteric neurons with an increase of intracellular Ca
2+ 
(Gomes et al., 2009; Gulbransen & Sharkey, 2009).  
Despite the complex and diverse roles of enteric glial cells there is no 
gastrointestinal disorder for which an underlying glial defect has been established. 
Nonetheless, it is possible that subtle changes in glial function may be involved in the 
etiopathogenesis of gastrointestinal disorders. 
 
(Dis)similarities between peripheral extraenteric glia, enteric glia and CNS astrocytes 
 
Enteric glial cells share certain characteristics with two other distinct glial cell 
populations, namely Schwann cells and CNS astrocytes (Table1.2). Like Schwann cells, 
enteric glia are derived from the neural crest and are involved in the structural support of  
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Table1.2 Comparison of the properties of Schwann cells, enteric glia and astrocytes 
Phenotypic and 
functional 
characteristics 
Schwann cells  Enteric glia  CNS astrocytes 
Origin Neural  crest  Neural crest  Neuroectodermal 
Morphology Regular  shape; 
ensheath axons 
individually
A 
Small star-shaped cells; 
extension of processes 
ensheathing bundles of 
axons
A  
Small star-shaped cells 
Markers Ran-1
B; SMP
C; 
S100 β 
GFAP, Ran-2; vimentin, 
S100β
D 
GFAP, Ran-2; vimentin, 
S100β
D 
 
Response to injury 
 
de novo expression 
GFAP
E 
 
Hyperplasia; upregulation of 
GFAP
F 
Hypertrophy, hyperplasia, 
upregulation of GFAP and 
vimentin 
A (Gershon & Rothman, 1991); B (Jessen & Mirsky, 1983); C (Dulac et al., 1988); D (Cabarrocas et al., 
2003); E (Jessen & Mirsky, 1992); F (Bradley et al., 1997); SMP, Schwann cell myelin protein; GFAP, 
glial fibrillary acidic protein. 
peripheral nerve fibers. However, whereas in most peripheral nerves and ganglia 
Schwann cells envelop neurons and axons individually, in the ENS a single glial cell 
unsheathes several densely packed enteric neurons (Gershon & Rothman, 1991). In 
addition to these structural differences, enteric glia are phenotypically and 
morphologically distinct from Schwann cells. Enteric glia do not express characteristic 
markers of Schwann cells, such as Schwann cell myelin protein (SMP; (Dulac et al., 
1988) and Ran-1, and they exhibit a smaller cell body and more irregular shape 
(Gabella, 1981).  
Despite having a different origin, enteric glia display many morphological 
similarities with CNS astrocytes. Furthermore, these two subtypes share a number of 
molecular characteristics; just like CNS astrocytes, enteric glial cells express S100β 
(Ferri et al., 1982), glutamine synthase (Jessen & Mirsky, 1983), Ran-2 (Jessen & 
Mirsky, 1985) and GFAP (Jessen & Mirsky, 1980; Jessen & Mirsky, 1983). The 
51 
 General Introduction 
morphological and phenotypic resemblance between enteric glia and CNS astrocytes has 
led to the hypothesis that the two cell types may be functionally related.  
In the adult CNS, distinct astrocyte cell types have been identified. The neurogenic 
astrocytes are the direct descendants of embryonic radial glia cells (Merkle et al., 2004; 
Merkle et al., 2007) and reside within rare germinal niches where they function as 
neural stem cells, continually renewing the granular and periglomerular interneurons of 
the olfactory bulb (Doetsch et al., 1999) and granular neurons of the adult hippocampus 
(Seri et al., 2001). In addition to neurogenic astrocytes, fully differentiated postmitotic 
astrocytes can also assume a stem-like profile in response to injury. These cells, called 
reactive astrocytes, are found within and surrounding a brain lesion and they are 
characterized for being highly proliferative and for exhibiting an enhanced expression of 
GFAP, nestin and other stem cell markers (Buffo et al., 2008; Lin et al., 1995). In vitro 
these proliferative astrocytes behave as multipotent self-renewing neural stem cells 
suggesting that brain injury might induce astrocytes to resume highly controlled 
developmental programs for neurogenesis (Buffo et al., 2008). Similar to reactive 
astrocytes, an increased proliferation of enteric glial cells has been documented in an 
inflammation mouse model (Bradley et al., 1997) and in patients with inflammatory 
bowel disease (Geboes & Collins, 1998; Storsteen et al., 1953). Using Brd-U to identify 
cycling cells, in the myenteric ganglia, Bradley et al., (1997) showed that a few 
proliferative cells are normally present in the ganglia of adult guinea pig and that these 
are glial cells. These observations expand the observations of Gabella (1990) that enteric 
glia can divide for some time after birth even when neurons have ceased to do so. 
However, the number of proliferative glia increases significantly with inflammation 
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suggesting that glial cells are able to respond to inflammatory mediators. Indeed, Ruhl 
and colleagues showed that the immunosuppressive cytokine IL-10 enhances 
proliferation of enteric glia (Ruhl et al., 2001b). Which cytokines are involved in the 
glia response to inflammation is unknown. In addition, the biological significance of this 
response is still unclear. 
 
1.4.4.Enteric neural stem cells 
Identification of enteric neural stem cells 
 
There are two main types of neural stem cells, CNS stem cells and NCSCs. CNS stem 
cells are defined by their ability to give rise to the neurons, astrocytes and 
oligodendrocytes of the brain (Temple & Alvarez-Buylla, 1999). NCSCs are defined by 
their ability to give rise to neurons and glia of the PNS (Morrison et al., 1999; Stemple 
& Anderson, 1992). As part of the PNS, the ENS is derived from NCSCs.  
Most, if not all, the cells that invade the foregut mesenchyme are multipotent self-
renewing NCSCs (Lo & Anderson, 1995; Rothman et al., 1990). At this point, eNCSCs 
express a number of markers that are valuable for their identification. Analysis of the 
expression profile of eNCSCs from E10.5-E13.5 mice showed that these cells express 
Sox10, Phox2b, p75 and RET (Anderson et al., 2006b; Young et al., 1999). However, 
expression of these markers is not exclusive of eNCSCs. For example, Sox10, Phox2b 
and p75 are expressed in enteric glial cells whereas RET expression is maintained in 
enteric neurons (Corpening et al., 2008; Young et al., 2003). The lack of specific and 
unique markers for eNCSCs makes their positive identification in vivo rather difficult. 
For that reason, the presence of these cells has been ascertained by their behaviour in 
culture. A number of different strategies have been used to isolate eNCSCs (Table1.3). 
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For instance, self-renewing multipotential progenitors of the ENS have been isolated 
from the gut of foetal, newborn and adult rodents using cell-surface markers, such as 
RET (Lo & Anderson, 1995; Natarajan et al., 1999) or p75 (Bixby et al., 2002; Kruger 
et al., 2002). In vitro clonogenic assays and in vivo engraftment of these cells showed 
that they are capable of generating both neurons and glial cells. eNCSCs have also been 
identified by culturing either a mixed population of gut cells (Schafer et al., 2003; 
Suarez-Rodriguez & Belkind-Gerson, 2004) or myenteric ganglion cells in isolation 
from the surrounding non-neuronal tissues (Saffrey et al., 2000; Schafer et al., 1997; 
Silva et al., 2008), in conditions that favour growth of cells of interest. In these studies, 
the presence of eNCSCs in culture was suggested by the expression of the neural 
progenitor marker nestin (Silva et al., 2008; Suarez-Rodriguez & Belkind-Gerson, 2004) 
and the formation of neurospheres (floating spherical colonies characteristic of neural 
stem cells) (Schafer et al., 2003); Silva et al., 2008) Using an approach that does not 
depend on expression of cell surface or intracellular markers, Bondurand et al. (2003) 
isolated eNCSCs using cultures of dissociated gut or outer muscle layers and retrovirus-
mediated gene transfer. In vitro, these cells were shown to undergo progressive 
differentiation thereby generating glial cells and different neuronal subtypes as indicated 
by the expression of TH, VIP, NPY and CGRP. eNCSCs have also been isolated from 
neurospheres obtained from foetal and postnatal bowel of surgical or post-mortem 
specimens in humans (Rauch et al., 2006). Despite the contribution of these reports to 
the better understanding of the properties of eNCSCs, the lack of markers and genetic 
lineage tools to follow the fate of these cells efficiently has hindered the study of this 
population in vivo. 
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Table1.3 Summary of strategies used to isolate eNCSCs. 
 
Source Selection 
method 
Multipotency Self-renewal 
capacity 
References 
Embryonic 
mouse gut 
Sort of RET
+ cells   
yes 
 
ND 
(Lo & Anderson, 1995; 
Natarajan et al., 1999) 
Embryonic/post
natal rat gut 
Sort of 
p75
+αintegrin4
+ 
cells 
 
yes 
 
+ 
 
(Bixby et al., 2002) 
Embryonic/post
natal mouse gut 
Culture of 
dissociated gut 
 
ND 
formation of 
neurospheres 
 
(Schafer et al., 2003) 
Embryonic/post
natal mouse gut 
Infection with 
GFP-containing 
retrovirus 
 
yes 
 
yes 
 
(Bondurand et al., 
2003) 
Postnatal rat gut  Culture of isolated 
myenteric ganglia 
 
ND 
Nestin+ cells; 
formation of 
neurospheres 
 
(Silva et al., 2008) 
 
Postnatal/adult 
mouse gut 
 
Culture of 
dissociated gut  
 
ND 
Nestin+ cells; 
formation of 
neurospheres 
 
(Suarez-Rodriguez & 
Belkind-Gerson, 2004) 
Postnatal/adult 
rat gut 
 
Sort of p75
+ cells 
 
yes 
 
yes 
 
(Kruger et al., 2002) 
 
Infant human 
gut 
 
Culture of isolated 
myenteric ganglia 
 
ND 
Nestin+ cells; 
formation of 
neurospheres 
 
(Rauch et al., 2006) 
ND, not determined; + positive 
 
Temporal changes in the properties of enteric neural stem cells 
 
A number of studies have highlighted the changes in the function of stem cells and other 
progenitors with age in diverse tissues, including the haematopoietic system, muscle and 
brain (Wagers & Weissman, 2004). These age-related differences have been associated 
with changes in the microenvironment but also with cell-intrinsic changes in the stem 
cells. In the case of neural stem cells, changes in the proliferative abilities, self-renewal 
and differentiation potential have been documented (Kruger et al., 2002; White et al., 
2001). Clonal analysis of p75-sorted cells showed that eNCSC isolated from postnatal 
and adult animals generate colonies with fewer cells than the colonies from embryonic 
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eNCSCs. Moreover, cell cycle analysis revealed that cultures derived from the gut of 
postnatal mice contain less mitotically active cells than cultures from the gut of E14.5 
embryos (Kruger et al., 2002). Similar results were obtained when eNCSCs were 
isolated using a retroviral approach (Bondurand et al., 2003). Selecting for proliferating 
cells, Bondurand et al. (2003) reported that ENS cells isolated from postnatal gut give 
rise to smaller neurosphere-like bodies, containing almost half of the proliferating cells 
present in the neurospheres from embryonic gut.  
Besides changes in proliferation, NCSCs also undergo temporal changes in self-
renewal and neuronal subtype potential (Kruger et al., 2002; Qian et al., 2000; White et 
al., 2001). Kruger et al. (2002) cultured p75
+ eNCSCs isolated from E14.5 and P22 mice 
and showed that E14.5 eNCSCs exhibit a higher self-renewal potential than P22 
eNCSCs. In terms of neurogenic potential, cultured postnatal eNCSCs were shown to be 
less responsive to the neurogenic factor BMP4 than E14.5 eNCSCs. Conversely, 
eNCSCs become more responsive to the gliogenic effects of soluble Notch ligand Delta-
Fc with increasing time after birth. This change in the responsiveness to factors in the 
microenvironment is likely to occur in vivo since, upon transplantation into developing 
peripheral nerve, E14.5 eNCSCs generate mainly neurons (Bixby et al., 2002) whereas 
postnatal eNCSCs generate mainly glia (Kruger et al., 2002). 
 
Adult CNS and ENS neural stem cells 
 
An increasing body of evidence has accumulated in recent years supporting the 
existence of adult stem cells in a large number of tissues. Interestingly, these cells are 
not only present in the hematopoietic system, intestine and skin, which have rapid 
physiological turnover rates, but also in organs with slow physiological cell turnover 
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rates that would be expected to have extremely poor ability to regenerate, including the 
CNS (Morrison & Spradling, 2008).  
During development, CNS neuroepithelial cells become radial glia by acquiring 
some glial features. This cell type was long thought as specialized glia that guides 
neuronal migration along the radial fibers, but recent studies revealed that these are 
embryonic neural stem cells (Alvarez-Buylla et al., 2001; Anthony et al., 2004). Radial 
glia undergo many rounds of asymmetric cell divisions forming one radial glial cell and 
one neuron from each cell division. After production of neurons, radial glial cells finally 
give rise to glial cells such as astrocytes and oligodendrocytes. From this point onwards, 
active neurogenesis becomes restricted to two discrete regions: the subventricular zone 
(SVZ) of the lateral ventricles in the forebrain and the subgranular layer (SGL) of the 
hippocampal dentate gyrus (Alvarez-Buylla et al., 2001). The identity (or identities) of 
adult neural stem cells in the CNS has been under debate. The prevailing model based 
on a series of genetic tracing, pharmacological ablation, and morphological and 
immunocytochemistry analysis suggests that special astrocytes are the adult NSCs in the 
SVZ and SGL (Alvarez-Buylla et al., 2001). These astrocytes are the direct descendants 
of embryonic radial glia (Merkle et al., 2004) and they exhibit radial glial properties. 
For example, they express GFAP and, unlike mature cortical astocytes, they maintain a 
thin process tethering them to the lateral ventricular wall and ventricular cavity. Despite 
sharing a number of features with radial glial cells, NSCs of the adult CNS show 
different developmental properties. Indeed, adult neurogenesis exhibits a more 
prolonged time course of neuronal maturation (Ge et al., 2006) and, unlike postnatal 
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neurogenesis, is dynamically regulated by stimuli that modulate the activity of the 
existing neuronal circuitry (Parent et al., 1997).  
Even though, ongoing neurogenesis in the intact mammalian brain is restricted to the 
SVZ and SGL, multipotent NSC capable of long term self-renewal and generating 
multiple neural lineages have been derived from regions throughout the adult CNS 
(Ming & Song, 2005). Whether and to what extent active neurogenesis occurs in these 
regions under physiological conditions is still unknown, but injuries and pathological 
stimuli such as stroke appear to activate the neurogenesis program outside of neurogenic 
regions (Ming & Song, 2005). For example, Carlen et al. (2009) showed that, upon 
injury CD133
+ ependymal cells lining the ventricles in the mammalian forebrain can be 
activated to function as adult neural stem cells. Also, postmitotic astrocytes have been 
shown to resume stem cell properties in response to injury. Buffo et al. (2008) showed 
that following brain damage, mature astrocytes, referred to as reactive astrocytes, 
resume proliferation and undergo a number of morphological and phenotypic changes, 
such as hypertrophy of their somata and processes (Wilhelmsson et al., 2006), increased 
synthesis of GFAP and re-expression of the progenitor markers vimentin and nestin (Lin 
et al., 1995; Sofroniew, 2005). These changes in astrocytes are accompanied by the 
acquisition of stem cell properties as astrocytes acquire the capacity to form multipotent 
and self-renewing neurospheres in vitro. In vivo, reactive astrocytes do not contribute to 
the neuronal population, probably due to the antineurogenic environment present in the 
adult brain parenchyma (Hampton et al., 2007; Yamamoto et al., 2001). These studies 
have contributed to strengthen the hypothesis that, after brain injury or disease, the 
release of growth factors, cytokines and other factors from at-risk or dying cells, in 
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addition to vascular- and immune-related elements might support a reactive cyto- or 
neurogenesis. Also, these studies suggest that distinct cells in the adult CNS can serve as 
NSC in mediating neurogenesis under normal conditions or after dramatic injuries as 
highlighted by the identification of different cell types with neural stem cell properties. 
In the PNS, the presence of adult neural stem cells has been demonstrated in 
mammalian olfactory neuroepithelium (Calof et al., 1998) and in the neural crest-
derived carotid body (Pardal et al., 2007). Studies by Pardal et al. (2007) showed that 
the carotid body harbours cells that are quiescent under normoxia but that can be 
activated in the context of the homeostatic adaptative response to chronic hypoxia. Thus, 
upon exposure to hypoxia, the carotid body that does not support ongoing neurogenesis 
increases in size due to the generation of new neurons. In vivo neurogenesis in this organ 
was shown to depend on the activation of a resident population of glial cells that in 
culture form multipotent self-renewing colonies. In response to hypoxia, these GFAP
+ 
glia cells are converted into actively proliferating GFAP
-  nestin
+ intermediate 
progenitors that give rise to mature neurons.  
In the adult ENS, the presence of neural stem cells in vivo has never been 
demonstrated and active neurogenesis is not known to occur under physiological 
conditions. However, eNCCs capable of long term self-renewal and of generating 
multiple neural lineages have been derived from the gut of adult animals suggesting that 
the adult ENS harbours progenitor cells (Kruger et al., 2002; Suarez-Rodriguez & 
Belkind-Gerson, 2004). This is further corroborated by evidence from injury models 
suggesting that enteric neural precursors that are probably quiescent in the adult gut may 
be stimulated to proliferate and differentiate in response to stimuli, such as injury, 
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contributing to the regeneration of the adult ENS (Filogamo & Cracco, 1995; Hanani et 
al., 2003; Ramalho et al., 1993). The identity of these cells and whether they constitute a 
permanent undifferentiated pool or are recruited in a regular basis is unknown. In 
addition, the potential role of these cells in normal intestinal physiology and in states of 
disease or injury is still unclear. 
1.5. Neurogenesis in the Enteric Nervous System 
Enteric neurons appear early during ENS development, soon after invasion of the 
foregut mesenchyme by eNCSCs, as evidenced by the detection of pan-neuronal 
markers (Baetge & Gershon, 1989; Young et al., 1999). However, different types of 
neurons appear at different stages of development (Branchek & Gershon, 1989); 
(Rothman & Gershon, 1982; Rothman et al., 1984) and some of them only at postnatal 
stages (Matini et al., 1997; Vannucchi & Faussone-Pellegrini, 1996). Furthermore, there 
is an increase in the number of enteric neurons until well after birth (Ali & McLelland, 
1979; Gabella, 1971; Liu et al., 2009). eNCSCs are, thus, thought to maintain their 
neurogenic potential for a long period but little is known about the rate and extent of 
neurogenesis in the ENS. 
 
1.5.1.Neurogenesis in the embryonic and postnatal ENS 
The timing of neurogenesis in the ENS has been documented in two birth-dating studies 
(Table1.1; (Chalazonitis et al., 2008; Pham et al., 1991). Unlike CNS neuronal 
precursors, enteric neuroblasts continue to divide after expressing pan-neuronal markers 
(Baetge et al., 1990a; Young et al., 2005) and so the birth date of an enteric neuron is 
defined as the stage at which the neuronal precursor exits the cell cycle. Pham et al. 
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(1991) determined the birth-date of specific subclasses of enteric neurons by providing a 
pulse of tritiated thymidine to timed pregnant or postnatal mice (Pham et al., 1991). 
Later, labelled nuclei were sought in different neuronal subtypes of the ENS. This 
revealed that the birth date of the different neuronal subtypes does not reflect the 
developmental stage at which they express specific markers at detectable levels for the 
first time. The time window during which each neuronal subtype exits the cell cycle is 
long, with major overlaps between the different types of neurons, thus suggesting that 
many neurons of all types are ceasing mitosis and differentiating simultaneously in the 
same gut region and probably in the same ganglia. Nevertheless, the birth of enteric 
neurons of different phenotypes occurs in sequential waves suggesting that generation of 
a specific class of enteric neurons may influence the formation of subsequent ones. It is 
presently unclear whether this pattern is due to a systematic change in the potential of 
eNCSCs/neuronal precursors during enteric neurogenesis or to the presence of multiple 
distinct pools of progenitors/precursors each generating a particular neuronal subtype.  
Interestingly, some enteric neuronal precursors, more specifically cholinergic and 
serotoninergic neuronal precursors, were shown to exit the cell cycle as early as E8, 
before invasion of the foregut mesenchyme (Pham et al., 1991). Peptidergic neurons 
were shown to be firstly born at around day E10, as the cells first enter the gut whereas 
NOS, calbindin and (GABA)ergic neurons withdraw from the cell cycle from E12.5 
onwards (Chalazonitis et al., 2008). All subclasses of myenteric neurons are born during 
fetal life except for VIP- and CGRP- expressing neurons, which were shown to be born 
during the first postnatal weeks. In fact, the last cells to withdraw from the cell cycle in 
the mouse myenteric plexus were VIP-expressing neurons, born at P5 (in the myenteric 
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plexus) or at P14 (in the submucosal plexus). These findings suggest that new neurons 
are added to the enteric plexuses after birth, when the gut has already become functional 
and, thus, maturation of the ENS is likely to continue long after embryogenesis. Because 
the mentioned birth dating studies are based on the incorporation of markers by enteric 
neuroblasts little is known about the population of multipotent, undifferentiated cells of 
the ENS and so the question of how long eNCSCs persist in the gut and how their 
neurogenic potential changes over the course of ENS development remains unanswered. 
 
1.5.2.Neurogenesis in the adult ENS 
Neurogenesis in the CNS was thought to be restricted to embryogenesis. However, 
recent studies showed unequivocally that neurons are born throughout life, particularly 
in the SVZ of the lateral ventricles and SGL of the dentate gyrus of the hippocampus 
(Alvarez-Buylla & Lim, 2004). Unlike the SVZ and SGL, active neurogenesis has not 
been detected in the adult mammalian ENS under physiological conditions. Birth-dating 
studies were unable to demonstrate neurogenesis in the ENS of adult mice and so the 
birth of enteric neurons is thought to occur exclusively during embryonic and early 
postnatal stages (Chalazonitis et al., 2008; Pham et al., 1991). Nevertheless, a number of 
cell culture studies showed that self-renewing progenitors capable of generating enteric 
neurons and glia can be isolated not only from embryonic gut but also from post-
neurogenic adult intestine (Kruger et al., 2002; Suarez-Rodriguez & Belkind-Gerson, 
2004). Using flow-cytometry, Kruger et al. (2002) isolated the 1-2% of cells that 
expressed highest levels of p75 from the gut of P5 to P110 rats. In culture, these cells 
were able to self-renew, proliferate and differentiate into neurons, glia and 
myofibroblasts suggesting the persistence of a population with neural stem cell 
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properties in the adult gut. Similar results were obtained by Suárez-Rodriguez and 
Belkind-Gerson, who found that in vitro, multipotent, proliferating cells isolated from 
the ENS of lactating and adult mice express stem cell markers, such as vimentin and 
nestin. The neurogenic potential of these cells in vivo and their functional significance in 
the adult gut is still unknown. However, these studies raise the possibility that a 
population of eNCSCs may persist in the adult ENS but become dormant due to cell-
intrinsic changes or extrinsic factors in the progenitor microenvironment.  
Changes in the niche following injury have been shown to activate neurogenesis in a 
number of systems (Carlen et al., 2009; Czaja et al., 2008; Ooto et al., 2004).  In the 
adult ENS, new enteric neurons have been shown to be generated and added to enteric 
ganglia when 5-HT agonists are provided (Liu et al., 2009). Liu et al. (2009) 
demonstrated that there is a physiological increase in the number of enteric neurons 
during the first 4 months after birth and this is 5-HT dependent. From that time point 
onwards there is an age-dependent decline in the number of neurons. However, 
activation of 5-HT receptors by appropriate agonists in adult mice is able to promote 
generation of new neurons that are incorporated into enteric ganglia. Interestingly, the 
progenitors of such newly generated neurons are located in germinal niches that lie in 
the vicinity but outside the myenteric plexus. The identity of such progenitors and the 
mechanisms that drive their neuronal maturation and their migration towards the enteric 
ganglia are still unknown.  
Neurogenic changes have also been reported in several injury models (Filogamo & 
Cracco, 1995; Hanani et al., 2003; Jew et al., 1989; Luck et al., 1993; Ramalho et al., 
1993; Tokui et al., 1994). Incomplete stenosis of the gut has been shown to result in 
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smooth muscle hypertrophy and a significant increase in the size and number of 
ganglionic cell bodies of the myenteric and submucosal plexus (Filogamo & Cracco, 
1995). This increase was reported to occur in the absence of mitotic nerve cells and so it 
was attributed to the differentiation of previously dormant postmitotic cells. 
Interestingly, Tokui et al. (1994) showed that after partial resection and reanastomosis of 
the intestine of the guinea pig, there is a time-dependent increase in the number of 
extraganglionic neurons in the areas adjacent to the lesion. Eventually, these ectopic 
neurons reach the lesion area where they form small clusters. Whether these ectopic 
neurons emerge de novo or migrate from adjacent ganglia is unclear. Another 
experimental model that has suggested neurogenesis in the adult ENS consists of the 
denervation of the gut using benzalkonium chloride (BAC; (Hanani et al., 2003; 
Ramalho et al., 1993). BAC is a cationic detergent that can cause severe cell damage. 
When high concentrations of BAC are applied to the intestinal serosa it causes 
generalized tissue damage, including disruption of the smooth muscle, lymphocytic 
infiltration, intestinal perforation and death. At lower concentration, this detergent can 
be used to selectively destroy the myenteric plexus without damaging the submucosal 
plexus or the smooth muscle (Fox et al., 1983; Ramalho et al., 1993; Sato et al., 1978). 
BAC has been used to generate animal models of aganglionosis (Sakata et al., 1979; 
Sato et al., 1978; Yoneda et al., 2002) and also to study the regenerative capacity of the 
ENS (Cracco & Filogamo, 1993; Hanani et al., 2003; Luck et al., 1993; Ramalho et al., 
1993). A time course analysis of the morphological changes in the myenteric plexus 
after BAC application was carried out by Hanani et al. (2003). This showed that, 2 days 
after BAC treatment, neurons are efficiently ablated from the treated area. However, by 
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day 7, the denervated region is invaded by regenerating nerve fibers, closely associated 
with glial cells. Moreover, from day 30 onwards, undifferentiating cells were identified 
around the treated area by electron microscopy.  In light of these results, the authors 
postulated that quiescent eNCSCs persist in the adult ENS and may be stimulated to 
proliferate and differentiate in response to stimuli, such as injury. This is further 
supported by studies of Williams and Jew (1991), who proposed that the differentiation 
of neural crest-derived precursors can be triggered by diffusible factors originated from 
the intestinal wall treated by the BAC where profound degenerative and regenerative 
processes take place. The existence of diffusible factors that stimulate neuronal 
differentiation can be deduced also by the observation that the PC12 cells transplanted 
in the intestinal wall of BAC treated animals rapidly give rise to long filaments and 
differentiate into mature neurons (Filogamo & Cracco, 1995). 
Further evidence for neurogenesis in the adult ENS comes from clinical studies.  In 
ulcerative colitis and Crohn’s disease, for example, neurodegeneration as well as an 
increase in both the size and number of neurons in the adult ENS have been described 
(Davis et al., 1955; Nadorra et al., 1986; Siemers & Dobbins, 1974; Storsteen et al., 
1953). Whether the increased number of neurons is related to the underlying cause of 
inflammation or is a secondary phenomenon due to the altered environment produced by 
inflammation is not known but it is interesting that serotonin availability, which has 
been shown to increase in inflammation murine models (Linden et al., 2003) has 
recently been linked to neurogenesis in the adult ENS (Liu et al., 2009). 
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1.5.3.Changes in enteric neurons with aging 
Unlike other parts of the nervous system, the ENS undergoes non-pathological age-
related neurodegeneration. Age-associated neuronal loss has been described in humans 
and rodents and it occurs in both the myenteric and submucosal plexus (Cowen et al., 
2000; de Souza et al., 1993; Gabella, 1989). In a detailed study carried out in rats, 
Philips and Powley (2001) found a linear rate of loss of myenteric neurons with 
increasing age starting in 12 month old animals. This decrease was dependent on the 
diet as rats maintained on an unrestricted diet lost about 50% of the myenteric neurons, 
whereas 4 and 24 month-old rats on a restricted diet had the same number of neurons 
(Cowen et al., 2000). Age-related loss of enteric neurons has been linked to an increase 
in the intraneuronal levels of reactive oxygen species (ROS; (Thrasivoulou et al., 2006). 
Thrasivoulou et al. (2006) further showed that neurotrophic factors, in particular GDNF, 
protect neurons against ROS-induced cell death by reducing ROS levels, an effect that is 
enhanced in diet restriction conditions. Interestingly, evidence suggests that age-
associated neuronal loss does not affect all neuronal subtypes equally. In fact, the loss of 
myenteric neurons is selective and it affects predominantly cholinergic neurons while 
nitrergic neurons are spared (Phillips et al., 2003; Wade & Cowen, 2004). The 
mechanisms underlying this selective vulnerability are poorly understood. In addition, it 
is still unclear how age-related changes in intestinal innervation affect gastrointestinal 
function but it is likely that these changes may compromise its effectiveness and maybe 
account, to some extent, for the gastrointestinal disorders that frequently affect the 
elderly, such as dysphagia, gastrointestinal reflux and constipation. 
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1.6.  Diseases of the Enteric Nervous System 
The ENS is involved in monitoring fundamental activities of the gut wall and so 
abnormalities in this system lead invariably to a more or less severe gastrointestinal 
dysfunction. Enteric neuropathies form the basis for a large proportion of digestive 
diseases (Di Nardo et al., 2008; Furness, 2008); they can be congenital or acquired and 
the underlying defect can range from subtle changes in the cellular composition of 
ganglia or connectivity of enteric neurons to complete absence of the enteric plexi from 
entire segments of the bowel.  
 
1.6.1.Hirschsprung’s disease and other congenital enteric neuropathies 
The most common and best understood congenital enteric disorder is Hirschsprung’s 
disease (HSCR). HSCR affects approximately 1 in 5000 newborns (Chakravarti, 2001) 
and it is associated with the absence of enteric ganglia in the most distal part of the 
intestine, although the extent of the aneural region is very variable. The functional 
characteristic of the disease is intestinal obstruction caused by the localized inability of 
the gut to transmit a motile relaxation and contraction (peristaltic) wave. As a 
consequence, the segment of the bowel proximal to this becomes grossly distended by 
faecal accumulation and this is termed megacolon.  
In a significant proportion of HSCR cases, abnormalities of ENS structure or 
function are not restricted to the aganglionic region. The area proximal to the 
aganglionic segment is called the transition zone and it can exhibit hypoganglionosis 
(White & Langer, 2000) or, conversely, hyperganglionosis (Schmittenbecher et al., 
1999; Szabolcs et al., 1996). Abnormalities in the transition zone, such as decrease in 
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the density of myenteric neurons and changes in neurotransmitter expression, have been 
reported also in mouse models of HSCR (Roberts et al., 2008; Sandgren et al., 2002). 
Infants with HSCR often exhibit severe constipation, growth failure and are at risk 
of dying from the complications of toxic megacolon (Swenson, 2002). The current 
treatment for HSCR is surgical resection of the aganglionic segment of the bowel but 
intestinal dysfunction may persist after surgery ranging from severe constipation to 
faecal incontinence (Thapar, 2009). It is presently unclear whether the post-operative 
morbidity is related to the surgery or to the potentially abnormal function of the residual 
ENS associated with the primary defect that initially caused aganglionosis.  
HSCR is a complex trait with a strong genetic component and great phenotypic 
variability pointing to considerable influences from environment and modifying genetic 
factors. Several genes have been found to be mutated in association to this intestinal 
disorder. Some of the identified mutations are sporadic, others are inherited, in which 
case inheritance in non-mendelian, suggesting that HSCR is a multifactorial disease. In 
most cases it occurs as an isolated trait (70%; (Amiel & Lyonnet, 2001) but it can also 
occur as part of a number of syndromes consisting of various congenital abnormalities, 
such as congenital central hypoventilation syndrome and a variant of Shah-Waardenburg 
syndrome (WS4). These abnormalities usually involve systems developmentally related 
to the neural crest and so HSCR is regarded as a neurocristopathy (Bolande, 1997).  
Animal models of HSCR have contributed significantly to the identification and 
functional analysis of genes underlying HSCR. Indeed, HSCR-like phenotypes have 
been reported in a wide array of organisms, including horse, pig, rat and mouse. In each 
of these cases, a single-gene mutation is the cause of congenital megacolon and the 
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extent of ENS absence varies between the different animal models. Mutations in the c-
Ret gene that lead to inactivation of the receptor tyrosine kinase RET have been shown 
to be central to the genesis of HSCR. Homozygous Ret-null mice show total absence of 
the ENS from all regions of the gastrointestinal tract except the esophagus. Similarly, 
mutations in other components of the RET signalling cascade such as gdnf also 
contribute to HSCR (Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996).  In 
humans, the c-Ret gene is the most frequently affected (Edery et al., 1994). 
Heterozygous mutations in this gene alone or in combination with alterations in other 
loci account for 15-35% of patients with sporadic HSCR and approximately half of all 
congenital HSCR cases (Brooks et al., 2005; Chakravarti, 2001). Furthermore, recent 
analysis of non-coding mutations in RET suggests that mutations in this gene are more 
frequent than previously thought and these may confer susceptibility in all HSCR cases 
(Chakravarti, 2001; Emison et al., 2005; Griseri et al., 2007).  
Another signalling pathway that is known to have a key role in ENS development is 
the EDNRB/ET-3 system.  Mice carrying mutations in EdnrB or Edn3 (gene that 
encodes ET-3) exhibit aganglionosis and pigmentation defects (Baynash et al., 1994; 
Hosoda et al., 1994). Similarly, heterozygous mutations in EDN3 and EDNRB have 
been identified in HSCR patients and these comprise approximately 5% of all HSCR 
cases (Amiel & Lyonnet, 2001).  
HSCR can also be caused by alterations in transcription factors or co-factors in 
eNCCs. For example, mice carrying Sox10 mutations exhibit aganglionosis and 
hypopigmentation (Kapur, 1999; Southard-Smith et al., 1998). In humans, mutations in 
this locus are associated with HSCR in Waardenburg syndrome (Waardenburg-Shan 
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syndrome; WS4; (Pingault et al., 1998; Southard-Smith et al., 1998) and accounts for 
less than 5% of HSCR cases.  
HSCR is the easiest congenital enteric neuropathy to diagnose because of the 
complete absence of enteric neurons from affected regions. However, other congenital 
disorders may involve a more restricted neuron loss or even loss or phenotype change of 
specific subtypes of neurons (De Giorgio et al., 2004). A peculiar neuropathological 
pattern with restricted neuronal loss is observed in hypertrophic pyloric stenosis 
(Vanderwinden et al., 1992). This disease is associated with the specific loss of 
inhibitory innervation of the pyloric sphincter. In contrast, some congenital disorders are 
characterized by an increase in the number of neurons. For example, grossly enlarged 
ganglia (ganglioneuromatosis) and increased number of ganglion cells (King et al., 
2006; Smith et al., 1999) is observed in tissue samples of patients with Multiple 
Endocrine Neoplasia type 2B (MEN 2B). MEN2A and MEN2B are rare hereditary 
syndromes associated with mutations in c-RET (Grieco et al., 1990; Mulligan et al., 
1993). Most patients exhibit mucosal neuromas, pheochromocytomas and medullary 
thyroid carcinoma, and some also experience gastrointestinal motility problems, 
including constipation and intestinal obstruction (King et al., 2006). Another congenital 
bowel condition that is functionally consistent with a developmental disturbance of ENS 
formation is Intestinal Neural Dysplasia type B (INDB). INDB has been described as a 
condition in which there is an increase in the number of neurons per submucosal 
ganglion, an increase in the number of submucosal neurons and ectopic ganglia in the 
muscularis mucosae and lamina propria (Meier-Ruge et al., 2004). Currently, diagnosis, 
treatment, and even existence of INDB as a distinct clinical identity, are controversial 
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and this is largely related to the difficulties associated with diagnosing quantitative 
changes in the ENS given the variability in ENS density between different regions of the 
intestine and different individuals (Cord-Udy et al., 1997; Koletzko et al., 1999). 
Interestingly, inflammatory cells have been described in the intestinal plexus of INDB 
patients. In CNS injury responses, inflammatory cells are known to secrete brain-
derived neurothophic factor (BDNF) and GDNF, which are active in promoting nerve 
growth (Batchelor et al., 2000). Whether a similar mechanism accounts for hyperplasia 
in the ENS in the context of INDB is unknown. 
 
1.6.2.Other ENS disorders  
Besides the developmental defects, the ENS can also be subject to injury. In fact, unlike 
the highly protected CNS, throughout life the ENS is exposed to pathogens, toxins, 
allergens and other potential insults that may result in ENS damage. 
10 to 20% of adults suffer from diseases involving the ENS, most notably irritable 
bowel syndrome (IBS; Ehrenpreis, 2005). IBS is a functional disorder associated with 
hyperactivity of the sensory nerve fibers and altered bowel motility (Camilleri & Choi, 
1997; Drossman, 1999). Even though IBS is not an inflammatory disease, a high 
proportion of cases can be traced back to an inflammatory episode (Neal et al., 1997; 
Spiller, 2003). Furthermore, the incidence of IBS increases following inflammation 
suggesting that inflammatory process can cause long-term changes in neuromuscular 
function that persist beyond the period of inflammation and may contribute to the 
symptoms of IBS (Sharkey & Kroese, 2001). The relation between inflammation and 
changes in the number, phenotype and/or function of enteric neurons is further 
confirmed by the documented effects of inflammation on enteric neurons in the context 
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of Inflammatory Bowel Diseases (IBD; (Davis et al., 1955; Geboes & Collins, 1998; 
Lomax et al., 2005; Nadorra et al., 1986; Siemers & Dobbins, 1974).  
IBD (i.e., ulcerative colitis and Crohn’s disease) are recurrent inflammatory 
disorders of the gastrointestinal tract. Early histopathological studies in adult Crohn’s 
ileitis patients, reported hypertrophy and hyperplasia of neurons and nerve fibers (Davis 
et al., 1955; Nadorra et al., 1986; Siemers & Dobbins, 1974). In contrast, in murine 
models of acute colitis, neuronal loss (Lin et al., 2005; Sanovic et al., 1999) and 
proliferation of glial cells (Bradley et al., 1997) has been reported in association with 
inflammation. In addition to changes in neuronal numbers, alteration of the 
neurochemical coding of enteric neurons have also been shown in Crohn’s disease 
patients (Boyer et al., 2007; Kimura et al., 1994) and in animal models of inflammation 
(Galeazzi et al., 2000; Lin et al., 2005).  
The ENS can also be damaged in the context of some forms of chronic disease, 
such as Parkinson’s disease (Micieli et al., 2003; Wakabayashi & Takahashi, 1997) and 
diabetic neuropathy (Vinik et al., 2003).   
 
1.6.3.Transplantation models 
Given the often unsatisfactory outcome of the available treatments for ENS defects, in 
particular HSCR, a number of investigators have suggested that therapeutic strategies, 
based on the replacement of missing or malfunctioning enteric ganglia, could play an 
important role in restoring functionality of aganglionic bowel (Thapar, 2009). Early 
avian grafting experiments have demonstrated the potential for cells to emigrate from 
grafts of embryonic gut tissue and to colonise and differentiate in the host gut (Rothman 
et al., 1990). Since then, a series of transplantation studies have been carried out. 
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Natarajan et al. (1999) grafted Ret
+ cells isolated from dissociated embryonic mouse gut 
into the wall of the stomach anlagen of cultured embryonic guts from wild-type and Ret-
null mice. The grafted cells were shown to proliferate extensively and to generate 
neurons and glia (Natarajan et al., 1999). Also using bowel explants, Bondurand et al. 
(2003) reported that transplanted enteric progenitor cells have the potential to generate 
differentiated progeny that localized within the intrinsic ganglionic plexus (Bondurand 
et al., 2003). Similarly, p75
+ eNCSCs cells microinjected into the trunk neural crest 
migratory route of developing chick embryos (Kruger et al., 2002) or into wild-type or 
aganglionic HSCR mouse model intestine (Kruger et al., 2003) gave rise to neurons and 
glia. More recently, NCSCs were also successfully transplanted into the peritoneal space 
of postnatal Sox10 mutant animals (Martucciello et al., 2007). Whether transplanted 
cells can be integrated in the endogenous enteric functional circuits is not clear. 
However, recent findings suggest that transplanted cells may be able to contribute to 
gastrointestinal function (Liu et al., 2007; Micci et al., 2001; Micci et al., 2005). Using 
CNS-derived stem cells, Micci et al (2005) grafted the gastric antrum of NOS-deficient 
mice, which display gastroparesis (partial paralysis of the stomach muscles) due to the 
lack of nitric oxide that relaxes gastric muscles.  One week after implantation, 
transplanted cells were shown to have differentiated into NOS
+ neurons and this was 
accompanied by a significant improvement in gastric transit. Restored function of 
denervated gut was also reported following transplantation of neuroepithelial stem cells 
into a BAC-treated colonic region in rats (Liu et al., 2007). Altogether, these studies 
suggest that cell therapy via transplantation may be of therapeutic benefit in pathological 
gastrointestinal conditions associated with the loss of neurons.    
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1.7. Aims of the work presented in this thesis 
The presence of stem cells in the migrating neural crest has long been established. Some 
of these NCSCs invade the gut during embryogenesis and give rise to the ENS. To form 
a mature functional ENS, eNCSCs must self-renew and generate correct numbers of 
neurons and glia in a spatiotemporal controlled manner. So far, the presence of eNCSCs 
and their properties has only been ascertained by their behaviour in culture. The study of 
this population in vivo has been hindered by the paucity of specific markers and genetic 
lineage tools to efficiently identify and follow eNCSCs. 
The overall aim of this work was to identify and characterise eNCSCs in vivo over 
the course of ENS development. At the outset, we focused on studying the lineage of 
Sox10-expressing cells in the ENS using the Cre-loxP genetic system. The purpose of 
this analysis was to determine whether Sox10-expressing cells give rise to both enteric 
neurons and glia. Secondly, a strategy to selectively label Sox10-expressing eNCSCs at 
particular developmental stages was devised and the neurogenic potential of temporally 
identified Sox10
+ progenitors in vivo was investigated. Next, we focused on elucidating 
whether Sox10
+ cells from the adult gut, the glial cells, possess neural stem cell 
potential. The goal of this part of the work was to establish the identity of eNCSCs that 
have been isolated from the adult gut and study their potential physiological function in 
vivo. 
Finally, as part of the study of eNCSCs in vivo we wished to further our 
understanding of the molecular mechanisms underlying cell fate decisions during enteric 
neurogenesis. Towards this end, a genetic strategy was developed to test the hypothesis 
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that RET is part of the molecular switch between the neuronal and glial lineage being 
able to divert differentiation of eNCSCs towards the neuronal fate.  
 
 
  
 
 
 
 
 
Chapter II 
 
 
Materials & Methods 
 
 Materials & Methods 
 
2.1. General materials and equipment 
2.1.1.General chemicals, buffers and solutions 
The following commonly-used buffers were prepared in-house at the MRC National 
Institute for Medical Research (NIMR) using reagents from Sigma or Fisher Scientific. 
All components are stated at final working concentration (1x). Specialized reagents are 
described in the relevant section in which they were first used. 
 
PBS     phosphate buffered saline pH7.4 
137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4 in 
dH2O 
 
TAE   Tris-acetate  EDTA,  pH8.3 
      40 mM Tris-acetate, 1 mM EDTA in dH2O  
 
TBE   Tris-borate EDTA pH8.0 
100 mM Tris-borate, 5 mM EDTA in dH2O 
 
SSC     sodium chloride-citrate buffer pH7.0-7.2 
      150 mM NaCl, 15 mM trisodium citrate, in dH2O 
 
LB (Agar)   Luria Broth (Agar) 
1% [wt/vol] Bacto tryptone, 0.5% [wt/vol] yeast extract, 
1% [wt/vol] NaCl, (2% [wt/vol] agar). 
 
2.1.2.Centrifuges 
All routine centrifugation was performed in a Heraeus Pico microcentrifuge (Thermo 
Scientific) fitted with 24x 1.5/2.0 ml rotor (Sections 2.6.1, 2.6.2, 2.6.7). 
For plasmid and PAC DNA isolation, large scale cultures were pellet using a 
Beckman J6-HC refrigerated centrifuge, fitted with rotor JS 5.2 or a Sorvall RC5C 
refrigerated centrifuge fitted with rotor SLA-1500. Further centrifugation of bacterial 
supernatants was performed using the same centrifuge fitted with rotor SS34 (Sections 
2.6.2 and 2.6.7). 
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Primary cell cultures were pellet in an IEC Centra-4R refrigerated centrifuge fitted 
with rotor IEC 215A (Section 2.8.1 and 2.8.2). ES cells were centrifuged in a MSE 
Centaur II centrifuge (Section 2.8.4). 
 
2.1.3.Polymerase Chain Reaction (PCR) machines 
PCR analysis was carried out in a DNA Engine Dyad Thermal Cycler Chassis (Biorad) 
or in a Hybaid Omn-E dryblock thermocycler (Thermo Scientific).  
 
2.1.4.Other equipment 
An INNOVA 4200 incubator shaker (New Brunswick Scientific) was used to grow all 
bacterial cultures at 32ºC or 37ºC with 225-250 rpm rotary shaking (Sections 2.2, 2.6.2, 
6.4, 6.5.3, 6.6.1, 6.6.4, 6.6.5). A LEEC incubator was used for growing colonies on 
plates (Sections 6.2, 6.4, 6.5.3, 6.6.1, 6.6.4, 6.6.5). A Hybaid Mini 10 oven (Thermo 
Scientific) was used for digestion of mouse biopsies in tail buffer (section 6.1.1), for the 
crosslink of DNA to the Southern Blot membrane (section 6.3.2) and for RNA in situ 
experiments (section 7.4). A Hybaid Shake 'n' Stack Hybridization oven (Thermo 
Scientific) was used for the hybridization of radiolabelled probes for Southern blotting 
(section 6.3.2).  
 
2.2. Generation of the Sox10iCreER
T2 construct and transgenic mice 
2.2.1.Generation of the targeting vector 
An AscI-SalI (460 base pairs - bp) fragment was used as the 5’ homology and a SpeI-
PacI (440 bp) fragment was used as the 3’ homology. Both fragments were amplified by 
PCR as outlined in Section 2.6.8.1, using the Sox10 phage artificial chromosome (PAC) 
as template and the oligonucleotide primers P1-P4 (see Table 2.1). PCR products were 
78 
 Materials & Methods 
run in a 1% agarose gel in TAE and purified as described in Sections 2.6.6.1. The 5’ and 
3’ homologies were cloned into pCR
®II-TOPO
® (Invitrogen K4600-01) and 
electroporated into XL1-Blue competent cells (Stratagene 200268; Section 2.6.6.3) 
which were plated onto LB-agar-Ampicilin-IPTG-XGal for blue/white selection 
(Section 2.6.6.3). Single white colonies were picked, grown in LB-Ampicilin at 37ºC 
overnight (O/N) and then DNA was isolated as described in Section 2.6.2. Finally, 5’ 
and 3’ homologies were sequenced to confirm the homology between the PCR-
amplified fragments and the template. 
A 3.3 Kb fragment containing the coding sequence of the iCreER
T2 recombinase 
followed by the chloramphenicol resistance gene (Cm
R), flanked by frt sites, was used 
as the targeting cassette (kindly provided by N. Kessaris; UCL, UK).  
5’ and 3’ homologies were released from the vector by AscI-SalI digestion and SpeI-
PacI digestion, respectively. The targeting cassette was isolated by SalI-SpeI digestion. 
DNA fragments were run on a 1% gel agarose in TAE and purified as described in 
Section  2.6.6.1. The targeting vector was generated by subcloning the AscI-SalI 5’ 
homology, the SalI-SpeI targeting cassette and the SpeI-PacI 3’ homology into the PacI-
AscI cloning sites of the vector pBlueScript PacAsc (pBlueScript with a modified MCS 
to introduce PacI and AscI, kindly provided by N. Kessaris; UCL, UK) in a four-way 
ligation (Fig.4.2). Once generated, the targeting cassette was electroporated into XL1-
Blue competent cells (Section 2.6.6.3) and these were plated onto LB-agar-Ampicilin-
IPTG-XGal for blue/white selection. Single white colonies were picked and grown in 
LB-Ampicilin at 37ºC, O/N. DNA was isolated, as described in Section 2.6.6.1, and then 
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digested with restriction endonucleases to confirm success of the ligation (Section 
2.6.6.2). 
LB (-agar-) Ampicilin: LB, (agar), Ampicilin at a final concentration of 100 µg/ml 
(Sigma A9518). 
LB-agar-Ampicilin-IPTG-XGal: LB-agar, 100 µg/ml of Ampicilin, 0.1 M isopropyl-1-
thio-β-D-galactopyranoside (IPTG) and 8 mg/ml of 2% 5-bromo-4-chloro-3-inodlyl-β-
D-galactopyranoside (X-Gal; 40 mg/ml stock in n,n’-dimethylformamide –DMF) were 
spread on solidified LB-agar plates 30 minutes prior to plating the transformations. 
 
2.2.2.Phage Artificial Chromosome (PAC) isolation and modification 
A genomic PAC (RP21-529-I6 from RPCI mouse PAC library 21, HGMP Resource 
Centre, UK) spanning 170 kilobases (Kb) around the Sox10 locus (Matsuoka et al., 
2005) was kindly provided N. Kessaris (UCL, UK) (Fig.4.2). PAC DNA was isolated 
and propagated as described in Sections 2.6.7. PAC modification was carried out in a 
bacterial system as previously described (Lee et al., 2001; see Sections 2.6.7.4  and 
2.6.7.5). Once modified, PAC DNA was isolated (Sections 2.6.7.2) and then checked for 
recombination events by restriction analysis followed by Pulse Field Gel Electrophoresis 
(PFGE) and Southern blot using the 3’ homology fragment as a probe (Sections 2.6.7.3 
and 2.6.3.2). Finally, the modified PAC insert was linearized by NotI digest and purified 
away from the vector pPAC4 backbone before microinjection into the pronuclei of 
fertilized mouse eggs as described in Section 2.6.7.6 (Fig.4.2).   
2.2.3.Generation of Sox10iCreER
T2 transgenics 
For the generation of the SOX10iCreER
T2, superovulated females were mated with 
(CBA/CAxC57BL/10)_F1 fertile males for the production of fertilized eggs. Typically, 
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4-6 female mated yielding a total of 100-200 fertilized eggs. Pseudopregnant mice were 
prepared by mating 6 weeks-4 months old (CBA/CA_C57BL/10)_F1 females in natural 
estrus with vasectomized males the day before implantation. After microinjection of 
DNA constructs into the pronuclei of fertilized mouse eggs, embryos were re-implanted 
into the oviducts of pseudopregnant foster mother for development. After weaning at 3-
4 weeks of age, the pups were genotyped (Section 2.6.8.3) and all transgene-positive 
offspring were kept to develop stable lines. At all times, animals were handled in 
compliance with the Animal (Scientific Procedures) Act 1986. 
 
2.3. Generation of R26
RET9 and R26
RET9(MEN2A) constructs and transgenic 
mice 
2.3.1.Construction of the transgenes 
The RET9-IRES-GFP and RET9
MEN2A-IRES-GFP cassettes were constructed as follows. 
A 161 bp (FA) and 153 bp (FB) fragments were amplified from the RET9 cDNA by 
PCR, using the primers P5-P8 (Section 2.6.8.1; Table 2.1).  FA was run on a 1% gel 
agarose in TAE, purified (Section 2.6.6.1) and cloned into the KpnI-XhoI double-
digested pBlueScript KS (pBS KS) generating pBS KS+FA.  FB was run on a 1% gel 
agarose in TAE, purified (Section 2.6.6.1)  and ligated to the HindIII-XhoI double-
digested pBS KS+FA. A 3 Kb fragment of RET9 or RET9
MEN2A cDNA (FC’) was 
released by AatII-NsiI digestion and cloned into pBS KS+FA+FB.  NheI digestion of 
pBS KS+FA+FB+FC released a 3.2 Kb fragment which was then cloned into the NheI- 
digested pBigT vector (kindly provided by S. Srinivas, University of Oxford, UK; 
Srinivas et al., 2001) (Fig.7.1 A). This plasmid includes a PacI site 5’ to the adenovirus 
splice acceptor sequence, the IRES-GFP cassette and an AscI site 3’ to the bovine 
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growth hormone polyadenylation sequence. These restriction sites were used to excise 
the RET9
MEN2A-IRES-GFP cassette and clone it into the pROSA26PA (a kind gift from 
S. Srinivas, University of Oxford, UK; Srinivas et al., 2001). This plasmid contains 
genomic ROSA26 sequences for homologous recombination and a diphtheria toxin gene 
for negative selection in ES cells (Fig.7.1 B). Finally, the R26
RET9(MEN2A) targeting 
vector was linearized by SfiI digest, separated from the plasmid backbone by gel 
electrophoresis and eluted as described in Section 2.6.3.1 and 2.6.6.1.  
 
2.3.2.Generation of transgenic mice  
The targeting vector was electroporated into the E14G2A Embryonic Stem (ES) cell line 
(kindly provided by A. Smith, Institute for Stem Cell Research, UK) as described in 
Section  2.8.4.3. ES clones carrying the transgene were identified by PCR (Section 
2.6.8.2; Table 2.1) and were further verified by Southern blot analysis (Section 2.6.3.2) 
using a 692 bp 5’ external probe (kind gift of A. Smith, Institute for Stem Cell Research, 
UK). Chimeric mice were generated by microinjection of the selected ES clones 
(heterozygous for the R26
RET9(MEN2A) transgene) into C57BL/6 blastocysts and transfer 
of the injected embryos into the uterus of pseudopregnant female mice. The chimeras 
were mated with C57BL/6 wild type mice and the offspring examined for germ line 
transmission of ES cell DNA, as determined by the presence of agouti coat colour, 
indicating the successful transmission of ES cell DNA through the germ line. Agouti 
offspring were genotyped by PCR as described in Section 2.6.8.3, using primers listed in 
Table 2.1. At all times, animals were handled in compliance with the Animal (Scientific 
Procedures) Act 1986.  
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2.4. Generation of Sox10Cre; R26ReYFP 
Sox10Cre transgenic mice were kindly provided by N. Kessaris (UCL, UK) and have 
been described (Matsuoka et al., 2005). For lineage analysis, Sox10Cre transgenic 
animals were crossed with the reporter line R26ReYFP
 (a kind gift from S. Srinivas, 
University of Oxford, UK; Srinivas et al., 2001). The Cre and R26ReYFP alleles were 
identified by PCR as described in Section 2.6.8.3. Timed matings for embryonic studies 
were generated by crossing Sox10Cre; R26ReYFP mice with Parkes (outbred) mice. At 
all times, animals were handled in compliance with the Animal (Scientific Procedures) 
Act 1986. 
 
2.5. Generation of hGFAPCreER
T2; R26ReYFP 
The hGFAPCreER
T2 transgenic mice were kindly provided by F. Guillemot (NIMR, 
UK) and were generated as described by (Ganat et al., 2006). hGFAPCreER
T2 mice 
were crossed with the reporter line R26ReYFP to generate hGFAPCreER
T2; R26ReYFP 
animals. The Cre and R26ReYFP alleles were identified by PCR as described in Section 
2.6.8.3. At all times, animals were handled in compliance with the Animal (Scientific 
Procedures) Act 1986. 
 
2.6. Molecular Techniques 
2.6.1.Genomic DNA Isolation 
2.6.1.1.DNA extraction from mouse biopsies 
Genomic DNA was extracted from tail snips/ear biopsy or yolk sacs using 500 µl of 
Proteinase K Tail Lysis Buffer and incubating the mixture at 55ºC, O/N. The DNA was 
precipitated by adding 500 µl of isopropanol and then centrifuged at 13200 rpm for 10 
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minutes, at room temperature (RT). The DNA pellet was air dried and ressuspended in 
50 µl of distilled H20 (dH2O).  
Proteinase K Tail Lysis Buffer: 100 mM Tris.HCl pH8.0, 5 mM EDTA pH8.0, 0.2% 
SDS (Biorad 1610418), 200  mM NaCl, 0.1 mg/ml Proteinase K (Roche 3 115 879). 
 
2.6.1.2.DNA isolation from ES cells 
In a confluent 48-well plate, cells were washed and trypsinized using 100 µl of 
Trypsin/EDTA solution/well. Following trypsinization, 100 µl of PBS (Ca
2+/Mg
2+-free, 
Invitrogen 14190-094) were added and cells were transferred to eppendorf tubes. Cells 
were centrifuged at 13000 rpm for 1 minute at RT, incubated in 500 µl of Proteinase K 
Tail Lysis Buffer O/N, at 55ºC and then 140 µl of 5 M NaCl were added. After shaking 
well, samples were centrifuged at 8000 rpm for 20 minutes at 4ºC; the supernatant was 
collected in a clean eppendorf and centrifuged again until no debris was visible. DNA 
was precipitated by adding 1ml of cold 100% ethanol, centrifuged at 8000 rpm for 10 
minutes, at 4ºC and then washed three times with cold 80% ethanol. Finally, the DNA 
pellet was air dried and dissolved in 10 µl of TE. 
TE: 5 mM Tris pH7.5, 1 mM EDTA pH8.0. 
 
2.6.2.Plasmid DNA isolation 
Plasmid DNA was isolated using QIAprep Spin Miniprep Kit (Cat. No. 27106) or 
QIAGEN Plasmid Maxi Kit (Cat. No. 12163), following manufacturer’s instructions. 
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2.6.3.Analysis of DNA 
2.6.3.1.Restriction enzyme digestion and agarose gel electrophoresis 
Restriction enzymes were supplied by New England Biolabs and Roche. Digestions 
were carried out using the appropriate buffer systems supplied with the enzyme and 
following manufacturer’s protocols. Conventional electrophoresis was performed in 
MultiSub gel apparatus. Horizontal minigels were prepared by dissolving molecular 
biology grade multi-purpose agarose (Roche 11 388 991 001) in either 1x TAE or 1x 
TBE. Typically, 0.6-2% (w/v) gels were used, depending on the molecular weight of the 
DNA of interest. DNA samples were mixed in a 9:1 ratio with 10x DNA Loading buffer 
before loading and electrophoresed in 1x TAE or 1x TBE running buffer at 120V. 
Nucleic acids were stained by the addition of 1 µg/ml ethidium bromide (VWR 
429912N) to the molten agarose prior to casting. In applications where the DNA product 
underwent downstream processing, staining was performed only upon completion of 
electrophoresis by soaking the gel in a 10 µg/ml solution of ethidium bromide in dH2O 
for 5-10 minutes. The size of nucleic acids was determined by comparison against a 1 
Kb DNA ladder (Invitrogen 1561 016). The DNA was visualized in a BioDoc-IT 
lightproof cabinet containing an ultraviolet transilluminator at 302nm (UVP) and a CCD 
camera.  
10x DNA Loading buffer: 20% Ficoll, 0.1 M EDTA, 1% SDS, 0.25% Orange G. 
 
2.6.3.2.Southern Analysis 
Probe synthesis and labelling 
Probes were synthesized by random priming using the Rediprime II DNA Labelling 
System (Amersham Pharmacia Biotech RPN1633). Unincorporated radioactivity was 
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removed by passing through a Microspin S-200HR column (Amersham Pharmacia 
Biotech 27-5120). Both kits were used following the manufacturer’s instructions. Probes 
were denatured by heating (95ºC, 5 minutes) and snap cooling (5 minutes, on ice) to 
prevent re-annealing. 
Southern Blotting 
Genomic DNA (8-10 µg) was digested O/N with restriction endonucleases and run in a 
1% agarose gel (90V) for 6-7 hours (Section 6.3.1). The gel was photographed and then 
incubated sequentially in Depurination solution (2x 5 minutes, RT), Denaturation 
solution (2x 30 minutes, RT) and in Neutralization solution (2x 30 minutes, RT). The 
gel was rinsed with dH2O between each solution. DNA was transferred O/N on a 
Hybond-N
+ membrane (Amersham Pharmacia Biotech RPN303B), using 20x SSC. 
After transfer, the DNA was fixed on the membrane either by baking (2 hours, 80ºC) or 
by using a UV crosslinker (UV Stratalinker 2400). The membrane was placed on a piece 
of nylon mesh whenever the ends of the membrane overlap, rolled up into a tight roll in 
2x SSC and placed in a hybridization bottle. 2x SSC was replaced by 20 ml of pre-
hybridization solution in which the membrane was incubated for 2 hours at 65ºC and 
then by hybridization solution containing the denatured probe. Following hybridization 
O/N at 65ºC, the membrane was washed in two solutions of increased stringency: 2x 
SSC, 0.1% (w/v) SDS (2x 15 minutes, 65ºC) and in 0.5x SSC, 0.1% (w/v) SDS (2x 15 
minutes, 65ºC).  Excess liquid was blotted off the radioactive membranes, which were 
then wrapped in Saranwrap and exposed to BioMax MS film (Kodak 832 6836) in a 
light-sealed cassette with 2 intensifier screens at -80ºC. Exposure time varied according 
to the intensity of the signal. 
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Depurination solution: 0.25 N HCl 
Denaturation solution: 1.5 M NaCl, 0.5 N NaOH 
Neutralization solution: 1.5 M NaCl, 0.5 M Tris.HCl pH7.5 
Pre-hybridization/Hybridization Solution: 3x SSC, 10x Denhardt’s (50x Denhardt’s 
Sigma D2532), 10% Dextran Sulphate (Amersham Pharmacia Biotech 17-0340), 0.1% 
SDS, 100 mg/ml denaturated salmon sperm DNA (Biochemika 31149). 
 
2.6.3.3.Quantification of DNA 
The concentration of DNA was assayed by submitting an aliquot of the DNA to agarose 
gel electrophoresis. The brightness of the band was compared to the 1 Kb DNA ladder 
(Invitrogen 1561 016) to have an estimate of the amount of DNA present. In parallel, 
concentration of DNA was determined using a NanoDrop ND-1000 spectrophotometer. 
 
2.6.4.Bacterial Strain, growth and storage 
Plasmids were maintained in E. coli strain One Shot® ([F
-  mcrA  (mrr-hsdRMS-
mcrBC)  80lacZ M15  lacX74 recA1 ara 139  (ara-leu)7697 galU galK rpsL (Str
R) 
endA1 nupG]; Invitrogen C4040-06 ) or XL1-Blue strain ([recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)]; Stratagene 200268) . 
PAC DNA was maintained in E. coli strain EL250 (DH10B [λcI857(cro-bioA)<> araC-
PBADflpe), a modified DH10B strain [GIBCO] containing defective lambda prophage 
(Yu et al., 2000) and arabinose-inducible flpe gene (Lee et al., 2001). Bacteria grew in 
LB or LB-agar plates containing the appropriate antibody at 32ºC (EL250) or 37ºC (One 
Shot® and XL1-Blue). For long-term storage of bacterial strains and clones, glycerol 
87 
 Materials & Methods 
was added to O/N cultures at a final concentration of 15% (v/v), and the stocks were 
stored in 1 ml aliquots at -70ºC. 
2.6.5. Colony lifts 
Colony lifts were performed by placing a nitrocellulose filter over the plate with 
colonies and then pressing it against a new wet filter. After the transfer, bacteria were 
grown on the filter at 37ºC, O/N. Filters were then incubated sequentially in 0.5 N 
NaOH (5 minutes, RT), 1 M Tris (pH7.5) (5 minutes, RT), 1 M Tris (pH7.5)/1.5 M 
NaCl (10 minutes, RT). Finally, the filter was  transferred to 2x SSC/0.1% SDS 
solution, rubbed with gauze and washed with 2x SSC. After baking for 2 hours at 80ºC, 
the filter was processed for Southern blot analysis as described in Section 2.6.3.2. 
 
2.6.6.Cloning techniques 
2.6.6.1.DNA fragment isolation 
DNA fragments were isolated from agarose gels using QIAquick Gel Extraction Kit 
(Cat. No. 28706), following manufacturer’s instructions. 
 
2.6.6.2.Ligation of DNA fragments 
Ligations here described involved DNA fragments digested with restriction enzymes 
and PCR products. Ligation of DNA fragments was performed using TaKaRa DNA 
Ligation Kit (TaKaRa 6022), following manufacturer’s instructions. Ligation of PCR 
products was carried out using pCR
®II-TOPO
® Cloning according to manufacturer’s 
instructions. 
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2.6.6.3.Transformation of competent bacteria 
Ligation constructs were transformed into chemically-competent One Shot® cells or 
into electro-competent XL1-Blue cells. PAC DNA was transformed into electro-
competent EL250 cells. 
Transformation of chemically-competent One Shot® cells was performed according 
to the manufacturer’s protocol. Briefly, plasmid DNA was added to 50 µl of competent 
cells. Reactions were incubated on ice for 30 minutes, followed by 30 seconds heat-
shock at 42ºC and further incubation on ice for 2 minutes. 250 µl of LB medium was 
added to each transformation reaction and incubated at 37ºC for 1 hour. 100 µl of each 
transformed culture was plated on LB-agar plates containing the appropriate antibody 
and grown O/N at 37ºC.  
For the transformation of electrocompetent cells (XL1-Blue and EL250), DNA was 
added to the cells and these were transferred to a chilled disposable electroporation 
cuvette (BioRad 1652088). Electroporation was performed using a Bio-Rad gene pulser 
set at 2.5KV (electroporation of plasmid DNA into XL-Blue strain) or 1.8KV 
(electroporation of PAC DNA into EL250 strain). Electroporated cells were transferred 
to an eppendorf in 500µl of LB medium and incubated at 37ºC (XL-Blue strain) or 32ºC 
(EL250 strain) for 30 minutes before plating.  
When using the XL-Blue strain, blue/white selection was used to distinguish 
recombinant plasmids from non-recombinant ones. Bacteria carrying the insert generate 
white colonies in the presence of the LacZ substracts IPTG and X-Gal due to the 
disruption of the LacZ gene of the cloning vector by the insert.  
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2.6.7.PAC techniques 
2.6.7.1.PAC isolation and propagation 
To isolate single colonies, the PAC clone was streaked onto LB-agar-Kanamycin and 
incubated at 32ºC, O/N. Single colonies were picked and grown in LB-Kanamycin at 
32ºC, O/N.  
LB (-agar-) Kanamycin: LB (agar), Kanamicin at a final concentration of 12.5 µg/ml 
(Sigma K0879). 
 
2.6.7.2.Small and large scale preparation of PAC DNA 
Small Scale PAC DNA isolation (MINIPREP) 
PAC bacterial colonies were grown in 2 ml of LB-Kanamycin, at 32ºC, O/N. Bacteria 
were harvested by centrifugation for 1 minute at 13000 rpm, resuspended in 100 µl of 
Solution I. Bacteria were lysed with 200 µl of Solution II and neutralized with 150 µl of 
Solution III. After centrifugation at 13000 rpm for 10 minutes, PAC DNA was 
precipitated by adding 900 µl of cold 100% ethanol and then washed in 70% ethanol. 
The dry DNA pellet was ressuspended in TE. Cut tips were used in all steps of the 
protocol to avoid shearing PAC DNA. 
Solution I: 50 mM Glucose, 25 mM Tris pH8.0, 10 mM EDTA pH8.0. 
Solution II: 0.2 N NaOH, 1% SDS. 
Solution III: 3 M KOAc, 1 N Glacial Acetic Acid. 
 
Large Scale PAC DNA isolation (MAXIPREP) 
PAC bacterial colonies were grown in 500 ml of LB containing 12.5µl/ml kanamycin 
O/N, at 32ºC. Bacteria were harvested by centrifugation for 10 minutes at 3750 rpm, 
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resuspended in 16 ml of Solution IV and incubated for 5 minutes at RT. Bacteria were 
lysed with 16 ml of Solution V for 5 minutes at RT, neutralized with 16 ml of cold 
Solution VI and then incubated for 1 hour at 4ºC. After centrifugation at 3750 rpm for 
15 minutes at 4ºC, PAC DNA was precipitated with ice-cold isopropanol, incubated for 
5 minutes at RT and then centrifuged at 3750 rpm for 15 minutes at 4ºC. DNA pellet 
was ressuspended in TE and then extracted using phenol:chloroform:isoamylacohol 
(25:24:1; Sigma P2069) and chloroform, followed by 100% ethanol precipitation (1:1), 
and an ethanol 70% wash. The dry DNA pellet was ressuspended in TE and kept at 4ºC 
until use. Cut tips were used in all steps of the protocol to avoid shearing PAC DNA. 
Solution IV: 50 mM Tris pH8.0, 10 mM EDTA, pH8.0, 100 µg/ml RNase A. 
Solution V: 0.2 N NAOH, 1%SDS. 
Solution VI: 3 M KOAc, 1 N Glacial Acetic Acid pH5.5. 
 
2.6.7.3.PAC analysis by pulse field gel electrophoresis 
Linear double-stranded DNA molecules longer than ~40 Kb in length migrate through 
agarose gels at the same rate making fractionation impossible. In PFGE, DNA 
molecules are subjected to an electrical field that switches periodically between two 
different directions. This permits fractionation of smaller molecules, which can reorient 
quicker and hence move faster, from larger molecules. PFGE was carried out in 0.5x 
TBE buffer (pH 8.0) at 4ºC using a countour-clamped homogenous electric field 
apparatus (Bio-Rad) with fluid circulation. PAC DNA was run in 1% agarose gel in 0.5x 
TBE at 5.8V/cm, initial switch 2.1 seconds and final switch 10 seconds, for 12.5 hours. 
Pulse Marker Ladder (Sigma D2291) was used. The gel was stained in ethidium 
91 
 Materials & Methods 
bromide diluted in water for 30 minutes and then washed in water, except when 
isolating PAC DNA for micro-injection.   
 
2.6.7.4.Homologous recombination in bacteria 
PAC modification was carried out as previously described (Lee et al., 2001). 
Electrocompetent EL250 E. coli were transformed with PAC DNA by electroporation as 
described in Section 2.6.6.3.  Transformed bacteria cells were plated onto LB-agar-
Kanamycin plates and incubated O/N, at 32ºC. Overnight cultures containing the PAC 
were grown from single colonies, diluted 50-fold in LB-Kanamycin and grown in a 
32ºC shaking incubator to an OD600=0.5-0.8. Induction was performed by transferring 
10 ml of the growing culture into 125 ml flask and placed it in a water-bath at 42ºC 
shaking for 15 minutes. Immediately after induction the flask was placed into ice bath 
slurry and shaken for 5 minutes to cool down. A non-induced culture was kept at 32ºC, 
placed into the ice bath slurry and used as a negative control. Cells were then 
centrifuged for 8 minutes at 1000g at 4ºC and washed with 1 ml ice-cold sterile water 
three times. After the final wash the cell pellet was resuspended in 100 µl of ice-cold 
sterile water. Immediately prior to electroporation, 100-300 ng of the targeting vector 
was mixed with 50 µl of the competent cells (from induced and non-induced culture) 
and transferred into an electroporation cuvette. Electroporation was performed as 
described in Section 2.6.6.3. Pulsed bacterial cells were incubated in LB in a 32ºC 
shaking incubator for 1.5 hours before plating on appropriate selective agar media (LB-
agar-Ampicilin plates) and non-selective agar media (LB-agar-Kanamicin plates). 
Single colonies were picked and grown in LB-Kanamycin at 32ºC, O/N.  
 
92 
 Materials & Methods 
2.6.7.5.Arabinose-inducible “FLPE” 
Removal of the cloramphenicol resistance cassette (Cm
R) was achieved by L-arabinose 
induction of flp recombinase present in the EL250 strain (Lee et al., 2001).  For this 300 
µl of EL250 bacterial culture containing the recombinant PAC was inoculated in 15 ml 
of fresh LB and grown at 32ºC to OD600=0.5-0.8 shaking. Sterile L-arabinose was then 
added (0.2%). After 1 hour at 32ºC, 1 ml of the bacterial culture was taken to inoculate 
10 ml of fresh LB and incubated for 2 hours at 32ºC before plating on appropriate 
selective agar media (LB-agar-Ampicilin) and non selective agar media (LB-agar-
Chloramphenicol) using a 1:100 dilution. Incubation was carried out at 32ºC, O/N. 
Removal of the selection marker was confirmed by Southern blot using the 3’ homology 
fragment as a probe and recombinant PAC DNA prior recombination as a negative 
control.   
LB-(agar)-Chloramphenicol: LB, cloramphenicol at a final concentration of 15 µg/ml 
(Sigma C7795). 
2.6.7.6.PAC linearization for microinjection 
The modified PAC DNA was linearized by restriction digest and isolated away from the 
vector by PFGE (Section 2.6.7.3). The marker lanes were cut off and stained in dH2O 
containing 0.5 µg/ml ethidium bromide for 10 minutes. These were used to localize the 
position of the PAC and vector bands in the unstained gel and excise them. The linear 
PAC DNA was concentrated in a 4% low-melting point (LMP) agarose gel in TBE by 
running it at 50V for approximately 9 hours at 4ºC. Considering the position of the 
vector DNA, the PAC DNA was localized in the 4% LMP agarose gel and 0.5-0.8cm 
block was excised. The block was equilibrated on a rotator in 12.5 ml of TENPA buffer 
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with 30 µM Spermine (Sigma S-1141) and 70 µM Spermidine (Sigma S-2501) for 1.5 
hours. To melt the agarose, the block was incubated at 68ºC for 3 minutes, pulse spun 
and incubated at 68ºC for 5 minutes. After agarose melting, 2 units of -agarase 
1000U/ml (New England Biolabs M0392S) was added to the molten gel slice and 
incubated at 42ºC for 3 hours. For dialysis of the PAC DNA, 3 membranes (Millipore 
VSWP01300, pore size 0.025 µm) were placed floating on microinjecton buffer 
containing fresh 30 µM Spermine and 70 µM Spermidine. 50 µl of the PAC DNA was 
put on top of each membrane and left at RT for 1 hour. The PAC DNA was then 
recovered from the top of the dialysis membranes and stored at 4ºC. DNA concentration 
and integrity was checked by running the purified, dialysed DNA by PFGE (Section 
6.6.3). PAC DNA was diluted in microinjection buffer with 3 mM Spermine and 7 mM 
Spermidine before injection into the pronuclei of fertilized mouse eggs.  
TENPA buffer: 10 mM Tris.HCL pH7.5, 1 mM EDTA pH8, 100 mM NaCl. 
Microinjecton buffer: 10 mM Tris.HCl pH7.5, 0.1 mM EDTA pH8, 100 mM NaCl 
 
2.6.8.Polymerase Chain Reaction (PCR) analysis 
PCR cycling parameters and primers sequence are listed in Table 2.1.  
 
2.6.8.1.PCR amplification of cloning DNA fragments 
5’ and 3’ homologies of the targeting vector pBS-iCreER
T2-frt-Cm
R-frt were amplified 
form the Sox10 PAC using the Expand High Fidelity PCR System (Roche 03 310 256). 
Primers P1 and P2 amplify a 460 bp fragment; primers P3 and P4 amplify a 440 bp 
fragment.  
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Fragments  FA and FB were amplified from the RET9
(MEN2A) cDNA using Expand 
High Fidelity PCR System (Roche 03 310 256) and the primers P5-P8. Primers P5 and 
P6 amplify a 161 bp fragment; primers P7 and P8 amplify a 153 bp fragment.  
 
2.6.8.2.PCR screen of ES cell clones 
ES cell clones carrying the transgene were identified by PCR as previously described 
(Philippe Soriano, 1999). Primers F1_PS and R1-PS identify the recombinant allele by 
amplifying a 1.2 Kb fragment, primers F1_PS and R2_PS identify the wild-type allele 
by amplifying a 1.4 Kb fragment. PCR reaction was prepared using 1x Modified 
Gitschier Buffer (MGB), 10% DMSO, 0.5% 2-mercaptoethanol, 0.1 µM each primer, 
0.5 mM each dNTP and 0.025 U/µl Taq DNA polymerase (Invitrogen 18038042). 
MGB:  670 mM Tris pH8.8, 166 mM Ammonium Sulphate, 65 mM MgCl2, 0.1% 
gelatin. 
 
2.6.8.3.PCR genotyping of transgenic strains 
PCR reactions were prepared with reagents obtained from Invitrogen (Taq polymerase, 
10x buffer, MgCl2) and Promega (dNTP’s). 
The genotype of Sox10Cre and hGFAPCreER
T2 mice were determined using 
primers CreF and CreR which amplify a 550 bp fragment. Standard PCR conditions 
were used, adding MgCl2 at a final concentration of 1.5 mM.   
The genotype of Sox10iCreER
T2 was determined using primers Cre250 and Cre880 
which amplify a 630 bp fragment. Standard PCR conditions were used, adding MgCl2 at 
a final concentration of 1.5 mM.   
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Table 2.1. Oligonucleotide primers and PCR cycling parameters 
PCR settings 
Step 1 
1 cycle 
Step 2 
# cycle 
Step 3 
#  cycle 
Step 4 
#  cycle 
Step 5 
1 cycle 
  
 
Primer Sequence (5’-3’)  ºC T  ºC  T  # ºC T #  ºC  T  # ºC  T 
5’Sox10 
hom 
(P1)GCGGCGCCCTGTCAG
AGCAGACGAGGGG 
(P2)GGCGACCATGGTGCT
CCCGGCCGCCGCCGCTT
CG  
 
 
94 
 
 
4’ 
 
94 
61 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
31 
 
 
72 
 
 
10’ 
3’Sox10 
hom 
(P3)ACTAGTAGGGGCCCT
GTCACCACCAGTGCC  
(P4)TTAATTAAAAGATCA
GAGTGTCCCACCCTGC  
 
 
94 
 
 
4’ 
 
94 
61 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
31 
 
 
72 
 
 
10’ 
RET9 FA  (P5)CAGGGTACCGCTAGC
GCCACCATGGCGAAGGC
GACGTCCGGTG 
(P6)CCGGCCGCCTGGTCC
ACATACAGC 
 
 
94 
 
 
4’ 
 
94 
61 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
31 
 
 
72 
 
 
10’ 
RET9 FB  (P7)GAGGAGGAGACACC
GCTGGTGG 
(P8)CCAAAGCTTGCTAGC
AGTGCAGAGGGGACAGC
GGTGC 
 
 
94 
 
 
4’ 
 
94 
61 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
5 
 
94 
59 
72 
 
30’’ 
50’’ 
90’’ 
 
 
31 
 
 
72 
 
 
10’ 
R26
RET(MEN2A)  (F1_PS)CCTAAAGAAGAG
GCTGTGCTTTGG 
(R1_PS)CATCAAGGAAAC
CCTGGACTACTG 
(R2)CATACTGTAGTAAG
GATCTCAAGC 
93 2’ 
93 
55 
65 
30” 
30” 
3’ 
40 -  -  - 
 
 
- 
 
 
- 
 
 
-  65 10’ 
Sox10Cre  (creF)ATCCGAAAAGAAA
ACGTTGA  
(creR)ATCCAGGTTACGG
ATATAGT 
 
94 
 
3’ 
 
94 
53 
72 
 
30’’ 
1’ 
90’’ 
 
35 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
72 
 
 
5’ 
 
Sox10iCre 
ER
T2 
(cre250)GAGGGACTACCT
CCTGTACC 
(cre880)TGCCCAGAGTCA
TCCTTGGC 
94 3’ 
94 
53 
72 
30” 
1’ 
90” 
35 -  -  - 
 
 
- 
 
 
- 
 
 
-  72 5’ 
 
hGFAPCre 
ER
T2 
(creF)ATCCGAAAAGAAA
ACGTTGA  
(creR)ATCCAGGTTACGG
ATATAGT 
 
94 
 
3’ 
 
94 
53 
72 
 
30’’ 
1’ 
90’’ 
 
 
35 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
72 
 
 
5’ 
R26ReYFP 
(F)GCTCTGAGTTGTTATC
AGTAAGG  
(R1)GCGAAGAGTTTGTCC
TCAACC  
(R2)GGAGCGGGAGAAAT
GGATAGT 
 
 
 
95 
 
 
 
6’ 
 
 
95 
55 
72 
 
 
30’’ 
30’’ 
45’’ 
 
 
 
35 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
 
 
72 
 
 
 
 
10’ 
P1, P3, P5, P7, F1-PS, CreF, Cre250, F – forward primer; P2, P4, P6, P8, R1_PS, R2, CreR, cre880, R – reverse primer; 
°C – temperature in Celsius degrees; T – incubation time; # - number of cycles, bp – base pairs. Restriction sites in primers 
P1-P8 are underlined. Materials & Methods 
The genotype of heterozygous and homozygous R26eYFP was established by PCR 
analysis using primers F, R1 and R2. Primers F and R1 identify the recombinant allele 
by amplifying a 350 bp fragment, primers F and R2 identify the wild-type allele by 
amplifying a 500 bp fragment. Standard PCR conditions were used, adding MgCl2 at a 
final concentration of 2mM.  
PCR products were electrophoresed through agarose gels containing ethidium 
bromide as described in Section 2.6.3.1. 
 
2.6.9.Riboprobe synthesis 
Riboprobes were generated by in vitro transcription reaction with RNA polymerase, 5x 
Transcription Buffer (Promega P1181), 10 mM DTT (Promega P1171), 10x DIG 
Labelling Mix (Roche 1 277 073), RNasin (Promega N2111) and 1-1.5 µg/µl linearized 
plasmid. Samples were treated with DNase I (Promega M610A) for 30 minutes at 37ºC. 
After DNAse I treatment, probes were precipitated using LiCl precipitation (25 minutes, 
-20ºC), re-dissolved in 50 µl of dH20 and stored at 20ºC.  
The probe for Cre was derived from a plasmid pBS-CreER
T2 (gift from N. Kessaris). 
The plasmid was linearized with NotI and transcribed with T7 RNA polymerase to 
generate an antisense cRNA probe. 
The probe for the mouse Sox10 gene was derived from plasmid pBS-Sox10 
containing an 800 bp fragment of the rat Sox10 cDNA cloned into pBluescript (gift from 
Michael Wegner). The plasmid was digested with EcoRI and transcribed with T7 RNA 
polymerase to generate an antisense RNA probe. 
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2.7. Tissue Manipulation Techniques 
2.7.1.Dissection of embryos and embryonic gut 
E12.5 and E16.5 embryos were harvested from pregnant females sacrificed by a 
Schedule One Method. The day at which vaginal plug was found was considered to be 
E0.5.  
Dissection of embryos was done in L15 medium (PAA Laboratories E15821), on 
ice. Embryos were dissected out of the uterus and isolated from the placenta and extra-
embryonic membranes. When required, a portion of the tail was collected to isolate 
DNA for genotyping. Whole embryos were fixed in 4% paraformaldehyde (PFA) in 
PBS for 2 hours at 4ºC and then washed in PBT (3x, 30 minutes) prior to any other 
treatment. 
Embryonic gut was isolated from the remaining tissue and processed for culture or 
fixed in 4% PFA in PBS for 2 hours at 4ºC and then washed in PBT (3x, 30 minutes). 
PBT: 1x PBS, 0.1% Triton X-100 (Sigma X100). 
 
2.7.2.Harvest of gut muscle strips with adherent myenteric plexus (MS-MP) 
Adult (P84 or older) Sox10iCreER
T2; R26ReYFP and hGFAPCreER
T2; R26ReYFP 
transgenic mice were sacrificed by a Schedule One Method. The small intestine was 
dissected and cut into smaller pieces. Using a 1ml pipette the pieces of small intestine 
were stretched. A cotton bud soaked in PBS was used to strip the inner and outer enteric 
muscle layers, together with the myenteric plexus, away from the submucosa of the gut. 
Muscle strips with adherent myenteric plexus (MS-MP) were then stretched and pinned 
flat onto sylgard-coated 6-well plates using insect pins. Once pinned, muscle strips were 
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either processed for immunostaining (Section 2.7.3.4) or cultured (Sections 2.8.2 and 
2.8.3).   
2.7.3.Immunohistochemistry (IHC) 
Primary and secondary antibodies are listed in Tables 2.2 and 2.3, respectively. 
2.7.3.1.Fluorescence IHC on cryostat sections 
Embryos were fixed for 2 hours at 4ºC in 4% PFA in PBS, cryo-protected in 30% 
sucrose in PBS, O/N at 4ºC, embedded in 15% sucrose; 7.5% gelatine in PBS and then 
frozen in Tissue-Tek OCT on dry ice. Cryosections were acquired on a Microm HM 560 
CryoStar cryostat (Thermo Scientific) at a thickness of 12 µm. For immunostaining, 
sections were post-fixed in 4% PFA in PBS for 10 minutes at RT, incubated in Blocking 
solution I for 2 hours and then incubated with the primary antibody diluted in Blocking 
solution I, O/N, at 4ºC. After washing with PBT (3x, 5 minutes) the sections were 
incubated with the secondary antibody diluted in Blocking solution I for 2 hours at RT. 
After extensive washes with PBT, preparations were mounted in Vectashield
TM 
Mounting Medium containing DAPI (Vector Labs H-1200). 
 
2.7.3.2.Fluorescence IHC on embryo and gut whole-mount preparations 
Embryos and guts were fixed for 2 hours at 4ºC in 4% PFA in PBS, washed in PBT 
three times for 5 minutes and then incubated in Blocking solution I for 2 hours at RT. 
Specimens were incubated with primary antibodies diluted in Blocking solution I, O/N, 
at 4ºC. After three 5 minutes washes with PBT, secondary antibodies diluted in 
Blocking solution I were added for 2 hours at RT.  After extensive washes with PBT, 
preparations were mounted in Vectashield
TM Mounting Medium containing DAPI 
(Vector Labs H-1200). 
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2.7.3.3.Fluorescence IHC on cell cultures 
Cultures were fixed in 4% PFA in PBS for 10 minutes, at RT. After washing twice in 
PBT, cells were incubated with Blocking solution II for 2 hours, at RT. Primary 
antibodies were diluted in Blocking solution II and applied to cells for 5 hours, at RT or 
O/N, at 4ºC. After three 5 minutes washes with PBT, secondary antibodies diluted in 
Blocking solution II were added for 2 hours, at RT.  Cells were washed with PBT 
extensively and then mounted in Vectashield
TM Mounting Medium containing DAPI 
(Vector Labs H-1200). 
Blocking solution II: 1x PBS, 0.1% Triton X-100, 1%BSA, 0.15%glycine. 
 
2.7.3.4.Fluorescence IHC on muscle strips 
Muscle strips were fixed in 4% PFA in PBS for 30 minutes, at RT. After fixation, 
muscle strips were unpinned and transferred to 24-well plates. Free-floating muscle 
strips were then washed in PBT three times for 5 minutes and incubated in Blocking 
solution I for 2 hours at RT. Tissue was incubated with primary antibodies diluted in 
Blocking solution I O/N, at 4ºC, followed by three washes in PBT for 5 minutes. 
Secondary antibodies were diluted in Blocking solution I, and the tissue was incubated 
for 2 hours at RT. Muscle strips were then extensively washed in PBT. If cell nuclei 
were required to be detected, TOTO-3-iodide (Molecular Probes T-3604) was applied 
for 15 minutes at RT followed by three 5 minutes washes in PBT. Finally, muscle strips 
were flat mounted in Vectashield
TM Mounting Medium containing DAPI (Vector Labs 
H-1200). 
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Table 2.2. Primary antisera used for immunofluorescence 
 
Antiserum 
 
Host 
 
Dilution 
 
Source 
 
B-FABP 
 
rabbit 
 
1:1000 
 
Thomas Muller 
 
Brd-U 
 
rat 
 
1:1000 
 
Oxford Biotechnology OBT0030CX 
 
DIG 
  
1:5000 
 
Roche 11 093 274 910 
 
GFP* 
 
rabbit 
 
1:1000 
 
Molecular Probes A11122 
 
GFP* 
 
rat 
 
1:1000 
 
Nacalai Tesque 0440484 
 
GFAP 
 
rabbit 
 
1:300 
 
DAKO Z0334 
 
HuC/D 
 
mouse 
 
1:500 
 
Molecular Probes A21271 
 
Mash1 
 
mouse 
 
1:500 
 
François Guillemot 
 
nNos 
 
rabbit 
 
1:200 
 
Zymed 617000 
 
NPY 
 
rabbit 
 
1:50 
 
Biogenesis 6730-0004 
 
Phox2b 
 
rabbit 
 
1:200 
 
Christo Goridis 
 
SMA 
 
rabbit 
 
1:250 
 
Sigma A2547 
 
Sox2 
 
rabbit 
 
1:500 
 
ISL GT15098 
 
Sox10 
 
goat 
 
1:200 
 
St Cruz Biotechnology sc-17343 
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Table 2.3. Secondary antisera used for immunofluorescence 
Primary 
specificity 
 
Host 
 
Fluorochrome 
 
Dilution 
 
Source 
 
anti-rat 
 
donkey 
 
Alexa Fluor 488 
 
1:500 
 
Molecular Probes A21208 
 
anti-rabbit 
 
goat 
 
Alexa Fluor 488 
 
1:500 
 
Molecular Probes A11034 
 
anti-rat 
 
goat 
 
Alexa Fluor 568 
 
1:500 
 
Molecular Probes A11077 
 
anti-rabbit 
 
goat 
 
Alexa Fluor 568 
 
1:500 
 
Molecular Probes A11011 
 
anti-mouse 
 
goat 
 
Alexa Fluor 568 
 
1:500 
 
Molecular Probes A11004 
 
anti-goat 
 
donkey 
 
Alexa Fluor 568 
 
1:500 
 
Molecular Probes A11057 
 
anti-rabbit 
 
donkey 
 
Cy5 
 
1:500 
Jackson ImmunoResearch 
711176152 
 
anti-mouse 
 
donkey 
 
Cy5 
 
1:500 
Jackson ImmunoResearch 
715175150 
 
 
2.7.4.RNA in situ hybridization (ISH) 
In situ hybridization was performed using digoxigenin-labeled cRNA probes on coronal 
cryosections of whole embryos or on whole-mount embryos as previously described 
(Schaeren-Wiemers & Gerfin-Moser, 1993).  
 
2.7.4.1.ISH on fixed sections 
Sections were fixed in 4% PFA in PBS for 10 minutes at RT. After three 5 minutes 
washes in PBT, sections were incubated in acetylation solution for 10 minutes, at RT 
and washed again in PBT. Sections were incubated in pre-hybridization solution for 4 
hours at RT and then in hybridization solution O/N at 72ºC (100 µl of Hybridization 
solution/slide). Slides were immersed in 5x SSC to remove coverslips, washed in 0.2x 
SSC (1 hour at 72ºC and then 5 minutes at RT) and equilibrated in B1 buffer for 5 
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minutes at RT.  After pre-blocking in B2 buffer for 2 hours at RT, slides were incubated 
with the antibody anti-DIG diluted in B2 buffer O/N at 4ºC. Sections were washed in B1 
three times for 5 minutes and then equilibrated in B3 buffer for 10 minutes at RT. 
Staining was performed using NBT/BCIP Section staining solution (in the dark) after 
which slides were washed and mounted with Glycergel Mounting Medium (DAKO 
C0563). 
PBT: PBS, 0.1%Tween-20 (Sigma P1379). 
Acetylation Solution: In 295 ml dH20 add 4 ml Triethanolamine (Fluka 90279) and 
525 µl HCl. After mixing on stirrer and just before immersing the slides, add 750 µl 
acetic anhydride. 
Pre-hybridization: 50% (v/v) de-ionized Formamide, 5x SSC, 5x Denhardt’s 
(Invitrogen 750018), 250 µg/ml yeast tRNA (Sigma R6750), 500 µg/ml herring sperm 
DNA (Promega D1816). 
Hybridization Solution: Pre-hybridization solution containing 200-400 ng/ml DIG-
labelled RNA probe. 
B1 buffer: 150 mM NaCl, 100 mM Tris.HCl pH7.5. 
B2 buffer: 10% heat inactivated sheep serum in B1. 
B3 buffer: 100 mM NaCl, 100 mM Tris.Hcl pH9.5, 50 mM MgCl2. 
NBT/BCIP Section staining solution: In 2 ml B3 add 6.75 µl NBT (Sigma N6639) 
solution (0.075g NBT in 70% DMF) and 5.25 µl BCIP (Sigma B1026) solution (0.050g 
BCIP in dH20). 
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2.7.4.2.Whole-mount ISH on mouse embryos 
Whole-mount in situ hybridization was performed as previously described (Wilkinson, 
1992). Embryos were fixed in 4% PFA in PBS, for 2 hours at 4ºC, washed twice in 
PBT, dehydrated and rehydrated in 25%-50%-75% Methanol in PBT, washed twice in 
PBT and bleached with 6% H2O2 in PBT for 1 hour. After three washes in PBT, 
embryos were treated with 10 µg/ml of Proteinase K in PBT for 30 minutes. Samples 
were then washed with 2 mg/ml glycine in PBT for 10 minutes to stop the Proteinase K 
reaction, post-fixed with 0.1% glutaraldehyde/4% PFA in PBT for 20 minutes and 
washed twice in PBT. Embryos were incubated in pre-hybridization buffer for at least 1 
hour at 70ºC and then the hybridization solution was added. Samples were kept in 
hybridization solution O/N at 70ºC, washed twice for 30 minutes at 70ºC with solution I, 
washed twice in solution II at 65ºC and then washed three times in TBST at RT for 5 
minutes. After incubation in Blocking solution for 2.5 hours at RT, samples were 
incubated with the antibody anti-DIG (Roche 11 093 274 910) diluted in Blocking 
solution, O/N, at 4ºC. Embryos were washed extensively in TBST and then in NTMT. 
Staining was performed using NBT/BCIP Section staining solution (in the dark) after 
which embryos were washed extensively. 
Pre-hybridization: 50% (v/v) de-ionized Formamide, 1.3x SSC, 5 mM EDTA, 0.2% 
Tween-20, 50 µg/ml yeast tRNA (Sigma R6750), 10% CHAPS, 100 µg/ml heparin 
(Sigma 3393). 
Hybridization Solution: Pre-hybridization solution containing 0.2 µg/ml DIG-labelled 
RNA probe. 
Solution I: 50% (v/v) de-ionized Formamide, 5x SSC pH4.5, 1%SDS.  
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Solution II: 50% (v/v) de-ionized Formamide, 2x SSC pH4.5.  
TBST: 137 mM NaCl, 27 mM KCl, 25 mM Tris.HCl pH7.5, 0.1% Tween-20, 2 mM 
Levamisole.  
NTMT: 100 mM NaCl, 100 mM Tris.HCl pH9.5, 50 mM MgCl2, 0.1% Tween-20, 2 
mM Levamisole. 
 
2.8. Cell Culture Techniques 
2.8.1.Short-term cultures of embryonic dissociated guts 
Whole gut from E16.5 embryos was dissected in L15 medium (PAA E15821), washed 
with PBS (Ca
2+/Mg
2+-free; Invitrogen 14190-094) and digested for 3 minutes with 1 
mg/ml dispase/collagenase (Roche 296638) at RT.  Dissociated tissue was washed with 
PBS and plated onto fibronectin-coated (20 μg/ml; Sigma F-1141) SONIC-SEAL slide 
wells (BDH 402 032350) in OptiMEM (GIBCO 31985) supplemented with L-glutamine 
(1 mM, Invitrogen 25030-024) and penicillin/streptomycin antibiotic mixture 
(Invitrogen 15140-122). Cultures were maintained for up to 4 hours in an atmosphere of 
5% CO2. 
 
2.8.2.Culture of dissociated MS-MP strips 
MS-MP strips were washed in 0.1% Penicillin/Streptomycin in PBS, cut into small 
pieces and then incubated in 1 mg/ml Collagenase (Sigma C0130), 100 µg/ml DNase I 
(Sigma D4513) for 1 hour, at 37ºC. After two washes in PBS, dissociated tissue was 
resuspended in NCSC medium and centrifuged at 900 rpm for 5 minutes, at RT. Cells 
were plated onto fibronectin-coated (20 μg/ml; Sigma F-1141) LabTek 8-well slide 
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chambers (VWR 734 2126) in NCSC medium. Cultures were maintained in an 
atmosphere of 5% CO2. 
Neural Crest Stem Cell (NCSC) medium: in 50ml of DMEM, add 15% CEE, 20 
ng/ml FGF (R&D System 233FB025), 20 ng/ml EGF (Merk Biosciences 324831), 1% 
N2 supplement (Invitrogen 17502), 2% B27 supplement (Invitrogen 17504-044), 1% 
Penicillin/Streptomycin (Invitrogen 15140-122), 50 µM β-mercaptoethanol (Sigma 
M3148), 35 ng/µl Retinoic Acid (Sigma R2625).  
 
2.8.3.Ex vivo culture of MS-MP strips 
MS-MP strips were kept pinned flat onto sylgard-coated 6-well plates and cultured in 
the different cell culture media: NCSC, Dulbecco’s Modified Eagle’s Medium (DMEM; 
Sigma D5671), DMEM_F, DMEM_E, DMEM_G. Cultures were maintained for up to 7 
days in an atmosphere of 5% CO2. 
DMEM_F: DMEM supplemented with 20 ng/ml FGF (R&D System 233FB025) 
DMEM_E: DMEM supplemented with 20 ng/ml EGF (Merk Biosciences 324831) 
DMEM_G: DMEM supplemented with 20 ng/ml GDNF (Peprotech 450-10) 
 
2.8.4.Mouse ES cell culture protocols 
2.8.4.1.ES cells media 
ES cells were grown in DMEM/high glucose (Sigma D5671) supplemented with 15% 
fetal bovine serum (HyClone SH30070.030E), 1 mM sodium pyruvate (Sigma S8636), 
0.1 mM non-essential amino acids (Invitrogen 11140-035), 2 mM L-glutamine 
(Invitrogen 25030-024), penicillin/streptomycin antibiotic mixture (100U/ml penicillin, 
100 µg/ml streptomycin; Invitrogen 15140-122), 0.1 mM β-mercaptoethanol (Sigma 
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M7522) and 10
3U/ml of leukaemia inhibitory factor–LIF (Chemicon ESG1107). Fresh 
medium was added every 24h. 
 
2.8.4.2.Standard ES cell culture procedures 
Gelatin treatment 
Cell culture dishes were pre-gelatinized with 5 ml of PBS with gelatin (Invitrogen 041-
94000M) for 30 minutes at RT. 
Trypsinization 
Cells were re-fed 2-4 hours before trypsinization. Culture medium was removed and 
cells were washed twice with 5 ml of PBS (Ca
2+/Mg
2+-free; Invitrogen 14190-094). To 
trypsinize cells, 500 µl of trypsin/EDTA solution were added for 2 minutes at 37ºC. 
Cells were vigorously resuspended in 4 ml of ES cell medium and transferred to a 15 ml 
Falcon tube. After centrifugation (800 rpm) for 5 minutes at RT, cells were 
ressuspended in fresh medium and plated in pre-gelatinized plates. 
Typsin/EDTA solution: 0.05% Trypsin, 0.02% EDTA in PBS (Ca
2+/Mg
2+-free). 
Freezing ES cells 
Cells were trypsinized as described above and then ressuspended in freezing medium in 
a cell density of 0.5-1.0x10
7 cells/ml. Aliquots of 1 ml were kept at -70ºC in isopropanol 
container for 24h and then transferred to liquid N2. 
Freezing medium: 90% FBS (Hyclone SH30070.030E), 10% DMSO (Sigma D2650). 
Thawing ES cells 
ES cells were thawed for 2-3 minutes, at 37ºC. Once thawed, cells were transferred to a 
15 ml Falcon tube in 9 ml of pre-warmed ES cell medium and centrifuged at 800 rpm, 
for 5 minutes, at RT. After centrifugation, the medium was aspirated, the cell pellet was 
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resuspended in fresh medium and then plated in a pre-gelatinized dish. Cells were re-fed 
the following day to remove dead cells and debris. 
2.8.4.3.ES cell electroporation and selection of clones 
In each experiment, approximately 1x10
7cells were electroporated with 30 µg of DNA. 
Cells were trypsinized as described and resuspended in 0.9 ml of DMEM/high glucose 
(Sigma D5671). DNA was diluted in 0.1 ml of dH2O and added to the cell suspension. 
Electroporation was performed by applying to successive shocks at 240V and 230V in a 
Gene Pulser X cell (Biorad) set to 500µF capacitance. After electroporation, cells were 
left on ice for 20 minutes and then plated with ES cell medium in pre-gelatinized 90-
mm
3 dishes. Transfected cells were selected for 10 days in medium containing G418 
(300 µg/ml; Invitrogen 10131019) added to cells 24h after electroporation. 
 
2.8.4.4.Picking, expanding and analysing ES cell clones 
At the end of the selection period, resistant clones were isolated. Plates were washed 
with PBS to remove any remaining debris and 10 ml of PBS were added. Resistant 
clones were picked using a P200 Gilson pipette under the microscope and transferred to 
96-well plates containing 50 µl of dilute tripsyn/EDTA solution (1:3 in PBS). After 
trypsinization form 2 minutes at 37ºC, cells were dispersed using a multi-pipette and 
transferred into pre-gelatinized 96-well plates containing 120 µl of ES cell 
medium/well. Cells were re-fed every 24 hours. Once wells were confluent, cells were 
trypsinyzed and plated in duplicate onto pre-gelatinized 48-well plates. One set of ES 
clones was frozen at -70ºC for subsequent aggregation with embryos and the other set 
was used to extract DNA for genotyping by Southern analysis. To freeze ES cell clones, 
cells from confluent 48-well plates were trypsinized using 100 µl of Trypsin/EDTA 
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solution and then 0.9 ml of Freezing Mix (8 volumes FBS: 1 volume DMSO) was 
added. Cells were resuspended and transferred to freezing vials. 
 
2.9. Tamoxifen Treatment 
4-hydroxytamoxifen (4-OHT; Sigma H-6278) was dissolved in ethanol/sunflower oil 
(1:9) mixture at the concentration of 10 mg/ml and stored at 4ºC for 2 weeks or at -20ºC 
for months. 
For embryonic studies, pregnant Parkes females crossed with Sox10iCreER
T2; 
R26ReYFP males were injected intraperitoneally with 0.2 mg/g of 4-OHT. To analyse 
neurogenesis in postnatal and adult ENS, 0.2 mg/g of 4-OHT was administered by 
intraperitoneal injection to SER26; R26ReYFP animals.  
To label single Sox10-expressing cells in vivo, SER93; R26ReYFP animals were 
injected intraperitoneally with 2 µg/g, 4 µg/g, 5 µg/g, 15 µg/g or 25 µg/g of 4-OHT. 
hGFAPCreER
T2; R26ReYFP animals were injected intraperitoneally with 0.2 mg/g 
of 4-OHT. Control mice were not injected or injected with ethanol/sunflower oil (1:9) 
mixture.  
 
2.10.  BAC Treatment 
SER26; R26ReYFP and hGFAPCreER
T2; R26ReYFP double transgenics, P84 or older 
were injected intraperitoneally with 0.2 mg/g of 4-OHT. All animals were operated upon 
general isoflurane anesthesia. A laparotomy with a midline incision was performed and 
a portion of the small intestine was exposed out of the abdomen. Paper gauze soaked in 
0.1% of BAC (Sigma B1383) in 0.9% Krebs solution was wrapped around 1-cm of the 
exteriorized intestine delineated with two serosal suture tags. The treatment was carried 
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out for 5 minutes after which the paper gauze was removed and the treated area and the 
peritoneum were thoroughly flushed with 0.9% saline. The wound was then sutured in 
two layers. After surgery, animals were allowed to recover, housed under controlled 
temperature conditions and allowed free access to water and food. 
The animals were sacrificed 3, 30, 80 days after treatment. The treated segment of 
bowel and untreated segments orad and aborad to the treated area were harvested from 
each animal and MS-MP strips were isolated for fluorescence immunohistochemistry.  
 
2.11.  Brd-U labelling in vitro 
For in vitro Brd-U labelling, specimens were incubated with 30 µg/ml of Brd-U solution 
in culture medium for up to 6 hours. Proliferating cells were identified by fluorescence 
immunohistochemistry, using rat anti-Brd-U antibody (Section 2.7.3 and 2.8.3). 
 
2.12.  Image processing and cell counting 
eYFP expression in Sox10Cre; R26ReYFP and Sox10iCreER
T2; R26ReYFP double 
transgenic embryos and guts was analyzed using a Zeiss M2-Bio stereofluorescent 
microscope. Images were acquired with Hamamatsu ORCA ER Digital Camera and 
Openlab software (Improvision). Immunostained cultures and muscle strips were 
examined with a Zeiss epifluorescent Axioplan and Openlab software (Improvision) or 
with a Bio-Rad/Radiance 2100 confocal laser scanning microscope and Lasersharp 
software (Biorad), using standard excitation and emission filters for visualizing DAPI, 
Alexa Fluor 488, Alexa Fluor 568 and Alexa Fluor 647. All images were processed with 
Adobe Photoshop CS 8.0 (software Adobe Systems, San Jose, CA).  
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Cell counts are presented as mean±SEM and are derived from at least three animals 
in three independent experiments.   
 
 
Chapter III 
 
Lineage analysis of Sox10-expressing 
cells in the ENS 
 
  Results 
3.1. Introduction 
 
The identification of eNCSCs and the lineages they produce is fundamental to 
understand ENS organogenesis. So far, the lack of specific markers and lineage tools to 
accurately identify eNCSCs and their progeny has hampered the study of this population 
in vivo.  
The transcriptional regulator Sox10 is the earliest neural crest marker to be found in 
the developing ENS. It is first detected in NCCs shortly after delamination from the 
neural tube and it continues to be expressed while these cells migrate and, eventually, 
invade the foregut (Anderson et al., 2006; Kuhlbrodt et al., 1998). Sox10 plays a critical 
role in ENS development as null mutations in this locus lead to a complete absence of 
enteric ganglia due to apoptosis of NCCs before reaching the gut (Kapur, 1999; 
Southard-Smith et al., 1998). This phenotype and the early onset of Sox10 expression in 
NCCs that enter the gut have led to the widely held belief that Sox10 is a marker for 
eNCSCs that give rise to both enteric neurons and glia. However, this conclusion is not 
entirely justified because Sox10 may function non-autonomously for ENS development, 
i.e., Sox10
+ progenitors may be required for the survival of adjacent (Sox10
-) precursor 
cells. Moreover, despite in vitro studies demonstrating that Sox10-expressing 
undifferentiated progenitors generate both enteric neurons and glia, in the adult gut 
expression of Sox10 is associated exclusively with mature glial cells (Bondurand et al., 
1998; Bondurand et al., 2003; Young et al., 2003). This raises the question whether in 
vivo both enteric neurons and glia derive from Sox10-expressing eNCSCs or whether 
there are two different progenitor populations: a Sox10
+ progenitor population that gives 
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rise to the glial lineage (Sox10
+) and Sox10
- progenitor cells that give rise to the 
neuronal lineage (Sox10
-). 
The lineage relationship between progenitor cells and their derivatives can be 
examined using lineage tracing analysis whereby cells are labelled or marked so that 
their progeny can be reliably identified throughout development. Earlier studies of cell 
lineage have employed either microinjection of lineage tracer dyes or infection by 
recombinant retrovirus carrying a marker gene (Stern & Fraser, 2001). These methods 
have the disadvantage of marking cells indiscriminately and, in most tissues, they cannot 
label specific sub-populations. Another approach is to genetically mark progenitor cells 
using endogenous gene expression patterns. Valuable insight into ENS development has 
emerged from the analysis of transgenic lines in which expression of an easily 
detectable marker is under the control of a promoter of interest. For instance, regulatory 
regions of dopamine β-hydroxylase linked to β-gal (Mercer et al., 1991) have been used 
to visualise a subpopulation of ENS cells (Kapur et al., 1992; Stewart et al., 2003). 
Also, the migratory paths and behaviour of these cells have been studied by knocking 
into the first exon of the Ret locus, a transgene that drives expression of GFP (Anderson 
et al., 2006; Enomoto et al., 2001). More recently, transgenic lines in which expression 
of a reporter is driven from the Sox10 (Deal et al., 2006) or the Phox2b (Corpening et 
al., 2008) promoter have also been described. The drawback of these transgenic 
approaches is that any progeny of the labelled cells that cease to express the chosen 
protein cannot be followed and so its usefulness for fate-mapping analysis is limited. 
Such limitation can be overcome using a genetic fate mapping system. This system 
makes use of two genetically engineered alleles to selectively and irreversibly mark cells 
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and their progeny. In one allele, tissue specific promoters drive expression of site-
specific recombinases, such as Cre, which acts on loxP sites or Flp, which acts on frt 
sites. In the other allele, tissue-specific or ubiquitous promoters drive expression of a 
reporter gene (e.g. lacZ, (Soriano, 1999); human alkaline phosphatase, (Lobe et al., 
1999); enhanced green fluorescent protein, (Srinivas et al., 2001)). In the absence of the 
site-specific recombinase, a loxP- or frt- flanked transcriptional terminator sequence 
located upstream of the reporter gene prevents its expression. However, in double 
transgenic animals the loxP- or frt- flanked sequence is excised following site-specific 
recombination.  This leads to the permanent and heritable expression of the reporter 
gene in the targeted cells. Thus, by using tissue-specific promoters to drive expression 
of site-specific recombinases, progenitor cells can be selectively and irreversibly marked 
permitting detection of progeny cells that no longer express the gene of interest.   
 
Here, we have investigated the lineage of Sox10-expressing cells in the ENS, in vivo, 
using genetic fate mapping. The purpose of this analysis was to determine whether both 
enteric neurons (Sox10
-) and glia (Sox10
+) arise from Sox10-expressing cells.  
 
3.2. Results 
 
3.2.1.Cre efficiently mediates recombination in the ENS of Sox10Cre; R26ReYFP 
transgenics 
 
To examine the lineage relationship between Sox10-expressing cells and mature enteric 
neurons and glia, we lineally marked the progeny of Sox10
+ cells using the Cre-loxP 
system. Transgenic mice expressing Cre under the transcriptional control of Sox10 
(Matsuoka et al., 2005) were crossed with the reporter line R26ReYFP (Srinivas et al., 
2001). In offspring carrying both alleles, the transcriptional terminator sequence flanked 
115 
 Results 
116 
 
by  loxP sites is excised specifically in Sox10-expressing cells leading to permanent 
expression of YFP in these cells and all their descendants (Fig.3.1 A). To establish that 
the Sox10Cre transgene confers expression on the YFP reporter analogous to that of 
endogenous Sox10, whole-mount preparations of E12.5 Sox10Cre; R26ReYFP embryos 
were immunostained for the reporter YFP using anti-GFP antibodies. The pattern of 
GFP fluorescence in double transgenics was then compared to Sox10 mRNA expression 
in wild-type embryos as detected by in situ hybridization using a Sox10 riboprobe. This 
analysis revealed appropriate expression of GFP within the Sox10 expression domain 
and in derivatives of Sox10
+ cells. In accordance, GFP fluorescence was detected in the 
cranial sensory ganglia, dorsal root ganglia and sympathetic chain (Fig.3.1 B, C). We 
also found GFP fluorescence within the ENS. The spatial distribution of GFP 
fluorescence in the gut of double transgenic embryos followed the pattern previously 
described for eNCCs as they colonise the gut (Kapur et al., 1992; Young et al., 1998; 
Young & Newgreen, 2001). Thus, in the bowel of E12.5 transgenics GFP-labelled 
eNCCs were observed throughout the stomach, midgut and past the caecum (Fig.3.1 D).  
To determine the efficiency of Cre-mediated recombination in the ENS of 
Sox10Cre; R26ReYFP mice, short-term cultures of dissociated gut from E16.5 embryos 
were immunolabelled with antibodies for GFP and Sox10 (Fig.3.1 E). GFP expression 
was detected in 83±4.2% (391 cells total from three mice) of the Sox10
+ cells (Fig.3.1 
F).   Results 
Figure 3.1. Sox10Cre; R26ReYFP transgenic line was used to lineally mark the 
progeny of Sox10-expressing cells in the ENS. 
 
(A) Top: Schematic of the Sox10Cre transgene generated by replacing Sox10 coding 
region (exon 3 to exon 5; exons are represented as black vertical lines) with that of Cre 
recombinase (orange box; Matsuoka et al., 2005). Middle: The Sox10Cre transgenic line 
was crossed with the reporter line R26ReYFP
 (Srinivas et al., 2001) in which the YFP 
sequence (green box) is disrupted by a transcriptional terminator cassette (a 
phosphoglycerate kinase promoter-neomycin selectable marker followed by a 
transcriptional stop sequence; grey box) flanked by loxP sites (red triangles). Bottom: 
Expression of YFP requires excision of the transcriptional terminator cassette by Cre-
mediated recombination at the loxP sites. (B) Sox10 expression pattern in an E12.5 
embryo as shown by whole mount in situ hybridization using a Sox10 riboprobe; x16 
magnification.  (C)  Whole mount GFP immunostaining of an E12.5 Sox10Cre; 
R26ReYFP double transgenic embryo showing expression of the transgene within the 
Sox10 expression domain; x12.5 magnification. (D) Whole mount GFP immunostaining 
of the gut of an E12.5 double transgenic embryo showing fluorescent eNCCs; x50 
magnification. (E) Short-term cultures of dissociated gut from E16.5 double transgenics 
were immunostained for GFP (green) and Sox10 (red). Most Sox10
+ cells undergo Cre-
mediated recombination and, therefore, express GFP (arrows). Arrowhead indicates a 
Sox10
+ cell that does not express GFP. x400 magnification. (F) Quantification  of 
Sox10
+ cells that undergo Cre-mediated recombination and therefore express GFP. 
Graph error bars, s.e.m.  CG, cranial ganglia; ov, otic vesicle; DRG, dorsal root ganglia; 
SC, sympathetic chain; Oe, oesophagus; St, stomach; Mg, midgut; Ce, caecum; Hg, 
hindgut. 
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3.2.2.A common pool of Sox10-expressing cells gives rise to enteric neurons and 
glia 
 
To follow the fate of Sox10-expressing cells in the ENS, we analysed co-expression of 
GFP and lineage markers in short-term cultures of dissociated gut from E16.5 
Sox10Cre; R26ReYFP transgenic embryos or whole-mount preparations of muscle 
strips with adherent myenteric plexus (MS-MP) from P30 animals of the same genotype. 
  At E16.5, 28±2.9% (523 cells from three mice) of the GFP
+ cells expressed the glial 
marker BFABP (Kurtz et al., 1994; Young et al., 2003) whereas a fraction of the GFP
+ 
cells expressed the pan-neuronal marker Tuj1 (47±4.7%; 514 cells from three mice). 
Approximately 25% of GFP
+ cells in the ENS of double transgenic mice were not 
labelled by either glial or neuronal markers (Fig.3.2 A, B, G). At P30, the majority of 
GFP
+ cells co-expressed the glial marker S100β (64±2.3%; 1981 cells from three mice) 
indicating that they are glial cells (Gershon & Rothman, 1991; Young et al., 2003), 
while 34±3.7% of GFP
+ cells expressed the neuron-specific RNA binding protein 
HuC/D (2180 cells from three mice), demonstrating that they represent enteric neurons 
(Marusich et al., 1994; Wakamatsu & Weston, 1997). At this stage, only approximately 
1% of GFP
+ cells present in the gut of double transgenic mice were not labelled with 
either the glial or neuronal marker (Fig.3.2 D, E, G). Finally, no co-localization between 
GFP and the myofibroblast marker smooth muscle actin (SMA; Morrison et al., 1999) 
was detected in the gut of Sox10Cre; R26ReYFP animals (644 cells from three E16.5 
mice; 527 cells from three P30 mice; Fig.3.2 C, F, G).  
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Figure 3.2. Both enteric neurons and glial cells derive from a common pool of Sox10-
expressing progenitors. 
 
(A-G)  Short-term cultures of dissociated gut from E16.5 Sox10Cre; R26ReYFP 
transgenic embryos (A-C) and whole mount preparations of MS-MP strips from P30 
animals of the same genotype (D-F) were immunostained for GFP (green) and lineage 
markers (glial markers: BFABP [A], S100β [D]; neuronal markers: Tuj1 [B], HuC/D 
[E]; myofibroblast marker: SMA [C, F]; red). Arrows indicate double positive cells. 
x400 magnification. (G)  Quantification of glial cells (BFABP
+ or S100β
+), neurons 
(Tuj1
+ or HuC/D
+) and myofibroblasts (SMA
+) in the GFP
+ population. Graph error 
 bars, s.e.m.
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3.3. Discussion 
 
In vitro experiments have suggested that Sox10-expressing eNCSCs give rise to both the 
Sox10
+ (glial cells) and the Sox10
- (neurons) lineages of the ENS (Bondurand et al., 
2003). However, the lineage relationship between Sox10-expressing cells and the 
neurons and glia of the ENS in vivo is currently unclear. To address this issue directly, 
we followed the fate of enteric Sox10
+ cells using a genetic fate mapping system that 
combines a Sox10Cre transgene (Matsuoka et al., 2005) with the Cre-dependent 
R26ReYFP reporter (Srinivas et al., 2001).  
The Sox10Cre transgene has been shown to be correctly expressed in the lineages of 
the cranial neural crest (Matsuoka et al., 2005). However, expression of this transgene 
within the developing and adult gut was not previously characterized. We used the 
R26ReYFP reporter (Srinivas et al., 2001) to monitor Cre-mediated recombination. 
Analysis of Sox10Cre; R26ReYFP embryos confirmed that the Sox10Cre transgene 
confers expression of the YFP reporter in Sox10-expressing cells and its derivatives, 
including the NCCs that colonise the gut. Moreover, we found that Cre efficiently 
mediates recombination in the ENS as the vast majority of Sox10
+ cells (83%) in the gut 
were GFP-labelled. These results establish the Sox10Cre; R26ReYFP transgene 
combination as a valuable tool for fate-mapping studies in the ENS.  
By following the progeny of Sox10
+ cells, we demonstrated that these cells have the 
potential to give rise to both enteric neurons and glia in vivo. The results from this direct 
cell lineage analysis eliminate uncertainties associated with the use of gene co-
expression as a lineage marker or the cell autonomy questions left open by the analysis 
of mutant phenotypes (see Introduction) and unequivocally establish Sox10-expressing 
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cells as the progenitors of both enteric neurons and glia. Since our lineage analysis did 
not resolve the multipotency of a single Sox10
+ cell but rather traced the fates of Sox10
+ 
cell populations, it is possible that Sox10-expressing cells are a mixture of neuronal and 
glial progenitors. Alternatively, our results may reflect the possibility that single Sox10
+ 
cells have the potential to generate both neurons and glia. Clonal cell fate analysis in 
vivo will be required to directly address the differentiation potential of single Sox10-
expressing cells.  
We also examined directly the lineage relationship between Sox10-expressing cells 
and myofibroblasts in vivo. Previous cell culture studies suggested that eNCSCs have 
the potential to give rise to myofibroblasts as identified by the expression of SMA 
(Bondurand et al., 2003; Kruger et al., 2002; Suarez-Rodriguez & Belkind-Gerson, 
2004). Bondurand et al. (2003) reported the presence of SMA
+ cells in the neurospheres 
generated by culturing dissociated gut cells from wild-type embryos and newborn mice. 
Similarly, Suarez-Rodriguez and Belkind-Gerson (2004) established adherent cultures 
from dissociated intestine and observed an increase of the expression levels of SMA 
transcripts throughout the culture period. In these studies, the lineage relationship 
between eNCSCs and SMA
+ cells was not addressed and so it is possible that the SMA
+ 
cells found in culture corresponded to contaminating muscle cells. Another possibility is 
that eNCSCs were able to generate myofibroblasts as in the case of other NCSCs 
(Joseph et al., 2004; Morrison et al., 1999). In accordance with this hypothesis, Kruger 
et al. (2002) found that single p75
+ cells isolated from the gut generate colonies that 
contain neurons, glia and myofibroblasts. In our study, we did not find co-localization 
between GFP and SMA in the ENS of E16.5 or P30 double transgenics, thus indicating 
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that Sox10
+ cells do not have the potential to give rise to myofibroblasts in vivo. The 
discrepancy between our findings and Kruger et al. observations may be explained by 
the possibility that Sox10
+ cells represent a population of neural stem cells different 
from the p75
+ cell population that includes myofibroblast progenitors. Alternatively, 
acquisition of a muscle cell phenotype by eNCSCs in culture may be associated with 
broadening of their developmental potential in vitro in ways that do not occur under 
physiological conditions. Such differences in the developmental potential exhibited in 
culture and in vivo have been reported for other progenitor cells (reviewed in Joseph & 
Morrison, 2005). 
Because in our lineage tracing system Sox10-expressing cells and their progeny are 
irreversibly labelled by GFP, the relative frequency of neurons and glia in the ENS at a 
given time can be examined by determining the frequency of GFP
+ neurons and glia in 
the GFP-labelled population. We found that at E16.5, 47% of the GFP
+ cells expressed 
the neuronal marker Tuj1, thus indicating that at this stage the eNCC population is 
comprised mainly of neurons. This is consistent with a previous report showing that at 
the same developmental stage the neuronal population corresponds to 50% of the 
eNCCs as identified by the expression of the transcription factor Phox2b (Young et al., 
2003). In contrast, at P30, 64% of the GFP
+ cells co-expressed the glial marker S100β 
indicating that glial cells become relatively more abundant than neurons. This 
observation is in accordance with previous reports and suggests that enteric glia are the 
most abundant cell type in the ENS of adult animals (Gabella, 1981; Hoff et al., 2008). 
Since our fate analysis did not distinguish between the potential of Sox10
+ cell 
populations and Sox10
+ single cells, these results raise two possible interpretations. One 
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possibility is that from embryogenesis to adulthood Sox10
+ gliogenic progenitors 
become predominant over neuronal progenitors. Alternatively, it is possible that Sox10
+ 
cells become biased to generate glial cells as development proceeds. Our data are 
consistent with findings of Kruger et al. who showed that in vitro eNCSCs exhibit 
reduced neurogenic potential and become biased to generate glia with increasing age. 
The authors further suggested that such changes in the potential of eNCSCs are 
associated with temporal differences in their responsiveness to lineage-determination 
factors present in the cellular micro-environment. Whether eNCSCs undergo similar 
changes in vivo and whether signals present in the extracellular environment can account 
for the shift between neurogenesis and gliogenesis is still unclear. 
Based on the assumption that undifferentiated, multilineage progenitors do not 
express neuronal or glial markers, Young et al. (2003) estimated that 2% of the cells in 
the myenteric ganglia of newborn animals are eNCSCs. However, the neural crest origin 
of the non-neuronal non-glia cells found in this study was not confirmed. In our study, 
most Sox10
+ cells and their progeny are permanently labelled and so the relative 
frequency of eNCSCs at a given time can be inferred by calculating the proportion of 
GFP
+ cells that do not express neuronal or glial markers. We estimated that eNCSCs 
correspond to 25% of all ENS cells at E16.5 and less than 1% in the adult ENS, thus 
suggesting a dramatic reduction in the number of eNCSCs with increasing age. This is 
in agreement with previous studies proposing a reduction in the size of the multipotent 
progenitor pool from embryonic to adult stages (Kruger et al., 2002; Young et al., 
2003).  
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Taken together, our data demonstrated that during gut organogenesis both neurons 
and glia of the ENS derive from a common pool of Sox10-expressing cells. 
  
 
 
 
 
Chapter IV 
 
 
Generation and Analysis of 
Sox10iCreER
T2 transgenics 
 
  Results 
4.1. Introduction 
 
As eNCSCs migrate away from the gut entry points and spread uniformly through the 
gastrointestinal tract, they respond to strong proliferative signals which increase their 
numbers dramatically (Gianino et al., 2003). In parallel, subsets of eNCSCs undergo 
sequential lineage restriction before differentiating into a vast array of phenotypically 
diverse neurons and glial cells. Thus, the development of the ENS is a complex, 
asynchronous process that relies on the temporal regulation of eNCSCs migration, 
proliferation and differentiation. It is still largely unknown how such cellular processes 
are appropriately controlled and integrated temporally in the context of the 
gastrointestinal tract, which is itself undergoing growth and morphogenesis. Previous 
reports suggested that this depends on temporal changes in both the environment and 
cell-intrinsic properties of eNCSCs over time (Bixby et al., 2002; Chalazonitis et al., 
1998; Chalazonitis et al., 2008; Gershon et al., 1993; Kruger et al., 2002).  In the 
absence of specific markers and tools to identify and follow eNCSCs in vivo, changes in 
the properties of these cells (i.e self-renewal capacity, neurogenic potential) over the 
course of ENS development have only been examined in culture, by studying the 
behaviour of prospectively identified cell populations (Bondurand et al., 2003; Kruger et 
al., 2002). Therefore, the question as to whether and how the properties of eNCSCs 
change over time in vivo in a manner consistent with the changing demands of tissue 
growth and maintenance remains unanswered.  
The study of temporally defined cell populations and their progeny in vivo can be 
achieved using an inducible genetic fate mapping system. This system makes use of a 
fusion protein in which the catalytic domain of Cre recombinase is fused with a mutated 
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ligand-binding domain of the human (ER
T; ER
T2) or mouse (ER
TM) estrogen receptor 
gene (Danielian et al., 1998; Feil et al., 1996; Feil et al., 1997). The mutated ligand-
binding domain of the chimeric CreER fails to bind the naturally occurring ER ligand 
17β-estradiol but has high affinity for the synthetic ligand tamoxifen (TM) and 4-
hydroxytamoxifen (4-OHT), a liver-generated metabolite of TM that induces Cre 
activity as effectively as TM (Danielian et al., 1993; Danielian et al., 1998). Unlike 
other Cre recombinases, CreER lacks a nuclear localization sequence and is sequestered 
in the cytoplasm in an inactive form by heat shock protein 90 (Hsp90). In the presence 
of TM/4-OHT, the fusion protein undergoes a conformational change that releases it 
from Hsp90 and allows it to be transported to the nucleus where it catalyzes 
recombination of a floxed transcriptional STOP signal, thereby allowing expression of a 
reporter encoded by an unlinked locus (Fig. 4.1). The recombination event that activates 
the reporter allele occurs within 6-12 hours after TM/4-OHT administration and 
continues for up to 36 hours (Hayashi & McMahon, 2002), consistent with TM 
pharmacokinetics in vivo (Robinson et al., 1991). Because of this 48 hour window of 
TM/4-OHT activity, cells expressing CreER at a specific developmental stage can be 
selectively labelled. Thus, this type of recombination can be used to follow the progeny 
of cells that express the gene of interest at defined developmental stages, including 
postnatal growth and during regeneration. 
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Figure 4.1. Schematic of tamoxifen-
induced Cre activity. The CreER 
fusion protein is transcribed under the 
control of a tissue specific promoter 
(1) and translated in the cytoplasm (2). 
Cre is retained in the cytoplasm until 
ligand binding (3) at which time the 
activated protein translocates to the 
nucleus (4) where it mediates 
recombination at the loxP sites in the 
genome (5) (adapted from (Zhang et 
al., 2005).   
 
A major limitation in mouse functional genetics is that it involves the generation of 
complicated targeting and selection constructs. Generation of such constructs is often 
restricted by the availability of appropriate restriction enzyme cleavage sites in both 
cloning vectors and genomic DNA. In the past years, highly efficient phage-based 
homologous recombination systems in Escherichia coli have been developed (Lee et al., 
2001; Yu et al., 2000). These systems make use of a defective λ prophage to supply 
functions that protect and recombine electroporated linear DNA. Most commonly, the 
defective λ prophage is integrated into the E. coli chromosome and its expression is 
driven by the strong PL promoter which itself is under the tight control of the 
temperature-sensitive repressor cI857. Expression of λ-encoded recombination functions 
and, consequently, homologous recombination is induced by shifting the bacterial 
cultures from 32ºC to 42ºC. The prophage-based recombination system has the 
advantage of being proficient with homology sequences as short as 30-50 bp. Thus, 
PCR-amplified fragments can be used to generate the targeting cassette and modify, 
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without using restriction enzymes or DNA ligase, large segments of genomic DNA, 
such as those carried on phage artificial chromosomes (PACs).  
 
Here, we have used a phage-based homologous recombination system to generate a 
novel Sox10iCreER
T2 transgenic line which allowed us to selectively label Sox10-
expressing cells at particular developmental stages. 
 
4.2. Results 
 
4.2.1.Generation of the Sox10iCreER
T2 transgenic line 
 
We generated transgenic mouse lines in which a tamoxifen-inducible Cre recombinase 
is expressed under the control of the Sox10 regulatory sequences. To this end, a 170 Kb 
PAC spanning the Sox10 locus plus, 62 Kb upstream and 57 Kb downstream of the 
Sox10 gene, was isolated from the RCPI 21 PAC library (from UK HGMP Resource 
Centre; (Matsuoka et al., 2005); Fig.4.2 A). The Sox10 PAC was modified using a 
phage-based homologous recombination system in E. coli, as previously described (Lee 
et al., 2001; Yu et al., 2000). First, the Sox10 PAC was electroporated into the 
recombinogenic bacterial strain EL250, a modified DH10B strain containing the 
defective  λ prophage and an arabinose-inducible flpe gene (Lee et al., 2001). 
Transformed bacterial colonies were selected based on their resistance to kanamycin 
conferred by a kanamycin-resistance (Kan
R) gene in the pPAC4 vector backbone (see 
Chapter II).   
To modify the Sox10 PAC, a targeting vector was built as follows (Fig.4.2 B). A 
cassette containing the coding sequence of iCreER
T2 (a second generation inducible Cre 
that is 4- to 10-fold more sensitive to 4-OHT than CreER
T; (Indra et al., 1999) followed 
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by the chloramphenicol-resistance gene (Cm
R) was isolated from the vector backbone 
by SalI-SpeI digestion. The selection marker Cm
R, used to identify the correctly targeted 
clones, was flanked by FRT sites which allow its removal, prior to pronuclear 
microinjection of the PAC DNA, by flpe-mediated recombination (see below and 
Chapter II). To introduce the iCreER
T2-frt-Cm
R-frt targeting cassette at the correct 
location, it was flanked with DNA fragments homologous to the 5’ and 3’ regions of the 
targeting site. More specifically, we used the Sox10 PAC as a template to amplify by 
PCR, an AscI-SalI (460bp) and a SpeI-PacI (440 bp) fragments corresponding to the 5’ 
and 3’ homology regions, respectively. The targeting vector was then generated by 
subcloning the AscI-SalI 5’ homology, the SalI-SpeI targeting cassette and the SpeI-
PacI 3’ homology into the PacI-AscI cloning sites of the vector pBlueScript PacAsc 
(pBlueScript with a modified MCS to introduce PacI and AscI, kindly provided by N. 
Kessaris; UCL, UK) in a four-step ligation (see Chapter II) .  
Targeting of the PAC clone was carried out by shifting EL250 cells carrying the 
PAC from 32ºC to 42ºC to induce expression of the phage-encoded recombination 
functions. EL250 cells were then electroporated with the targeting cassette. By 
homologous recombination, the targeting cassette was inserted between exon 3 (coding 
for the translation initiation site ATG) and exon 5 of the Sox10  locus in the PAC, 
thereby replacing the coding sequence of Sox10 with that of the iCreER
T2 (Fig.4.2 C). 
To test whether the PAC DNA was correctly modified by homologous recombination, 
Southern blot analysis was performed. PAC DNA isolated from chloramphenicol-
resistant bacterial colonies was digested with BglII and the 3’ homology of Sox10 gene 
was used as a probe. A difference of 800 bp between modified (6807 bp) and 
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unmodified (7622 bp) Sox10 PAC was seen as expected for all the colonies tested 
(Fig.4.3 A). 
Next, the Cm
R selectable marker was removed to prevent its possible interference 
with  iCreER
T2 expression. Besides homologous recombination functions (the λ 
prophage genes), the EL250 strain carries also site-specific recombination functions, 
namely an arabinose-inducible flpe gene which encodes for the genetically enhanced 
recombinase Flp. In the presence of arabinose, the flpe gene is expressed leading to the 
removal of the frt-flanked selection marker from the targeted locus by Flp-mediated 
recombination. Removal of the selection marker was confirmed by Southern blot 
analysis of the modified PAC DNA digested with BglII using the 3’ homology fragment 
as a probe. A difference of 1.8 Kb between modified PAC with and without the Cm
R 
selectable marker confirmed correct targeting in all colonies tested (Fig.4.2 C, Fig.4.3 
B).  
Finally, the modified PAC DNA was linearized by restriction digest with NotI 
endonuclease generating 116 Kb, 16.7 Kb and 13.8 Kb bands (Fig.4.3 C).  The 116 Kb 
band corresponding to the modified Sox10 locus was isolated, concentrated in a 0.5-0.8 
cm agarose gel block (Fig.4.3 D), purified and checked by PFGE before injection into 
the pronuclei of fertilized mouse eggs (Fig.4.3 E; see ChapterII). 190 pups were born 
from injected eggs and genotyped for the presence of the transgene. Sixteen founder 
transgenic mice (8 males; 8 females) carrying the Sox10iCreER
T2  transgene were 
identified based on genotyping by PCR (Fig.4.3 F; see Chapter II). Four males showed 
germline transmission of the transgene and these were bred with the R26ReYFP reporter 
line. Results 
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Figure 4.2. Strategy used to generate Sox10iCreER
T2 PAC transgenic mice.  
 
(A) Schematic representation of the 170 Kb PAC indicating the intron-exon structure of 
the Sox10 locus (exons - white/blue rectangles; introns – black lines), initiator ATG, 
extent of the genomic regions upstream and downstream of the Sox10 locus in the PAC 
insert and relative locations of BglII and NotI restriction sites. (B) A gene cassette 
comprising 400-500 bp 5’ and 3’ homology regions (white boxes), CreER
T2 coding 
sequence (grey box) and chloramphenicol resistance (Cm
r) expression cassette (green 
box) flanked by FRT sites (black arrows) was used as the targeting vector for 
homologous recombination. Relative locations of AscI, BglII, SalI, SpeI and PacI 
restriction sites and the location of the 3’ UTR probe used to hybridize to Southern blots 
of BglII-digested DNA are depicted. (C) Schematic representation of the PAC vector 
after removal of the Sox10 locus (top) and the Cm
R cassette (bottom) by homologous 
recombination.
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Figure 4.3. Generation of the Sox10iCreER
T2 PAC transgenic mice.  
 
(A) Targeting of the Sox10 locus by homologous recombination. Southern blot analysis 
of BglII-digested PAC DNA from modified Sox10 PAC using as a probe the 3’ 
homology of Sox10 gene (3 mini-preps plus the negative control -Sox10 PAC DNA- are 
shown). The expected fragment sizes are indicated on the left. (B) Removal of the Cm
R 
cassette by homologous recombination. Southern analysis of BglII-digested PAC DNA 
from modified Sox10 PAC with and without the selection marker Cm
R, using the 3’ 
homology of Sox10 gene as a probe (5 mini-preps plus the negative control -targeted 
Sox10 PAC- are shown). The expected fragment sizes are indicated on the left. (C-E) 
Isolation of PAC DNA prior to  microinjection into the pronuclei of fertilized eggs. 
Targeted PAC DNA was purified away from the vector backbone by restriction digest 
with NotI (C), concentrated in a 0.5-0.8 cm agarose gel block (D) and quantified by 
PFGE (E; see Chapter II). Shown on the left are the molecular weights in kilobases. (F) 
Identification of founders by PCR genotyping using Cre primers (Table 2.1) and tail 
DNA. Representative samples depicting the presence of a single 550 bp fragment 
corresponding to a positive genotype. A 550 bp fragment was amplified from the 
modified PAC, used as positive control [C(+)]. Lanes corresponding to the negative 
control DNA [C(-)] and water were blank. The molecular weights in kilobases are 
shown on the left. 
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4.2.2. Sox10iCreER
T2 transgene is appropriately expressed within the Sox10 
expression domain 
 
To establish that expression of the Sox10iCreER
T2 transgene faithfully recapitulates 
expression of endogenous Sox10, we performed in situ hybridization using Sox10 and 
Cre riboprobes on adjacent coronal sections of E12.5 double transgenic embryos treated 
with 0.2 mg/g of 4-OHT at E9.5 (Fig.4.4 A and C). In parallel, embryo serial sections 
were also immunostained for GFP to confirm that the transgene is capable of inducing 
recombination on the reporter R26ReYFP. In all four independent transgenic lines, 
expression of the transgene Sox10iCreER
T2 and GFP fluorescence were detected 
exclusively in Sox10-expressing neural crest derivatives, such as the dorsal root ganglia 
(DRG), the sympathetic chain ganglia and the ganglia of the oesophagus, stomach and 
intestine (Fig.4.4 B, D). Three transgenic lines (SER26, SER66, and SER87) exhibited 
consistent and comparable patterns of transgene expression and GFP fluorescence 
(Fig.4.4 B). In the remaining mouse line (SER93) the transgene and, consequently, GFP 
were expressed only in a subset of Sox10-expressing cells (Fig.4.4 D). Transgenic lines 
SER26 and SER93 were selected for subsequent analysis.   
Appropriate expression of the Sox10iCreER
T2 transgene was further confirmed by 
analysing the GFP fluorescence pattern in whole embryos and dissected guts of E12.5 
SER26; R26ReYFP double transgenics treated with 4-OHT at E9.5 (Fig.4.4 E ii-viii and 
F ii, iv).  Appropriate expression of GFP was found in the cranial ganglia (Fig.4.4 E ii, 
vi), dorsal root ganglia (Fig.4.4 E ii, iii) and sympathetic chain (Fig.4.4 E ii, iii). We 
also observed expression of GFP very distinctly in the nerve fibers leaving the spinal 
cord area (Fig.4.4 E ii, iv), in the radial and ulnar nerves of the limbs (Fig.4.4 D v) and 
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in the otic vesicle (Fig.4.4 E ii). Coronal sections of E12.5 double transgenics confirmed 
GFP expression in cranial ganglia and in the heart (Fig.4.4 E vii-viii). Finally, GFP 
expression was clearly visible in eNCCs in gut whole mount samples of E12.5 embryos 
(Fig.4.4 F ii, iv). This expression pattern is consistent with in situ hybridization analysis 
of Sox10 mRNA in mouse (Fig.3.1 B; (Kuhlbrodt et al., 1998) as well as with GFP 
expression pattern in the Sox10Cre, R26ReYFP trangenics (Fig.3.1 C; see Chapter III) 
and X-gal staining pattern in Sox10βGeoBAC transgenic line (Deal et al., 2006).  
 
4.2.3.Sox10iCreER
T2 –mediated recombination is inducible 
 
To examine whether the Sox10iCreER
T2 transgene is capable of inducing a temporally 
controlled recombination of the reporter R26ReYFP, we compared the pattern of GFP 
immunoreactivity in E12.5 Sox10iCreER
T2; R26ReYFP transgenic embryos collected 
from females treated with 4-OHT 9.5 days post-coitum or from control (uninjected or 
corn oil-injected) females. GFP was detected only in neural crest derivatives in embryos 
from treated pregnant females and was essentially absent from their untreated 
counterparts (n=8; Fig.4.4 E i, ii and F i, ii -SER26; R26ReYFP-; Fig.4.4 F iii, iv -
SER93; R26ReYFP-). More specifically, we observed that upon administration of 4-
OHT at E9.5, 88±8.6% of the Sox10
+ cells of SER26; R26ReYFP double transgenic 
embryos (1177 cells total from three mice) expressed the YFP reporter, as assessed by 
immunostaining for GFP, and Sox10. In contrast, only 3±1.1% (1219 cells total from 
three mice) of the Sox10
+ cells were GFP
+ in control embryos (Fig.4.4 F vi). In the 
SER93; R26ReYFP transgenic line, upon administration of 4-OHT at E9.5, 8±0.6% of 
all Sox10
+ cells (953 cells total from three mice) were GFP
+ whereas no Sox10
+ cells 
were GFP
+ in the absence of 4-OHT (1460 cells total from five mice) (Fig.4.4 F v).  Results 
Figure 4.4.  Expression of YFP in R26ReYFP embryos carrying the transgene 
Sox10iCreER
T2 recapitulates expression of endogenous Sox10 and is inducible.
  
 
(A and C) Pregnant females were injected with 4-OHT (0.2 mg/g) 9.5 days post-coitum 
as indicated by the red arrow.  Sox10iCreER
T2; R26ReYFP embryos were harvested and 
analysed at E12.5. (B, D) Adjacent coronal sections through SER26; R26ReYFP (B) 
and SER93; R26ReYFP (C) double transgenic embryos were used for in situ 
hybridization using Sox10 (i) and Cre (ii) riboprobes and for GFP immunostaining (iii). 
Images show specific expression of the transgene iCreER
T2 and the reporter within the 
Sox10 expression domain, namely, in the dorsal root ganglia (DRG), sympathetic chain 
(SC), oesophagus (Oe) and loops of the gut (Gut). Arrows indicate CreER
T2-expressing 
cells (B-ii) and GFP
+ cells (B-iii). All sections were 12µm. (E-i, ii) GFP whole-mount 
immunostaining of SER26; R26ReYFP double transgenic embryos harvested from an 
uninjected female (control) (i) or a female exposed to 4-OHT (ii). Arrows in (ii) point to 
nerve fibers leaving the spinal cord area. (iii-v) Magnification of boxed area in (ii) 
showing DRGs and sympathetic ganglia (iii), magnification of the nerves fibers 
sprouting from the spinal cord area (iv) and the radial and ulnar nerves of the limb (v). 
(vi-viii) GFP immunostaining of coronal sections of SER26; R26ReYFP transgenic 
embryo showing expression of YFP in the cranial ganglia (vi and vii) and heart (viii). 
(F) GFP immunostaning of guts from SER26; R26ReYFP (i, ii) and SER93; R26ReYFP 
(iii, iv) double transgenic embryos showing minimal or no induction of YFP in the 
absence of 4-OHT (i, iii), whereas, in the presence (ii, iv) of 4-OHT iCreER
T2 efficiently 
mediates recombination in enteric cells. Inset: Higher magnification (x400) of ENS cells 
at the neural crest front of migration. Quantification of the number of GFP-labelled cells 
in the Sox10
+ population in the gut of SER26; R26ReYFP and SER93; R26ReYFP 
embryos is shown in the graphs vi and v, respectively. Graphs error bars, s.e.m; Cg, 
cranial ganglia; SC, sympathetic chain; DRG, dorsal root ganglia; Oe, oesophagus; St, 
stomach; Mg, midgut; Ce, caecum; Hg, hindgut. i and ii; x16; iii and iv, x40; v, x32; vi- 
viii, x100; (F) i-iv, x50.
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4.2.4. In vivo labelling of single Sox10-expressing cells 
 
To establish a system of single cell-labelling, we examined reporter activation in the gut 
of E12.5 SER93; R26ReYFP transgenic embryos treated with different dosages of 4-
OHT at E9.5. We consistently found absence of GFP
+ cells in the gut of double 
transgenics upon treatment with 2 µg/g of 4-OHT, indicating that this dose is below the 
threshold for activation of the Sox10iCreER
T2 recombinase (n=14; data not shown). In 
contrast, we found scattered isolated GFP
+ cells along the gut of double transgenic 
embryos treated with 4 µg/g of 4-OHT (n=6; Fig.4.5 A). Progressively higher dosages 
of  4-OHT led to a reproducible increased frequency of GFP
+ gut cells, thus suggesting a 
dose-dependent response of the extent of recombination in eNCCs (Fig.4.5 B-D; 5 µg/g, 
n=8; 15 µg/g, n=5; 25 µg/g, n=4).  
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Figure 4.5. Single-cell labelling of Sox10-expressing cells. 
 
(A-D)  Immunostaining of dissected guts from E12.5 SER93; R26ReYFP double 
transgenic embryos for GFP (green) and the pan-neuronal marker Tuj1 (red) showing 
GFP fluorescence in small clusters of eNCCs. Embryos were treated with 4 µg/g (A), 5 
µg/g (B), 15 µg/g (C) or 25 µg/g (D) of 4-OHT. x50 magnification. Inset in B: Higher 
magnification (x400) of single GFP-labelled eNCCs. Representative embryos are 
shown. oe, oesophagus; st, stomach; mg, midgut; ce, caecum; hg, hindgut. 
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4.3. Discussion 
 
Our current understanding of the changes eNCSCs undergo over time and the 
mechanisms that regulate their orderly differentiation into distinct lineages is based 
mainly on in vitro observations (Bondurand et al., 2003; Kruger et al., 2002). The study 
of the properties of eNCSCs in vivo relies on the ability to positively identify and follow 
them. One way to study eNCSCs as they exist in vivo and follow these cells during ENS 
development, homeostasis and regeneration is to use the Cre-loxP lineage-labelling 
system to indelibly mark the descendants of specific cell types. However, because in this 
system Cre is constitutively expressed, cells are marked from the time when the 
promoter driving Cre expression is first turned on in development. Marked progeny 
accumulate as development proceeds and new cells activate Cre. Thus, it is not possible 
to follow the progeny of cells that express the gene of interest at defined developmental 
stages. The inducible CreER-loxP overcomes such limitations by allowing temporal 
control of recombination.  
Aiming at exploring the temporal changes in the developmental potential of ENS 
progenitor cells in vivo during pre- and post-natal stages and having established that 
Sox10 is expressed by ENS progenitor cells, we developed mouse lines transgenic for 
the tamoxifen-inducible Sox10iCreER
T2 cassette. To this end, we used PAC transgenics. 
PACs are vectors derived from the P1 bacteriophage that can carry large fragments of 
genomic DNA (100-300 Kb in size). Given their large size, PACs have a high 
probability of harbouring most, if not all, regulatory elements of the gene of interest. 
This is particularly important in light of recent studies demonstrating that the regulation 
of Sox10 is not strictly controlled by proximal promoter elements associated with the 
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start site of transcription but by cis-elements situated at a great distance (Antonellis et 
al., 2006; Deal et al., 2006). For instance, Antonellis et al. (2006) showed that a 16 Kb 
region localised 47 Kb upstream of the Sox10 gene is required for Sox10 expression in 
early neural-crest progenitors. Taking those observations into account, we chose a large 
PAC clone (170 Kb) spanning the Sox10 locus plus 62 Kb upstream and 57 Kb 
downstream of the Sox10 gene. The Sox10 PAC was modified employing established 
PAC modification techniques thereby inserting the
  coding sequence  of  iCreER
T2 in 
frame with the initiating ATG of the Sox10 locus in the PAC (Lee et al., 2001). By 
rigorously comparing expression of Sox10iCreER
T2  transgene with the expression 
pattern of endogenous Sox10, we found appropriate expression of the transgene in all 
four independent transgenic lines generated. We never observed expression of the 
transgene in regions other than cell types and tissues originated from Sox10-expressing 
cells, thus ruling out any potential ectopic expression of the transgene due to position 
effects. This is consistent with accumulating evidence from analysis of PAC transgenics, 
which suggest that the extensive flanking regions incorporated in such constructs make 
PAC transgenics less susceptible to position effects and more likely to confer position-
independent transgene expression (Deal et al., 2006; Wells & Carter, 2001). 
Using a Rosa26-based reporter system we demonstrated that besides being 
appropriately expressed, the Sox10iCreER
T2  transgene was able to mediate 
recombination leading to YFP expression exclusively in Sox10-expressing neural crest 
derivatives. More specifically, we observed expression of YFP in the intrinsic ganglia of 
various embryonic organs, including the lungs, the heart and intestinal tract. This is in 
accordance with previous studies reporting expression of Sox10 in the peripheral nerves 
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in the lung (Burns & Delalande, 2005), autonomic nerves of embryonic chick heart 
(Montero et al., 2002) and gut (Paratore et al., 2002; Young et al., 2003). Outside the 
peripheral nervous system, we observed expression of YFP in regions where Sox10 
expression has been documented, such as the nerves of the limbs, brain, spinal cord and 
otic vesicle (Britsch et al., 2001; Kuhlbrodt et al., 1998). Taken together, our results 
suggest that the extensive flanking regions carried in the Sox10 PAC clone include the 
necessary regulatory elements to direct faithful and tissue-specific expression of the 
Sox10iCreER
T2 transgene.  
To induce Cre-mediated recombination in double transgenic embryos 0.2 mg/g of 4-
OHT were administered to pregnant females. Based on macroscopic and histological 
evaluation, exposure to the dose of 4-OHT used did not reveal any developmental 
defects nor did it affect embryonic viability or delivery of the pups. This is in contrast to 
other studies reporting that the dose of ligand required to activate Cre recombinase is 
close to that which interferes with the maintenance of pregnancy (Danielian et al., 
1998). Furthermore, we demonstrated that administration of 0.2 mg/g reliably induced 
recombination in R26ReYFP embryos carrying the iCreER
T2 transgene.  In the SER26; 
R26ReYFP transgenic line, we observed a very low percentage (3%) of Sox10
+ cells 
within the gut that underwent recombination in the absence of 4-OHT thus, indicating 
slight “leakiness” of the iCreER
T2 transgene. In contrast, when 4-OHT was provided at 
E9.5, the time point when NCSCs invade the gut, almost all (88%) Sox10
+cells in the 
gut of SER26; R26ReYFP transgenic line were labelled which demonstrates the 
feasibility of this system for fate-labelling ENS progenitors.  
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Unlike SER26; R26ReYFP transgenics, the SER93; R26ReYFP transgenic line did 
not exhibit Cre-mediated recombination in the absence of 4-OHT. Interestingly, we 
observed that administration of 0.2 mg/g of 4-OHT to pregnant females induced low-
level recombination as only 8% of the Sox10
+ cells in the gut of SER93; R26ReYFP 
were GFP-labelled. Furthermore, our results showed that the extent of recombination in 
eNCCs of SER93; R26ReYFP embryos was dose-dependent. By lowering the dose of 4-
OHT administered, we were able to control the efficiency of recombination in target 
cells in such a way that single cells or small populations of cells were labelled. The 
ability to target small populations of cells at a specific time point can be a considerable 
advantage. In a similar approach to that used in genetic analysis of Drosophila 
development, this transgenic line can potentially be used to study gene function by 
generating genetically mosaic animals in which a particular mutation (gene inactivation 
or overexpression) is restricted to a small population of cells, at a desirable time, in an 
otherwise wild-type background (see Chapter VII). Moreover, this system can be 
exploited to study cell morphology and visualize wiring patterns in the ENS; to isolate 
progenitor cells and their progeny for gene expression analysis to investigate the 
mechanisms of cell fate, specification and differentiation and to perform lineage analysis 
at the single-cell level. For instance, our data demonstrated that Sox10-expressing cells 
are multipotent at the population level (Chapter III), however, the potential of single 
Sox10
+ cells to generate both neurons and glia and to differentiate into various neuronal 
subtypes is still unknown. By lowering the dose and changing the time of 4-OHT 
administered to SER93; R26ReYFP transgenics it is possible to label Sox10
+ cells 
present in the gut at different developmental stages and then trace their fates clonally in 
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vivo. Further refinement to this analysis can be added by combining the SER93; 
R26ReYFP transgenic line with a Brainbow-like reporter system (Livet et al., 2007), 
thereby labelling genetically with different colors, cell clusters derived from different 
single Sox10
+ cells. Identification of the cell types present in such clusters will provide 
valuable insight into the clonal relationship between neurons and glia, as well as 
between different enteric neuron subtypes.  
In summary, our results demonstrated a 4-OHT-dependent and cell type-specific 
activation of Cre recombinase in Sox10iCreER
T2; R26ReYFP mice and established this 
as a valuable genetic system in which Sox10-expressing progenitor cells can be lineally 
marked as a population (SER26; R26ReYFP) or as single cells (SER93; R26ReYFP) at 
specific pre- and post-natal stages in vivo. 
 
 
  
 
 
 
 
Chapter V 
 
 
Temporal regulation of the neurogenic 
potential of Sox10-expressing cells in the 
ENS 
 
  Results 
5.1. Introduction 
 
The mature ENS contains a vast number of neurons that differ in neurotransmitter 
expression, morphology, electrophysiology and function (Furness, 2000; Gershon et al., 
1993). Generation of correct numbers and types of neurons by eNCSCs is crucial for the 
development of a functional ENS. In accordance, motility defects have been reported in 
mutant mice in which myenteric neuron density is increased (Taketomi et al., 2005) or 
decreased (Roberts et al., 2008).  
Previous studies have suggested that enteric neurogenesis extends through a 
considerable period of time. Based on the expression of neuron-specific markers, 
differentiating neurons are found amongst the first wave of eNCCs that invade the 
foregut at E9.5 (Baetge & Gershon, 1989; Young et al., 1999) and, by E10.5-E11.5, they 
comprise 10-15% of the eNCCs within the bowel (Young et al., 1999). As development 
proceeds, there is an increase in the absolute number of differentiating neurons, which 
continues until well after birth (Ali & McLelland, 1979; Gabella, 1971; Liu et al., 2009). 
Furthermore, differentiation of neuronal precursors into different neuron subtypes 
(identified by the combined expression of specific neurotransmitters and the enzymes 
responsible for their synthesis) occurs at different stages of development and some of 
them are only found in the gut at postnatal stages (Branchek & Gershon, 1989; Rothman 
& Gershon, 1982; Rothman et al., 1984; Matini et al., 1997; Vannucchi & Faussone-
Pellegrini, 1996). Analysis of the time window during which neuronal precursors 
differentiate into different neuron subtypes showed that myenteric neurons are born 
from E8 to P5 whereas submucosal neurons are born from E8 to P14 (Chalazonitis et 
al., 2008; Pham et al., 1991). Therefore, eNCSCs are thought to maintain their 
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neurogenic potential during embryogenesis and early postnatal life. However, little is 
known about the developmental changes these cells undergo during maturation of the 
ENS in terms of neurogenic potential, and how this affects the rate and extent of 
neurogenesis in the ENS.  
Reports over the past years showed that neural stem cells change their intrinsic 
properties over time in a way that influences the number and type of neurons they can 
generate (Qian et al., 2000; White et al., 2001). Analysis of the behaviour of cell 
populations isolated from the gut, in culture, suggested that this might be the case also 
for eNCSCs (Kruger et al., 2002). p75
+ cells isolated from postnatal gut were shown to 
exhibit a reduced sensitivity to neurogenic factors in comparison to their embryonic 
counterparts. Such changes in the differentiation potential of these cells with age were 
further observed upon transplantation of p75
+ cells into developing chick nerves. 
Whether, in vivo, eNCSCs undergo significant changes in their neurogenic potential 
with time, as suggested by in vitro studies, remains unknown.  
 
Here, we have examined the temporal changes in the neurogenic potential of Sox10-
expressing cells in vivo using the Sox10iCreER
T2; R26ReYFP transgene combination to 
label temporally distinct populations of eNCSCs. 
 
5.2. Results 
 
5.2.1.Generation of neurons from Sox10-expressing progenitor cells decreases 
progressively with time  
 
To address the temporal regulation of the neurogenic potential of Sox10-expressing 
progenitor cells, 0.2 mg/g of 4-OHT was administered to SER26; R26ReYFP animals at 
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different developmental stages that broadly correspond to specific stages of enteric 
neurogenesis. Previous studies have shown that activation of Cre and recombination of 
target loxP sequences occurs within 48 hours after 4-OHT administration (Hayashi & 
McMahon, 2002; Robinson et al., 1991). Therefore, Sox10
+ cells present within double 
transgenic animals at or shortly after the time of 4-OHT administration will be marked 
by the permanent induction of YFP. The identity of their progeny can be established by 
double immunolabelling of adult gut MS-MP for GFP and appropriate lineage markers. 
For our present studies, 4-OHT was administered at E7.5, E8.5, E12.5, P0, P7, P30 and 
P84. The population of enteric neurons generated from Sox10-expressing ENS 
progenitors present in the gut at a given developmental stage was determined as the 
proportion of HuC/D
+ cells that co-expressed GFP. Two or more segments of MS-MP 
from the small intestine of P84 (for the E7.5-P30 stages) or P140 (for the P84 
administration) animals were examined (Fig.5.1 A).  
For all the time points considered, the difference in the proportion of GFP-labelled 
cells in the HuC/D
+ population between different regions of the small intestine was 
consistently less than 2.5% (Fig.5.1 J) and was statistically not significant (p>0.05). In 
the absence of 4-OHT, 0.6±0.8% of HuC/D
+ cells (1589 cells total from three mice) 
were co-labelled for GFP, indicating low background levels of Cre activity (Fig.5.1 B, 
K). When 4-OHT was administered to double transgenics at E7.5, 23.5±1.5% of the 
HuC/D
+ neurons co-expressed GFP (1280 cells total from three animals), indicating that 
almost a quarter of the enteric neurons in P84 mice are generated from Sox10-expressing 
cells after E7.5 (Fig.5.1 C, K). From E8.5 onwards the neurogenic potential of Sox10-
expressing cells decreased progressively. Thus, 39.5±10.6% (3013 cells total from five 
155 
 Results 
156 
 
animals) of the neurons in P84 animals were generated after E8.5 (Fig.5.1 D, K), 
36.9±6.4% (1606 cells total from four animals) after E12.5 (Fig.5.1 E, K) while only 
7.9±1% (2748 cells total from four animals) at around P0 (Fig.5.1 F, K). An even 
smaller fraction of enteric neurons was generated from Sox10
+ progenitors that persist at 
postnatal stages: 2.9±1.7% (2471 cells total from three animals) were generated from 
progenitors after P7 (Fig.5.1 G, K) while 1.7±1.1% (3579 cells total from four animals) 
from progenitors present in the gut at P30 (Fig.5.1 H, K). Finally, animals treated with 
4-OHT at P84 (0.6±0.2%; 3457 cells total from four animals) showed no GFP-labelled 
enteric neurons above background levels at P140 (Fig.5.1 I, K), indicating that by this 
stage the number of Sox10-expressing cells that differentiate into enteric neurons is 
negligible. 
 
5.2.2.All Sox10
+ cells in the ENS of P84 and older animals are glial cells 
 
The MS-MP strips of adult double transgenic mice treated with 4-OHT from P84 
onwards was triple immunolabelled for GFP, the neuronal-specific marker HuC/D and 
the glial marker S100β. No GFP
+HuC/D
+ cells were found above background levels. 
Moreover, 100% of the GFP
+ cells co-expressed the glial marker S100β (3081 cells total 
from four animals) (Fig.5.2). This data indicates that all the GFP
+ cells in the myenteric 
plexus of P84 or older double transgenic mice represent glial cells.  Results 
Figure 5.1. The neurogenic potential of Sox10-expressing ENS progenitor cells 
decreases progressively over time.  
 
(A)  SER26; R26ReYFP transgenic animals were treated with 4-OHT (0.2 mg/g) at 
different developmental stages (arrows) and their myenteric plexus was analysed (☺) at 
P84 (animals treated up to P30) or P140 (for animals treated at P30). (B-I) Confocal 
microscope images of representative whole mount preparations of the MS-MP strips 
from P84 or P140 transgenic mice not treated (B) or treated with 4-OHT at E7.5 (C), 
E8.5 (D), E12.5 (E), P0 (F), P7 (G), P30 (H) or P84 (I). Whole mount preparations of 
the MS-MP strips were immunostained for GFP (green) and HuC/D (red) and nuclei 
were labelled with TOTO3. x400 magnification. Insets show higher magnifications 
(x1080) of the boxed areas. Arrowheads point to GFP
+/HuC D
+ double labelled cells 
which correspond to neurons generated after 4-OHT administration. Arrows indicate 
GFP
-/HuC D
+ neurons. (J) Quantification of the difference in the proportion of 
GFP
+/HuC D
+ cells in the HuC/D
+ population between different regions of the small 
intestine. (K) Quantification of GFP
+ cells in the HuC/D
+ population is shown in the 
graph. The error bars indicate s.e.m.  
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Figure 5.2. All Sox10
+ cells in the ENS of P84 or older animals are glial cells. 
 
(A) MS-MP whole mount preparations from P140 SER26; R26ReYFP mice exposed to 
4-OHT at P84 and immunostained for GFP (green), HuC/D (blue) and S100β (red); 
x400 magnification. Inset shows higher magnification (x1080) of the boxed area: 
arrowheads point to GFP
+/HuC D
-/S100β
+cells while arrows indicate GFP
-/HuC D
+ 
cells. (B) Graph depicts quantification of the percentage of HuC/D
+ and S100β
+ cells in 
the GFP
+ cell population of P140 animals treated at P84. The error bars indicate s.e.m. 
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5.3. Discussion 
 
To form the mature ENS eNCSCs must generate correct numbers of neurons and glia in 
a developmentally appropriate manner. The neurogenic potential of eNCSCs in response 
to lineage determination factors was analysed in vitro (Kruger et al., 2002). However, 
the temporal regulation of neurogenesis in vivo during ENS development and maturation 
remained unknown.  
Here, we employed the Sox10iCreER
T2; R26ReYFP transgene combination to 
examine the neurogenic potential of Sox10
+ progenitors over the course of ENS 
development in vivo. At the outset, we determined the background levels of iCreER
T2 
activity in the neuronal population of adult SER26; R26ReYFP mice. Our results 
demonstrated that the Sox10iCreER
T2 transgene can mediate recombination in the 
myenteric plexus of adult double transgenics in the absence of 4-OHT, as previously 
shown in double transgenic embryos (Chapter IV). Nevertheless, we found that less than 
1% of the myenteric neurons were GFP-labelled, confirming that 4-OHT-independent 
recombination occurs at low levels in the neuronal progeny of Sox10
+ cells.  
Earlier reports showed that Sox10 expression is first detected in NCCs at E8.5 
(Anderson et al., 2006; Kuhlbrodt et al., 1998). As 4-OHT is active in injected mice for 
around 48 hours (Hayashi & McMahon, 2002), by administering this compound to 
double transgenics at E7.5 we expected to label most of the Sox10-expressing ENS 
progenitors. However, administration of 4-OHT at E7.5 resulted in GFP-labelling of 
only a quarter of all neurons (23%). One possible explanation for this result is the fact 
that the chorio-allantoic placental connection is only established after E9 which may 
lead to inefficient delivery of 4-OHT prior to this stage and, consequently, low levels of 
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iCreER
T2 activity to mediate recombination. Moreover, as shown previously (Chapter 
IV), recombination mediated by the Sox10iCreER
T2 transgene following administration 
of 0.2 mg/g of 4-OHT is insufficient to induce all the CreER
T2+ cells to undergo 
excision. Higher doses of 4-OHT, however, could not be administered without toxic side 
effects. Finally, another possible explanation for the incomplete labelling observed is 
that some NCCs may have started to express Sox10 when 4-OHT was no longer active 
(from around E9 onwards).  
  We analysed the neurogenic potential of enteric Sox10-expressing cells in vivo by 
labelling temporally distinct Sox10
+ subpopulations and following their progeny. 
Analysis of the proportion of GFP-labelled neurons in different regions of the small 
intestine of adult double transgenics revealed no differences for any of the 
developmental stages considered, which strongly suggests that the rate of neurogenesis 
is equivalent throughout the small intestine. In contrast, we found that the neurogenic 
potential of Sox10
+ cells is temporally regulated. The proportion of lineally marked 
neurons in the myenteric plexus of adult double transgenics was highest when 4-OHT 
was administered at midgestation (E8.5-12.5) and decreased progressively at postnatal 
stages. Consistent with our results, Pham et al. (1991) reported that the rate of birth of 
most neuronal subtypes was higher during embryogenesis. The reason for the 
progressive reduction of the neurogenic potential of Sox10-expressing cells with 
increasing developmental age is unclear. It is possible that changes in the 
microenvironment, for example, in signal availability, account for the changes in 
developmental potential here reported. Alternatively, these findings can also reflect 
differences among progenitor cells at different ages in terms of their competence to 
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respond to specific environmental cues. In support of the latter is work published 
recently emphasizing that neural stem cells change their cell-intrinsic properties over 
time in a manner that influences cell fate determination. For example, radial glial cells 
of the cerebral cortex isolated from later embryonic stages were shown to give rise to 
fewer neurons before initiating gliogenesis than their earlier counterparts (Qian et al., 
2000). Similarly, eNCSCs from postnatal gut were shown to generate neurons less 
efficiently than embryonic eNCSCs upon transplantation into the same environment (the 
neural crest migratory pathway of chick embryos; Kruger et al., 2002). The molecular 
basis for these cell intrinsic changes is still not clear but analysis of the behaviour of 
eNCSCs in vitro suggested that it might involve changes in the sensitivity to lineage 
determination factors present in the microenvironment. In comparison to embryonic 
eNCSCs, eNCSCs from postnatal animals were shown to exhibit decreased sensitivity to 
the neurogenic effects of BMP4 and increased sensitivity to the gliogenic effects of the 
soluble Notch ligand Delta-Fc and neuregulin (Kruger et al., 2002). It is still unknown 
whether similar mechanisms and cues account for reduction of the neurogenic potential 
of eNCSCs in vivo. Also, it remains uncertain how this reduction in neurogenesis relates 
to the timing of gliogenesis.  
  As in other parts of the nervous system, in the ENS glial cells appear after neurons. 
However, formation of new neurons persists after the appearance of glial cells 
suggesting that neurogenesis and gliogenesis co-exist for some time.  Given that Sox10 
expression is maintained in glial cells throughout adulthood (Kuhlbrodt et al., 1998), 
administration of 4-OHT from E11.5 (time point at which expression of the glial marker 
BFABP is first detected in the gut) onwards labelled eNCSCs as well as glial cells. For 
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that reason, changes in the gliogenic potential of Sox10
+ progenitors over the course of 
ENS development in vivo could not be addressed with our experimental strategy.  
A significant finding of our lineage tracing analysis was the generation of new 
neurons in adult animals after P30. Previously, neurons were thought to be generated 
during embryogenesis and early postnatal life (Chalazonitis et al., 2008; Pham et al., 
1991). However, from postnatal to adult stages, the ENS enlarges massively as the gut 
grows in length and diameter, thus suggesting that neurons continue to be generated. By 
administering 4-OHT to P30 double transgenic animals we found 2% of GFP-labelled 
cells in the neuronal population, indicating that new myenteric neurons are added to the 
mature ENS. In contrast with our results, a previous study of enteric neuronal birthdays 
was unable to detect neurogenesis in the myenteric plexus beyond P5 (Pham et al., 
1991). In this report, radiolabelled-thymidine was administered to pregnant females and 
to P0 to P21 mice for a 24 hour period. Such a regime would, however, be unlikely to 
detect neurogenesis if the cell cycle length of adult neuroblasts is long; to detect low rate 
neuronal birth days with a single systemic injection of radiolabelled-thymidine, a 
terminal mitosis would have to occur precisely during the period of time that 
radiolabelled-thymidine is available which would be a rare event. Similarly, serial 
injections of Brd-U for 7 days failed to detect generation of new neurons in 6 week old 
animals, further supporting the idea that adult eNCSCs undergo mitosis infrequently 
(Liu et al., 2009). In our lineage tracing system, Sox10-expressing progenitor cells and 
all their progeny were irreversibly labelled independently of their cell cycle length 
allowing the identification of newly generated neurons from the time point of 4-OHT 
administration.  
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Importantly, our results demonstrated that after P84 the number of Sox10-expressing 
cells that differentiate into enteric neurons is negligible. 4-OHT administration at P84 
failed to label enteric neurons above the background level, thus suggesting that 
subsequent to this stage, the adult ENS does not support neurogenesis under 
physiological conditions. Interestingly, cells isolated from the adult ENS have been 
shown to exhibit neurogenic potential in vitro (Kruger et al., 2002). This may reflect 
reprogramming of adult ENS cells in culture in such a way that they acquire neurogenic 
potential. Indeed, there are several well-documented examples of cells that change their 
developmental potential in culture in ways that do not appear to occur under 
physiological circumstances (reviewed in Joseph & Morrison, 2005). Alternatively, it is 
possible that Sox10
+ progenitor cells in the adult ENS retain neurogenic potential but 
only reveal it under conducive conditions (e.g. in culture) remaining quiescent 
otherwise. In support of this hypothesis, Liu et al. (2009) suggested that failure to detect 
neurogenesis even after long-term exposure to BrdU results from the fact that generation 
of new neurons in the adult ENS occurs in vivo at a rate too low to be detected unless it 
is increased by a stimulus, such as activation of 5-HT receptors. If quiescent Sox10
+ 
progenitor cells remain in the adult ENS we would expect to find undifferentiated GFP-
labelled cells in the myenteric plexus of adult animals treated with 4-OHT after P84. 
Instead, we found that all GFP-labelled cells in the myenteric plexus of these animals 
were S100β
+, which strongly suggests that all Sox10-expressing cells in the adult ENS 
are glia. These results raise the possibility that the pool of Sox10-expressing eNCSCs 
with neurogenic potential becomes depleted as development proceeds. In support of this 
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view, the self-renewal capacity of eNCSCs in vitro has been shown to decline with 
increasing age (Kruger et al., 2002).  
Taken together, our data demonstrated that the neurogenic potential of Sox10-
expressing cells of the mammalian gut is temporally regulated. Sox10
+ progenitors 
showed strong neurogenic potential during embryogenesis which was progressively lost 
as development proceeded. In the adult, virtually all Sox10-expressing cells were 
identified as glia. 
   
 
 
 
 
Chapter VI 
 
 
Identification of neural stem cells in the 
adult ENS 
 
  Results 
6.1.  Introduction 
 
An increasing body of evidence has accumulated in recent years supporting the 
existence of adult stem cells in a large number of tissues, including the nervous system 
(Morrison & Spradling, 2008). Contrary to previous beliefs, the adult CNS is now 
known to contain neural stem cells that sustain ongoing neurogenesis in two discrete 
neurogenic niches, the SVZ of the lateral ventricles and the SGL in the hippocampus 
(Alvarez-Buylla & Lim, 2004). Besides SVZ- and SGL-resident neural stem cells, cells 
capable of long-term self-renewal and multipotency have been derived from regions 
throughout the adult CNS and neurogenesis has been shown to be activated outside of 
the CNS neurogenic niches, in response to injuries and pathological stimuli (Ming & 
Song, 2005). In vivo neurogenesis has also been reported in the adult PNS, more 
specifically, in the rat nodose ganglia, following capsaicin-mediated destruction of 
existing neurons (Czaja et al., 2008) and in the neural crest-derived carotid body in 
response to hypoxia (Pardal et al., 2007).  
Another important development that has had major impact in our understanding of 
adult neurogenesis was the realisation that glia can perform dual functions of providing 
homeostatic support and participating in neurogenesis (Alvarez-Buylla et al., 2001; 
Doetsch et al., 1999). A variety of approaches demonstrated that ongoing neurogenesis 
in the CNS is ensured by GFAP-expressing progenitors with the characteristic 
morphological appearance of astrocytes (Doetsch et al., 1999; Seri et al., 2001). 
Moreover, glial cells are the source of new neurons in the injured retina (Ooto et al., 
2004) and in the neural crest-derived carotid body (Pardal et al., 2007) of adult 
mammals. 
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With regard to the adult ENS, neural stem cells have not been identified in vivo 
and constitutive neurogenesis is not known to occur under physiological conditions. 
Long-term exposure to BrdU has failed to identify newly generated neurons in the intact 
adult mammalian ENS (Liu et al., 2009) and our data using a genetic labelling system 
suggested that Sox10-expressing progenitor cells loose their neurogenic potential at 
some point between P30 and P84 (ChapterV, Fig.5.2). Nevertheless, self-renewing 
progenitors can be identified in cultures of post-neurogenic adult intestine (Kruger et al., 
2002; Suarez-Rodriguez & Belkind-Gerson, 2004). Moreover, a recent report has 
provided evidence for enteric neurogenesis in adult animals upon pharmacological 
stimulation (Liu et al., 2009), strengthening the possibility that cells with neurogenic 
potential persist in the adult gut. This is further corroborated by studies using injury 
animal models. Experimental intestinal obstruction, for example, has been shown to lead 
to a significant increase in the number of enteric neurons in the regions proximal to the 
affected area (Filogamo & Cracco, 1995). Similar neurogenic changes have been 
reported in rodents treated with the cationic detergent BAC (Hanani et al., 2003; Luck et 
al., 1993; Ramalho et al., 1993). BAC has been shown to efficiently destroy the 
myenteric plexus (Fox et al., 1983; Sato et al., 1978) and so it has been used to study the 
regenerative capacity of the ENS (Hanani et al., 2003; Ramalho et al., 1993).  In this 
context, it was demonstrated that BAC treatment results in an initial reduction in the 
number of myenteric neurons followed by regeneration of enteric nerve fibers and re-
population of the lesioned area by neurons and glia. In light of these results, it has been 
suggested that quiescent eNCSCs may persist in the adult ENS and be stimulated to 
proliferate and differentiate in response to stimuli, such as injury. The identity of adult 
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eNCSCs and whether they constitute a permanent undifferentiated pool or are recruited 
in a regular basis is still unclear. The identification of these cells and their potential role 
in ENS homeostasis and intestinal physiology can have major implications for the 
understanding of ENS development and maintenance and the treatment of its diseases.  
We have demonstrated that, during gut organogenesis, Sox10-expressing cells give 
rise to neurons and glia (Chapter III, Fig.3.2) but, eventually, these cells loose their 
neurogenic capacity in vivo (ChapterV, Fig.5.1). Furthermore, our data suggested that 
all Sox10-expressing cells in the mature ENS are glia (ChapterV, Fig.5.2). This raises 
the possibility that enteric glia may be the source of ENS progenitors identified in 
cultures of post-neurogenic adult intestine and potentially involved in injury-induced 
neurogenesis. The experiments described in this chapter address such a possibility. 
 
6.2. Results 
 
6.2.1.Glia-derived GFP
+ cells of the adult SER26; R26ReYFP show neural stem cell 
properties in vitro 
 
To directly test whether enteric glia could be a source of neural stem cells in vitro, we 
genetically labelled enteric glia and followed their fate in culture. To this end, 4-OHT 
was administered to adult (>P84) SER26; R26ReYFP animals, which results in 
expression of GFP exclusively in enteric glia, as previously shown (Chapter V, Fig.5.2). 
MS-MP strips from 4-OHT-treated double transgenic mice were then isolated, 
dissociated enzymatically and cultured in a medium that supports proliferation and self-
renewal of ENS progenitors (NCSC medium; Morrison et al., 1999; Fig.6.1 A). Triple 
immunostaining of such cultures for GFP, the glial marker GFAP and the neuronal 
marker Tuj1 showed that, 24 hours after plating, all GFP
+ cells express GFAP (100%; 
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428 cells total from three mice), confirming that GFP
+ cells present within MS-MP 
strips represent glial cells. Expression of Tuj1 was found exclusively in GFP
- cells 
(Fig.6.1 B, F). 
After 4 days in vitro (DIV), we observed a dramatic increase in the number of GFP
+ 
cells relative to the number present in the cultures shortly after plating. These GFP
+ cells 
were found as part of small individual colonies, morphologically similar to the colonies 
generated by embryonic eNSCCs (Bondurand et al., 2003; Stemple & Anderson, 1992). 
The colonies contained between 3 to 29 GFP
+ cells (average 9.6±6.3% of GFP
+ cells per 
colony) and the majority of these (73.2±11.3%) co-expressed GFAP, indicating that they 
are glial cells. Interestingly, we found that 26.5±10.9% of the GFP
+ cells did not express 
glial (GFAP) or neuronal (Tuj1) markers (246 cells total from three mice; Fig.6.1 C, F). 
This raised the possibility that these GFP
+Tuj1
-GFAP
- cells represent glial-derived 
eNCSCs. To test this hypothesis, we further characterized the expression profile of 
GFP
+Tuj1
-GFAP
- cells in day 4 GFP
+ colonies for expression of different eNCSCs 
markers. eNCSCs have been shown to express the transcription factor Sox10 (Anderson 
et al., 2006). However, Sox10 is not a specific marker of eNCSCs as it is also expressed 
in glial cells (Young et al., 2003). Therefore, to examine whether DIV4 colonies 
contained non-glial Sox10
+ cells, triple-label immunofluorescence experiments were 
performed using antisera for GFP, Sox10 and GFAP. As shown in Fig6.1 G, we found 
that the majority of the GFP
+GFAP
- cells expressed Sox10. We also found that a 
fraction of GFP
+ cells in DIV4 colonies expressed Phox2b
+, another marker of eNCSCs 
(Fig.6.1 H). Phox2b expression is also maintained in a subpopulation of glial cells 
(Corpening et al., 2008; Young et al., 1999), however, analysis of Phox2b expression in 
170 
 Results 
the non-glial GFP
+ population was precluded because Phox2b and GFAP antibodies 
were raised in the same species. Besides Sox10 and Phox2b, we examined GFP
+Tuj1
-
GFAP
- cells for the expression of the HMG transcription factor Sox2. Sox2 has been 
extensively used to label CNS neural stem cells and it has been shown to be expressed in 
the ENS (Heanue & Pachnis, 2007). By performing triple-labelling experiments, we 
found that the majority of GFP
+Tuj1
-GFAP
- expressed Sox2 (Fig.6.1 I). These data 
suggest that GFP
+ glial cells are able to generate, in vitro, cells that exhibit an 
expression profile similar to embryonic ENS progenitor cells.  
Next, we sought to test whether glia-derived GFP
+ cells are able to activate a 
neurogenic programme. For this, GFP
+ cells present in 4-day cultures were analysed for 
the expression of the pro-neural transcription factor Mash1. Mash1 is expressed 
transiently in a subset of enteric neuron precursors but it is extinguished as they 
differentiate into neurons (Blaugrund et al., 1996). We found that a fraction of GFP
+ 
cells in DIV4 colonies expressed Mash1 (Fig.6.1 J) suggesting that, after 4 days in 
culture, a subset of the glia-derived GFP
+ cells had already taken a step towards neural 
maturation. Despite the presence of GFP
-Tuj1
+ neurons 24 hours after plating no 
neurons could be found in 4 day cultures, consistent with the idea that differentiated 
neurons isolated from the gut do not survive past the first days of culture in NCSC 
medium (Bondurand et al., 2003). 
Next, we examined the neurogenic potential of glia-derived GFP
+ cells. To this end, 
7 day cultures were shifted to differentiating conditions (laminin substrate and 
neurobasal medium). Three days later (10 DIV) the expression profile of GFP
+ cells in 
culture was assessed by triple immunofluorescence experiments using antisera for GFP, 
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Tuj1 and GFAP. We identified 3 different subpopulations of GFP
+  cells within the 
colonies generated in vitro: 46.1±0.6% of the cells were negative for the neuronal 
marker Tuj1 and the glial marker GFAP, 11±3.3% co-expressed GFAP and 40.5±3.8% 
co-expressed Tuj1 or HuC/D (265 cells total from three mice; Fig.6.1 D, K, F). 
Subsequently, we examined the potential of GFP
+ cells to differentiate into distinct 
neuronal subtypes. For this, 10 day cultures were double-labelled with GFP and 
antibodies against Nitric Oxide Synthase (nNOS), Vasoactive Intestinal Peptide (VIP) 
and Neuropeptide Y (NPY). nNOS, VIP and NPY are all expressed by subsets of enteric 
neurons in vivo (Qu et al., 2008). We found co-expression of GFP and all neuronal 
subtype markers considered, thus indicating that GFP
+ cells have the ability to generate 
neurons that express a variety of neurotransmitters normally found in the ENS (Fig.6.1 
L-N).  
Similar to cultures of dissociated embryonic gut (Bondurand et al., 2003), after a 
few days in vitro GFP
+ cells started to pile up and, by day 20, most of these cells were 
found as part of neurosphere-like bodies (NLBs) which eventually detached and floated 
in the medium (Fig. 6.1 E). GFP
+ cells could be propagated without losing GFP 
expression for at least 25 passages and they were kept in culture for up to 6 months. 
Even in these late cultures, the GFP
+ population contained cells that were GFP
+HuC D
-
GFAP
- and cells that expressed neuronal (Tuj1 and HuC/D) or glial markers (GFAP) 
(Fig. 6.1 O). 
Taken together, our data suggest that, even though Sox10-expressing cells in the 
adult ENS loose their neurogenic capacity in vivo, Sox10-expressing glial cells can be 
activated in vitro to generate eNCSCs with self-renewal and neurogenic potential.  Results 
Figure 6.1. GFP
+ glial cells isolated from the ENS of adult SER26, R26ReYFP are 
the origin of in vitro neural stem cells.  
 
(A) MS-MP strips of adult (>P84) SER26, R26ReYFP transgenic animals exposed to 4-
OHT at P84 were dissociated and cultured under standard conditions (Bondurand et al., 
2003).  (B-E)  Cell cultures were immunostained for GFP (green), the pan-neuronal 
marker Tuj1 (red) and the glial marker GFAP (blue) at day in vitro (DIV) 1 (B), DIV4 
(C), DIV10 (D) and DIV20 (E). On DIV1, all the GFP
+ cells expressed GFAP 
(arrowhead in inset of panel B). Tuj1
+ neurons were all GFP
- (arrow in inset of panel B). 
In DIV4 cultures, the GFP
+ population includes glial (GFP
+Tuj1
-GFAP
+) and non-glial 
non-neuronal (GFP
+Tuj1
-GFAP
-) cells (arrowhead and arrow in inset of panel C, 
respectively). After 10 DIV, GFP
+ population includes glia (arrows in insets of panel D), 
non-glial non-neuronal cells and also neurons (GFP
+Tuj1
+GFAP
-; arrowheads in insets 
of panel D). In DIV20 cultures, most GFP
+ cells are found in NLB’s. (F) Quantification 
of the fraction of neurons and glia in the GFP
+ population in culture. (G-J) DIV4 
cultures were immunostained for GFP (green), GFAP (blue) and the transcription factor 
Sox10 (red, G) or Sox2 (red, I). Sox10 and Sox2 were expressed by GFP
+GFAP
+ cells 
(arrows) as well as by GFP
+GFAP
- cells (arrowheads). Note the presence of a GFP
+ 
dividing cell on a DIV4 colony (diamond arrow in panel I). Alternatively, DIV4 cultures 
were immunostained for GFP (green) and Phox2b (red, H) or Mash1 (red, J). 
Arrowheads in panels H and J indicate double positive cells. (K-N) Immunostaining of 
DIV10 cell cultures for GFP (green) and Tuj1 (red, K) or the neuronal subtype markers 
nNos (red, L), VIP (red, M) and NPY (red, N) showed that glial cells can give rise to 
nNos
+, VIP
+ and NPY
+ neurons. (O) Immunostaining of late cultures (6 months in 
culture) for GFP (green), the neuronal marker HuC/D (red) and the glial marker GFAP 
(blue). In late cultures the GFP
+ population included HuC/D
+ neurons (arrow), GFAP
+ 
glial cells (arrowhead) and HuC D
-/GFAP
- cells (diamond arrow). B-D, x400; insets of 
 B-D, x1080; E, x200; K and O, x400; L-N, x600.
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6.2.2.Glia-derived GFP
+ cells of the adult hGFAPCreER
T2; R26ReYFP show 
neural stem cell properties in vitro 
 
By treating P84 SER26; R26ReYFP transgenics with 4-OHT we were able to 
genetically label only glial cells, however, with these experiments one cannot exclude 
the possibility that a small residual population of undetected Sox10
+GFAP
- progenitors 
were the source of enteric neurons in culture. To provide further evidence that enteric 
glial cells are indeed the source of neural stem cells in vitro, we carried out a similar 
experiment using a transgenic line in which a tamoxifen-inducible form of Cre is 
expressed under the control of a 2.2 Kb region of the human GFAP promoter 
(hGFAPCreER
T2; Ganat et al., 2006). The hGFAPCreER
T2 transgene has been shown to 
be correctly expressed in the CNS (Ganat et al., 2006). To confirm appropriate 
expression of the hGFAPCreER
T2 transgene in the ENS, transgenic mice were bred with 
the R26ReYFP reporter line and double transgenics were assessed for YFP expression 
(using GFP antibodies) in response to 0.2 mg/g of 4-OHT. Analysis of MS-MP strips of 
P140 hGFAPCreER
T2; R26ReYFP animals after administration of 4-OHT at P84, 
revealed GFP expression within the myenteric plexus. More specifically, we found 
expression of GFP and the glial marker S100β
 in 19±7.4% (988 cells total from five 
animals) of the S100β
+ glial cells. No GFP-labeled cells expressed the neuronal marker 
HuC/D confirming that Cre-mediated recombination is restricted to the glial population 
(Fig.6.2 A, B).  
Having established that the hGFAPCreER
T2 transgene targets Cre recombination to 
enteric glial cells in vivo, we then tested whether GFP
+ glial cells isolated from MS-MP 
strips of 4-OHT-treated hGFAPCreER
T2; R26ReYFP mice could generate neural stem 
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cells in vitro. To this end, we cultured dissociated MS-MP strips isolated from P140 
double transgenics treated with 4-OHT at P84. We found that, similar to SER26; 
R26ReYFP
  transgenics, GFP
+ glial cells from 4-OHT-treated hGFAPCreER
T2; 
R26ReYFP mice generated self-renewing GFP
+Tuj1
-GFAP
- cells. In neuron-promoting 
culture conditions these cells were able to give rise to GFP
+ neurons that co-expressed 
pan-neuronal markers such as Tuj1 and also markers for different neuronal subtypes, 
namely, nNos, NPY (Fig. 6.2 C-F) and VIP (data not shown). These findings show that 
the GFP
+ glial cells isolated from the adult gut of SER26; R26ReYFP or 
hGFAPCreER
T2; R26ReYFP  display properties of neural stem cells, including 
neurogenic potential. 
 
6.2.3.GFP
+ glial cells generate neurons in ex vivo cultures of MS-MP 
 
Next, we examined whether the neurogenic potential of enteric glia can be activated in 
the context of intact enteric ganglia. MS-MP strips were isolated from the small intestine 
of SER26; R26ReYFP transgenics treated with 4-OHT after P84 and cultured (without 
prior enzymatic dissociation) for 7 days in NCSC medium. This resulted in extensive 
proliferation of GFP
+ glial cells as assessed by Brd-U incorporation (Fig.6.3 A, I). Also, 
similar to the cultures of dissociated MS-MP strips, a large number of GFP
+HuC/D
+ 
cells was observed (Fig.6.3 E, I).  
Understanding the environmental signals that trigger GFP
+ glial cells to acquire neural 
stem cell properties in vitro is instrumental for unravelling the mechanisms underlying 
adult neurogenesis in the ENS. For this, we tested whether exogenous growth factors are 
capable of stimulating glial cells to generate new neurons by replacing NCSC medium 
with DMEM or DMEM supplemented with EGF, FGF2 or GDNF (for experimental Results 
 
 
 
Figure 6.2. GFP
+ glial cells form hGFAPCreER
T2; R26ReYFP ENS show Self-
Renewing, Multipotent NSC properties in vitro 
 
(A) hGFAPCreER
T2; R26ReYFP double transgenics were treated with 4-OHT 
(0.2mg/g) at P84 and then analysed at P140. Immunostaining of MS-MP whole mount 
preparations for GFP (green), HuC/D (red) and S100β (blue) showed that GFP 
expression is restricted to the S100β
+ population (arrowheads in inset of panel A). No 
GFP
+/HuCD
+ cells were found. Arrows and diamond arrow in insets of panel A point to 
GFP
-/HuCD
+/S100β
- and GFP
-/HuCD
-/S100β
+ cells, respectively. (B) Quantification of 
the fraction of GFP
+ cells in the S100β
+ population. The error bars indicate s.e.m. (C-F) 
Cell cultures from dissociated MS-MP strips were immunostained for GFP (green), the 
pan-neuronal marker Tuj1 (red, C) or the neuronal subtype markers nNOS (red, D) and 
NPY (red, E). A, x400 (insets: x1080); C-E, x1080. 
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details see Chapter II). The mitogenic factors EGF and FGF2 are part of the NSCS 
medium and they have been shown to promote proliferation of embryonic eNCSCs 
(Fuchs et al., 2009), whereas GDNF has been implicated in proliferation (Hearn et al., 
1998; Taraviras et al., 1999) and neuronal differentiation (Chalazonitis et al., 1998) 
during ENS development. MS-MP strips cultured in the absence of growth factors 
showed no GFP
+ cells or HuC/D
+ neurons suggesting that DMEM does not support the 
survival or differentiation of GFP
+ glial cells in culture (data not shown). In the presence 
of EGF a small number of GFP
+ cells could be found in the cultured myenteric ganglia. 
Despite its strong mitogenic effect on embryonic eNCSCs (Fuchs et al., 2009), only 
5.9±2.1% (543 GFP
+ cells total from 2 mice) of the GFP
+ cells present in adult MS-MP 
strips were found to incorporate Brd-U in the presence of EGF and only 8.6±2.4% (383 
GFP
+ cells total from 2 mice) were HuC/D
+ neurons (Fig.6.3 B, F, I). In contrast, in 
MS-MP strips cultured in presence of FGF2 or GDNF most cells in the myenteric 
ganglia were GFP
+. Proliferation analysis showed that 38±1.2% (395 cells total from 2 
mice) and 34±2% (443 cells total from 2 mice) of GFP
+ cells proliferated in FGF and 
GDNF supplemented medium, respectively (Fig.6.3 C, D, I). Also, we found that 
39±1.7% (372 cells total from 2 mice) and 33±1.9% (403 cells total from 2 mice) of the 
GFP
+ cells co-expressed HuC/D
+ neurons in FGF and GDNF supplemented medium, 
respectively (Fig.6.3 G, H, I). These results suggest that FGF and GDNF signalling 
pathways might be implicated in triggering glial cells to proliferate and differentiate into 
enteric neurons.  
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Figure 6.3. GFP
+ glial cells generate neurons in ex vivo cultures of MS-MP strips 
 
(A-I) MS-MP strips were isolated from the small intestine of adult (>P84) SER26; 
R26ReYFP transgenics treated with 4-OHT after P84 and cultured without prior enzyme 
dissociation for 7 days in standard medium (Bondurand et al., 2003) (A, E), 
DMEM+EGF (B, F), DMEM+FGF (C, G) or DMEM+GDNF (D, H) medium. (A-D) 
Cultured MS-MP strips were immunostained for GFP (green) and Brd-U (red). A 
fraction of the GFP
+ cells underwent cell division in culture (arrowheads). Arrows point 
to GFP
+ cells that did not incorporate Brd-U. (E-H) Alternatively, cultured peels were 
triple-labelled for GFP (green), HuC/D (red) and S100β (blue). Arrowheads point to 
GFP
+/HuC D
+ double labelled cells which correspond to newly-generated neurons. 
Arrows indicate GFP
+/Hu C D
- and diamond arrows GFP
-/HuC D
+. x400 magnification. 
(I) Quantification of the fraction of Brd-U
+ cells and HuC/D
+ neurons in the GFP
+ 
population. Error bars in the graphs indicate s.e.m. 
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6.2.4.Neurons generated in vitro from GFP
+ glial cells express molecular markers 
associated with synaptogenesis 
 
To get insight into the functional properties of glia-derived neurons, thus far identified 
by morphological and molecular criteria, we analysed GFP
+ neurons generated in 
culture for the expression of the synaptic marker synaptophysin. Synaptophysin is a 
synaptic vesicle glycoprotein present in virtually all neurons that participate in synaptic 
transmission and so its expression is an indicator for the formation of synapses (Vanden 
Berghe & Klingauf, 2007). Triple immunofluorescence experiments revealed co-
expression of synaptophysin, GFP and the neuronal subtype marker nNos (Fig.6.4), thus 
suggesting that GFP
+ neurons generated de novo in culture are able to establish synaptic 
contacts.  
 
6.2.5.GFP
+ glial cells generate neurons in vivo upon injury 
 
Having established that enteric glial cells can generate new neurons in culture, we 
wished to address whether these cells also exhibited neurogenic potential in vivo. Since 
we could not detect neurogenesis in the ENS of adult (>P84) SER26; R26ReYFP 
animals (Chapter V, Fig.5.2), we hypothesized that the neurogenic potential of enteric 
glial cells may be revealed only upon disruption of tissue homeostasis. To test this 
premise, we used our genetic lineage marking system and explored the possibility that 
enteric glia can generate neurons in vivo, in response to injury that eliminates enteric 
neurons. The cationic chemical BAC has been shown to destroy the myenteric plexus in 
a dose-dependent manner when applied to the serosal surface of the intestine (Fox et al., 
1983). To generate a BAC injury model we first established a protocol for efficient 
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Figure 6.4. Neurons generated from GFP
+ glial cells express molecular markers 
associated with synaptogenesis 
 
Dissociated MS-MP strips of adult (>P84) SER26; R26ReYFP transgenic animals 
treated with 4-OHT at P84 were cultured under neuron-promoting conditions and 
immunostained for GFP (green), the neuronal marker nNOS (blue) and the synaptic 
marker synaptophysin (red). Arrows in panels point to the cell body and projection of a 
GFP
+nNOS
+ neuron that exhibit punctuate expression of the synaptic protein 
synaptophysin. x680 magnification. 
 
182 
 Results 
ablation of myenteric neurons by applying different concentrations of BAC to a 1 cm 
segment of the small intestine of wild-type mice. 3 days after BAC treatment, MS-MP 
strips from the treated segments were immunostained for Tuj1 to highlight the myenteric 
plexus. This showed that application of 0.05% BAC for 5 minutes was insufficient to 
destroy the myenteric plexus (Fig.6.5 A). In contrast, application of 0.1% BAC for 20 
minutes (n=4) (Fig.6.5 B) or 0.05% BAC for 30 minutes (n=2) (data not shown) led to 
effective ablation of enteric neurons. However, this was accompanied by generalized 
tissue damage, constriction of the treated segment and dilation of the adjacent proximal 
area (megacolon) and, in some instances, death. Treatment with 0.1% BAC for 5 
minutes proved to efficiently destroy myenteric neurons without causing constipation or 
death of the animal (Fig.6.5 C). Therefore, we used this regime in all following 
experiments. 
To directly test whether GFP
+ glial cells are able to generate new neurons in 
response to neurodegeneration, we applied BAC to the small intestine of adult SER26; 
R26ReYFP and hGFAPCreER
T2; R26ReYFP mice (>P84) that had been previously 
treated with 4-OHT (to lineally mark glial cells). MS-MP strips from the treated and 
adjacent areas were analysed at different time points after BAC application for 
expression of GFP, the pan-neuronal marker HuC/D and the glial marker S100β. 
Consistent with previous reports (Hanani et al., 2003; Ramalho et al., 1993), three days 
after treatment, enteric ganglia were eliminated from the region of BAC application and 
only cellular debris could be found (n=3; Fig.6.6 A). Analysis of MS-MP strips isolated 
from the treated area 30 days after BAC treatment showed invasion of the aganglionic 
area by GFP
+S100β
+ glial cells, which formed network-like structures reminiscent of an 
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enteric plexus. No GFP
+ neurons were found in the aganglionic intestinal segment or in 
the area adjacent to the BAC-treated region, where most ganglia included GFP
+ glial 
cells but no neurons, as assessed by expression of HuC/D (n=3; Fig.6.6 E, D). Away 
from the treated area, we found morphologically normal ganglia containing GFP
-
/HuCD
+ neurons and GFP
+S100β
+ glial cells (Fig.6.6 C). The absence of neurons within 
the BAC-treated area was maintained in both transgenic lines even 70-80 days after 
BAC application. However, in SER26; R26ReYFP transgenics, analysis of the area 
bordering the aganglionic area revealed a relatively large fraction of GFP
+/HuCD
+ cells 
(9±4%, 3197 HuC/D
+ scored from 4 animals) indicating that they are derived from GFP-
expressing glial cells. The percentage of GFP
+ enteric neurons detected within enteric 
ganglia was inversely proportional to their distance from the treated area, ranging from 
0.5% (background level at segments distant from treated region) to 9% (adjacent to the 
treated area) (Fig.6.6 F-I). In hGFAPCreER
T2; R26ReYFP mice, 1 of the two animals 
analyzed exhibited a single GFP-labelled HuC/D
+ neuron (377 HuC/D
+ scored; data not 
shown) suggesting that low recombination efficiency in this transgenic line may 
preclude detection of GFP
+ glial-derived neurons. These results strongly suggest that 
enteric glial cells possess neurogenic potential not only in culture but also in vivo being 
able to generate neurons in response to injury.  Results 
 
 
 
 
 
 
 
 
 
 
Figure 6.5. Acute destruction of myenteric neurons using the cationic detergent BAC 
 
 (A-C) The cationic chemical BAC was applied to 1 cm segment of the small intestine 
of wild-type animals. Three days after BAC treatment MS-MP whole-mount 
preparations of the BAC-treated area were isolated and immunostained for Tuj1. 
Different regimes were tested regarding their efficiency to acutely destroy myenteric 
neurons: 0.05%, 5 minutes (A); 0.1%, 20 minutes (B); 0.1%, 5 minutes (C).  x50 
magnification. 
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Figure 6.6. GFP
+ glial cells from the ENS of adult SER26
2; R26ReYFP mice generate 
neurons, in vivo, upon injury. 
 
(A-I) SER26; R26ReYFP animals (P84 or older) were treated with 4-OHT and then 
BAC-treated a week later. (A) Confocal microscope images of MS-MP whole mount 
preparations from the BAC-treated area 3 days after the treatment. Inset shows absence 
of GFP
+, HuC/D
+ or S100 β
+ cells in the treated area. (B) Schematic representation of 
enteric plexus that includes an area which as a result of BAC treatment becomes 
aganglionic (area 4).  (C-E) Confocal microscope images of MS-MP whole mount 
preparations from distant, adjacent and treated areas analysed 30 days (C, D and E, 
respectively) and 80 days (F, G and H, respectively) after BAC-treatment.  MS-MP 
strips were immunostained for GFP (green), HuC/D (red) and S100β (blue). Arrowheads 
in insets of panel G point to a GFP
+/HuC D
+ double labelled cell which corresponds to a 
newly-generated neuron. Arrows indicate GFP
+/HuC D
-/S100β
+ cells. Diamond arrow 
in panel D point to spaces within the ganglia suggesting that neuron loss has occurred. 
(I) Quantification of the number of GFP-labelled HuC/D
+ cells in an area distant to the 
BAC-treated region (1), in the vicinity (2), at the border (3) and within the treated area 
(4). Note that the percentage of GFP
+ neurons detected within enteric ganglia was 
inversely proportional to their distance from the treated area. The error bars indicate 
s.e.m. A, x50 (inset: x200); C and F, x200 (inset: x600); D and G, x400 (inset: x1080);  
E and H, x200 (inset: x400).
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6.3. Discussion 
 
Enteric glia share many morphological and phenotypic characteristics with CNS 
astrocytes, which has led to the hypothesis that the two cell types may be functionally 
related. Despite recent reports highlighting an active participation of glial cells in the 
control of gastrointestinal functions (Bush et al., 1998; Cabarrocas et al., 2003), the 
potential role of enteric glia as a source of neurons had not been considered so far. We 
tested the possibility that, as SVZ and SGL astrocytes of the adult brain, enteric glial 
cells from the mature ENS can exhibit neural stem cell potential. This potential, 
however, is likely to remain dormant under the constraints of the non-neurogenic 
environment of the mature ENS and only become apparent when the enteric glia 
environment is altered, either by removing them from their niche (e.g culture) or 
perturbing the niche (e.g. injury). Here, we report that enteric glia isolated from the adult 
gut exhibit neural stem cell properties in culture. In addition, we provide direct evidence 
that enteric glial cells can generate new neurons both in culture and in vivo upon injury. 
Using the Cre-loxP system, we lineally marked enteric glial cells isolated from the 
mature ENS and followed their fate in vitro. The results from these experiments 
demonstrated that enteric glia from the adult are a source of neural stem cells in vitro. 
Two previous cell culture studies have reported the isolation of enteric cells that in 
culture behave as neural stem cells. Suárez-Rodriguez and Belkind-Gerson (2004) 
cultured partially digested adult gut and reported the presence of different cell types in 
vitro, including glial cells, myofibroblasts and also nestin
+ cells, to which neural stem 
cell properties were attributed. In this study, however, the lineage relationship between 
the different cell types in culture was not addressed. In another report, high level of p75 
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expression was used to select for eNCSCs (Kruger et al., 2002). This approach was 
assumed to prospectively identify ENS progenitor cells in vivo, however, besides 
embryonic eNCSCs, p75 is also expressed in differentiated glial cells (Young et al., 
2003). Even though we cannot rule out the presence of different populations of neural 
stem cells in the mature ENS, in light of our results we propose that glial cells are the 
origin of neural stem cells identified in vitro previously. 
Our fate-tracing experiments also provided some insight into the stepwise changes 
enteric glia undergo in culture. By performing a time course analysis of the fate of glial 
cells isolated from the mature ENS, we demonstrated that in culture these cells change 
their phenotypic profile. Glial cells were shown to loose GFAP expression while 
maintaining expression of markers that are common to embryonic eNCSCs and glial 
cells (Sox10 and Phox2b). Interestingly, we found that the majority of GFAP
- lineage-
labelled cells expressed Sox2, a transcriptional regulator that is expressed in CNS neural 
stem cells from embryogenesis through adulthood (Pevny & Placzek, 2005; Suh et al., 
2007). Although we cannot exclude direct conversion of glial cells into neurons, our 
time course analysis is consistent with a process whereby glial cells dedifferentiate to a 
more embryonic-like state prior giving rise to new neurons.  
It is generally thought that epigenetic changes that underlie reprogramming events 
are most easily made during cell division. We observed that, in parallel to changes in the 
expression profile, GFP-labelled glial cells undergo extensive proliferation giving rise to 
colonies similar to those generated by embryonic eNCSCs (Bondurand et al., 2003). Our 
experiments did not address this issue directly and so it is still unclear whether 
dedifferentiation of glial cells into eNCSCs involves obligatory proliferation steps but it 
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is possible that in vitro activation of cell proliferation is accompanied by conversion of 
glial cells into GFAP
- progenitors that resume phenotypic features of embryonic 
eNCSCs.  
Besides glia-derived eNCSCs, 4 day colonies included also a large number of GFP
+ 
glial cells. The origin of these cells is currently unclear. It is possible that GFP
+ glial 
cells have derived from proliferation of single GFP
+ glia present in culture on DIV1. 
Alternatively, glia-derived eNCSCs may retain differentiation potential to generate glial 
cells. 
Importantly, our fate-mapping studies revealed that enteric glia have the potential to 
generate new neurons in vitro. We observed that, similar to embryonic eNCSCs, a 
fraction of the glia-derived neural stem cells expressed Mash1 as early as 4 days after 
plating. Mash1 is expressed in neuron-committed progenitors and it has been shown to 
promote neurogenesis by activating the expression of neuron-specific genes, as well as 
to inhibit the expression of glia-specific genes (Guillemot et al., 1993; McNay et al., 
2006; Nieto et al., 2001; Parras et al., 2002; Tomita et al., 2000).  Expression of Mash1 
in a fraction of glia-derived neural stem cells is consistent with the acquisition of 
neurogenic potential by these cells. Indeed, we observed that in neuron-promoting 
conditions glia-derived neural stem cells efficiently differentiated along the neuronal 
lineage giving rise to different neuronal subtypes. We further demonstrated that glia-
derived neurons generated de novo in culture expressed the pre-synaptic protein 
synaptophysin, a vesicle protein that has been implicated in the regulation of vesicle 
recycling (Evans & Cousin, 2005). Expression of this protein in glial-derived neurons 
suggests that besides exhibiting neuron-specific morphology and molecular features, 
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these cells were able to establish synaptic contacts in culture. Whole-cell recordings by 
patch-clamp will be required to further dissect the electrophysiological properties of 
these GFP
+ neurons.  
We also examined whether the neurogenic potential of GFP
+ glial cells could be 
revealed in ex vivo cultures of MS-MP strips. In these cultures, we found that GFP
+ glial 
cells were activated to proliferate and generate new HuC/D
+ neurons, suggesting that the 
disruption of short-range cell-cell interactions through tissue dissociation is not required 
to activate the neurogenic potential of GFP
+ glial cells. Nevertheless, isolation of MS-
MP strips is likely to involve resection of axons of subsets of enteric neurons and some 
perturbation of normal cell-cell interactions which may determine or, at least, contribute 
to trigger the neurogenic potential of glial cells.  
Indeed, acute elimination of neurons has been shown to stimulate neurogenesis in 
vivo in a number of systems including the retina (Fischer & Reh, 2003), cortex (Magavi 
et al., 2000) and nodose ganglia of the PNS (Czaja et al., 2008). Neural regeneration 
following ablation of neurons in the adult ENS has also been reported (Hanani et al., 
2003; Luck et al., 1993; Ramalho et al., 1993). However, it remained unclear whether 
the neurons that repopulated the denervated area were actually newly generated neurons 
or cells that migrated from adjacent ganglia. By combining a lineage tracing strategy 
and an injury model, we demonstrate here that new neurons are generated in vivo, in 
response to injury. Furthermore, our results provide direct evidence that enteric glial 
cells can be a source of new neurons generated in the adult ENS.  
In this study, acute destruction of myenteric neurons was achieved by applying to 
the serosal surface the cationic detergent BAC. As reported by other authors (Ramalho 
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et al., 1993; Sato et al., 1978; Yoneda et al., 2002), we found that BAC acts on a dose-
dependent manner. A preliminary analysis was carried out using different concentrations 
of BAC solution for different periods of time. We successfully developed an 
experimental protocol in which we induced chemical ablation of the myenteric plexus 
producing an aganglionic segment without interfering with the survival of the animals. 
As early as 3 days after BAC treatment, we observed effective destruction of neurons 
and nerve fibers of the myenteric plexus. This is consistent with a previous study 
demonstrating that BAC leads to a reduction of approximately 90% of neurons 6 hours 
after application (Ramalho et al., 1993).   
From day 3 to day 30 after BAC treatment, we observed invasion of the aganglionic 
area by GFP
+ glial cells. It is unclear at this stage whether these are cells that have 
migrated from the regions surrounding the lesion or newly-generated glial cells. This 
issue was not directly addressed but results from our lineage tracing analysis in vitro 
demonstrating generation of a large fraction of GFAP
+ glia are consistent with the latter 
case. Furthermore, previous studies have highlighted the proliferative capacity of glial 
cells in vivo in the adult ENS (Bradley et al., 1997; Liu et al., 2009). By administering 
short pulses of BrdU to adult rats, Bradley et al. (1997) showed that a small fraction of 
glial cells are able to proliferate under physiological conditions and similar results were 
obtained recently in adult mice (Liu et al., 2009), thus indicating some resting mitotic 
activity of these cells. Interestingly and similar to CNS astrocytes, enteric glia display an 
increased proliferative capacity in response to intestinal inflammation (Bradley et al., 
1997). It is possible that the maintenance of mitotic quiescence of glial cells in the adult 
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ENS is perturbed upon injury leading to active proliferation and consequently, 
generation of new glial cells that invade the aganglionic area.  
Interestingly, in the areas adjacent to the aganglionic segment, we found a number of 
morphologically abnormal ganglia containing GFP
+ glial cells but no HuC/D
+ neurons. 
This observation suggests that neuronal cell loss takes place also in the transition zone, 
next to the BAC-treated area. Whether and how acute destruction of neurons following 
BAC application triggers neuronal degeneration in adjacent ganglia is unclear. A 
possible scenario is that neurons in the transition area die secondarily due to the death of 
their post-synaptic targets in the BAC-treated region.  
Despite our in vitro data suggesting that GFAP
+ glial cells give rise to GFAP
- 
progenitors that resume phenotypic characteristics of embryonic eNCSCs, we could not 
find in the transition zone any GFP
+HuC/D
-S100
- cells. Thus, it remains unclear whether 
similar to what we observed in culture, glia-response to injury in vivo involves 
proliferation and parallel acquisition of neural stem cell-like properties. Noteworthy, 
electron microscopy studies by Hanani and colleagues (Hanani et al., 2003) suggested 
the presence of undifferentiated cells in the ganglia surrounding the treated segment. 
  In contrast with results from Hanani et al. (2003) who found isolated PGP9.5
+ 
neurons in the treated area after 30 days, we could not identify any HuC/D
+ neuron in 
the aganglionic segment 30 or even 80 days after treatment. The reason for this 
discrepancy may be the severity of BAC treatment which, in our system, may lead to a 
longer recovery period. Nevertheless, 80 days after BAC application in SER26; 
R26ReYFP we were able to unequivocally identify glia-derived newly generated 
neurons in the areas adjacent to the aganglionic segment. The number of GFP
+ neurons 
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decreased progressively with increasing distance to the BAC-treated region. Whether 
the newly-generated neurons in the vicinity of the aganglionic segment eventually 
migrate and colonise the treated area, as suggested by Hanani’s results, was not possible 
to address with the time points considered. In addition, although our data provide 
evidence for the generation of new neurons following BAC treatment in adults, there is 
as yet no evidence that the new neurons establish connections with previously 
innervated tissues. Functional experiments will be required to address whether newly 
generated neurons contribute to functional regeneration following denervation.  
Unlike the BAC-treated SER26; R26ReYFP mice, we did not observe glia-derived 
newly generated neurons in hGFAPCreER
T2; R26ReYFP transgenics, even 80 days after 
BAC treatment. The fact that the hGFAPCreER
T2 transgene targets only a small fraction 
of glial cells (19%) may contribute to this observation. An alternative possibility is that 
the hGFAPCreER
T2 transgene is expressed exclusively in a non-neurogenic group of 
glial cells. Further experimentation will be required to address whether all or only a 
subset of enteric glia has the potential to form neurons.  
Given that similar to CNS astrocytes, enteric glia express multiple stem 
cell/progenitor-specific genes, it may not be surprising that these cells carry out dual 
roles of: a) supporting neuronal functions; and b) participating in neurogenesis, 
providing that the environment allows it. Indeed, after a certain developmental point, the 
intact adult ENS does not support neurogenesis and so it is likely that the neurogenic 
potential of glial cells remains under the constraints of the non-neurogenic environment 
of the adult ENS. The mechanisms underlying activation of enteric glia are unknown but 
they are likely to involve cell-intrinsic and cell-extrinsic factors. One possible scenario 
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is that destruction of neurons may lead to the activation/abrogation of specific pathways 
that activate enteric glia to acquire neural stem cell properties and neurogenic potential. 
In the ENS, despite recent studies demonstrating neuron-glial cell communication 
(Gomes et al., 2009; Gulbransen & Sharkey, 2009), little is known about the 
physiological role of these communication pathways, for example, in the proliferative 
ability of glial cells and maintenance of the glial identity. However, co-culture studies 
have demonstrated that CNS neurons can inhibit glial proliferation (Gomes et al., 1999) 
and, in the adult Drosophila brain, neuronal programmed cell death has been shown to 
induce glial cell division (Kato et al., 2009). How can the ablation of neurons activate 
glial cells to proliferate and acquire neural stem cell properties? A recent study showed 
that ependymal cells, that under physiological conditions are quiescent, in response to 
stroke loose their characteristic features, enter the cell cycle and give rise to neuroblasts 
and astrocytes. Interestingly, in this system, ependymal cell quiescence was shown to be 
actively maintained by canonical Notch signalling. In the ENS, Notch signaling has 
been implicated in the maintenance of embryonic eNCSCs (Okamura & Saga, 2008; 
Taylor et al., 2007) but its role on the adult ENS has not been addressed yet. 
Nevertheless, expression of Notch and Notch ligands have been reported in the adult 
ENS (Sander et al., 2003) thus suggesting a continuing role for this signalling pathway 
at later stages. Based on the fact that Notch ligands are produced by neurons (Sander et 
al., 2003), we speculate that ablation of subsets of neurons may lead to abrogation of the 
canonical Notch signalling pathway in enteric glial cells prompting them to proliferate 
and acquire neural stem cell properties. This may be accompanied by acquisition of 
responsiveness to specific environmental signals that regulate their proliferation and 
195 
 Results 
neurogenic potential. In accordance, we found that in ex vivo cultures of MS-MP strips, 
the growth factors FGF2 or GDNF can induce a response similar to that observed in 
dissociated cultures and in vivo. FGF and GDNF mediate their biological responses in 
the target cells by binding to the tyrosine kinase receptors FGFR and RET, respectively. 
FGF2 has been shown to have a mitogenic effect on eNCSCs during embryonic 
development. In the adult, expression of the FGF2 receptor, FGFR2, in postnatal ENS 
ganglia (Yoneda et al., 2001) suggests a possible role for FGF signalling in the mature 
ENS. Such a role is supported by an in vitro study showing that FGF promotes 
proliferation of enteric glial cells from the adult ENS (Eccleston et al., 1987). Whether 
in vivo this factor is involved in the proliferation of enteric glia in physiological 
conditions and/or in response to injury is unknown but FGF2 has been implicated in the 
reactive response of astrocytes to brain lesion and in neural regeneration in the retina 
(Chadashvili & Peterson, 2006; Fischer et al., 2002). 
GDNF also promotes proliferation of eNCSCs during development (Chalazonitis et 
al., 1998; Taraviras et al., 1999; Gianino et al., 2003). In addition to its mitogenic role, 
GDNF has a strong neurotrophic effect, as in its absence development of enteric neurons 
is impaired (Chalazonitis et al., 1998; Taraviras et al., 1999). The role of GDNF/RET 
signalling pathway in neuronal development is further supported by data showing that in 
the absence of the tyrosine kinase inhibitor Sprouty2, the GDNF/RET system leads to 
ENS hyperganglionosis (Taketomi et al., 2005). We observed efficient generation of 
glia-derived neurons in the ex vivo cultures in the presence of GDNF. Since glial cells 
do not express Ret (Young et al., 2003), the response to GDNF should not result from a 
direct effect of this factor on glial cells. Instead, it is likely that glial-derived eNCSCs 
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start expressing Ret as their embryonic counterparts and become responsive to GDNF 
and to its neuron-promoting effect. Further experiments will be required to dissect the 
role of both FGF and GDNF in adult neurogenesis in the ENS. 
In conclusion, our data demonstrate for the first time that, in the adult mammalian 
gut, glial cells can generate neurons that become integrated into enteric ganglia. The role 
of glial cells in adult neurogenesis suggests that these cells may serve as a potential 
target for cellular manipulation for treating ENS degeneration. Further characterization 
of the genetic properties of adult glial cells and glial-derived neural stem cells should 
give insight into the mechanisms involved in development and remodelling of the ENS.  
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Concluding Remarks 
 
  Concluding Remarks 
The mammalian nervous system comprises a vast number of neurons and glia and an 
astonishing diversity of neuronal subtypes. All neurons and glia are ultimately generated 
from neural stem cells which have the capacity for long-term self-renewal and 
generation of distinct differentiated neural lineages. The identification of neural stem 
cells and the characterization of their properties is crucial for understanding how these 
cells expand in number and undergo differentiation in an orchestrated manner to form a 
functional nervous system. 
Significant progress has been made towards the identification and characterization of 
neural stem cells from the embryonic and mature brain. Outside the CNS, progenitors 
with neural stem cell properties have also been isolated from neural crest derivatives, in 
particular the ENS. These cells have been termed eNCSCs and were shown to have the 
capacity for self-renewal and differentiation into multiple lineages, such as neurons, glia 
and myofibroblasts, in vitro (Bondurand et al., 2003; Kruger et al., 2002; Morrison et 
al., 1999; Silva et al., 2008; Stemple & Anderson, 1992).   
So far, the properties of eNCSCs in vivo have been deduced from studies on 
clonogenic cultures of cells isolated on the basis of molecular or functional 
characteristics (Bondurand et al., 2003; Kruger et al., 2002). Such studies have 
previously suggested that Sox10-expressing cells give rise to both the Sox10
+ (glial 
cells) and the Sox10
- (neurons) lineages of the ENS (Bondurand et al., 2003). However, 
the lineage relationship between Sox10
+ cells and enteric neurons and glia in vivo 
remained unclear. Using a genetic fate mapping system, we demonstrate here that 
Sox10
+ cells of the gut generate both enteric glia and neurons in vivo and therefore 
represent multilineage ENS progenitors.  
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At present, little is known about the mechanisms by which ENS progenitors 
integrate spatial and temporal cues that instruct them to generate the correct numbers of 
enteric neuron subtypes and glia at the right place and the right time. Some insight into 
such mechanisms has been provided, however, by examining other parts of the nervous 
system and two alternative models have been proposed. According to the first model, a 
single type of neural stem cells gives rise to both neurons and glia in a defined temporal 
sequence (neurons first and then glia - switching model); alternatively, distinct 
subpopulations of stem cells  are intrinsically committed to generate one or the other cell 
type (segregating model). The segregating model is supported by a number of reports 
showing that neuron-restricted and glia-restricted progenitors can be isolated from the 
embryonic spinal cord and cerebral cortex (Qian et al., 2000; Rao et al., 1998). On the 
other hand, the switching model is consistent with neurogenesis and gliogenesis in 
Drosophila in which asymmetric division of neuroblasts can produce neurons, glial cells 
or both (Doe et al., 1998). The fate map analysis in our studies has not resolved the issue 
of multipotency of single Sox10
+ cells but rather traced the fates of a Sox10
+ cell 
population. Therefore, it remains unclear whether in the ENS single Sox10-expressing 
cells have the potential to produce both neurons and glia via asymmetric division 
(switching model), or the Sox10
+ cells constitute a mixture of lineage committed 
neurogenic and gliogenic progenitors (segregating model). Lineage tracing at the clonal 
level in vivo will be crucial to directly address the differentiation potential of individual 
Sox10-expressing cells in the ENS and distinguish between these two differentiation 
models. A potential approach to address this issue is the administration of suboptimal 
doses of 4-OHT to SER93; R26ReYFP transgenic mice which, as our preliminary data 
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indicate, are capable of lineally marking a very small number of Sox10-expressing ENS 
progenitors.   
Having developed the tools to genetically mark ENS progenitor cells in vivo, we 
have also determined how the neurogenic potential of these cells changes over the 
course of ENS maturation by following the fate of Sox10-expressing cells present in the 
gut at a given developmental stage. Results from these studies have established that the 
neurogenic potential of eNCSCs is temporally regulated and that the capacity of Sox10-
expressing cells to generate enteric neurons is reduced over the course of gut 
organogenesis. A similar time course of neurogenic potential (high early, low later) has 
been observed in other parts of the nervous system. For example, neural stem cells 
isolated from E16 cortex generate fewer neurons before initiating gliogenesis relative to 
their E10 counterparts (Qian et al., 2000). There are however, significant differences 
between the biological “timer” underlying the differentiation of CNS stem cells and 
eNCSCs. For instance, in the cerebral cortex differentiation of radial glial cells follows a 
precise temporal and spatial order: pyramidal neurons with distinct molecular and 
physiological characteristics are generated sequentially in an “inside-out” manner, with 
early-born neurons occupying the bottom cortical layers and late-born neurons residing 
in the most superficial layers. In contrast, the different subtypes of enteric neurons are 
not generated in spatially defined positions; instead, all enteric neuron subtypes and glial 
cells are born in an apparently uniform environment and they are, in general, evenly 
(and perhaps randomly) distributed throughout the gut as components of distinct 
ganglia. Furthermore, while genesis of neurons and glia in the CNS are temporally 
segregated, in the ENS there is considerable overlap between the period of neurogenesis 
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and gliogenesis. Thus, long after the first appearance of glial precursors in the 
developing gut at E11.5, eNCSCs continue to generate new neurons. Indeed this was 
documented in the present study in which we demonstrate that myenteric neurons 
continue to be generated in adult animals even after P30. These data indicate that 
neurogenesis and gliogenesis co-exist for a considerably long period and imply that new 
neurons continue to be integrated in the ENS circuitry long after it becomes functional. 
  How is the generation of a large array of enteric neuron subtypes (that are more or 
less evenly distributed throughout the gut) integrated in time and space? Are the number 
and type of neurons generated at various developmental stages dependent on temporal 
changes in the expression of neurogenic signals in the microenvironment of eNCSCs? 
Alternatively, do cell-intrinsic changes alter the competence of progenitor cells to 
respond to multiple co-existing signals?  Of course, and as is often the case, these 
alternative mechanisms are not mutually exclusive and it is likely that both are 
implicated in enteric neurogenesis. In vitro experiments have revealed temporal 
differences in the responsiveness of eNCSCs to lineage determination factors, such as 
BMP4, suggesting that the differentiation potential of eNCSCs is controlled, at least 
partly, by cell-intrinsic changes in growth factor sensitivity (Kruger et al., 2002). Such 
changes in the responsiveness to environmental cues may involve, for example, 
quantitative adjustments in the expression of cell-surface receptors (Lillien, 1995; 
Lillien & Wancio, 1998). In this context, it would be interesting to explore how changes 
in the expression levels of the RET RTK, which has been implicated in ENS 
differentiation, affect the neurogenic-gliogenic switch in the ENS. Also, the intrinsic 
epigenetic status of progenitor cells may modulate the response to extrinsic cues in a 
202 
 Concluding Remarks 
way that is developmentally appropriate. For example, a recent study by Nahimira et al 
(2009) showed that in the developing brain the response of neural precursors to 
astrocyte-inducing cytokines depends upon a feedback signal whereby committed 
neuronal precursors and young neurons promote demethylation of astrocyte-specific 
gene promoters in neural precursor cells thus conferring gliogenic differentiation 
potential. Such a signal is mediated by the Notch pathway. Neuroblasts and young 
neurons express Notch ligands that are capable of activating the Notch signalling 
cascade in the neighbouring progenitor cells. Notch-activated neural precursors undergo 
demethylation of astrocytic-specific gene promoters (e.g gfap promoter) and acquire the 
ability to become astrocytes in response to astrocyte-inducing cytokines (Namihira et 
al., 2009). Whether similar mechanisms are involved in the modulation of the 
differentiation capacity of eNCSCs in vivo is unknown. Insight into such mechanisms 
will be important not only in the understanding of normal developmental mechanisms 
but also they raise the possibility of manipulating mature and injured ENS with the aim 
of promoting regenerative neurogenesis.  
Our lineage tracing analysis revealed that despite a long neurogenic period, enteric 
Sox10-expressing cells lose their neurogenic potential at some point between P30 and 
P84. This is in keeping with previous reports that have failed to identify newly 
generated neurons in the intact adult mammalian ENS (Liu et al., 2009) and suggests 
that unlike the adult CNS, which is known to harbour neural stem cells that sustain 
neurogenesis throughout life, the mature ENS does not support constitutive 
neurogenesis. Despite these observations, self-renewing progenitors capable of 
generating enteric neurons and glia can be identified in cultures of post-neurogenic adult 
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intestine (Kruger et al., 2002). Moreover, a recent report has provided evidence for 
enteric neurogenesis in adult animals upon pharmacological stimulation (Liu et al., 
2009), reinforcing the idea that cells with neurogenic potential persist in the adult ENS 
and can be activated to generate new neurons under specific conditions. The identity of 
these cells and their physiological role, however, has remained elusive. Our results 
provide strong evidence that the elusive source of multilineage progenitors in cultures of 
adult ENS are the GFAP
+ enteric glial cells. Moreover, these mature glial cells can also 
be activated to generate neurons in an animal injury model of the ENS. 
Once thought to be passive and merely supporting partners of neurons, glial cells 
have recently emerged as active regulators of many neuronal functions (Aoki et al., 
1991; Araque et al., 2001). Furthermore, several reports have highlighted a close 
relationship between neural stem cells and glia. Ongoing neurogenesis in the CNS is 
ensured by GFAP-expressing progenitors with structure and molecular characteristics of 
astrocytes (Doetsch et al., 1999; Seri et al., 2001). Moreover, glial cells are the source of 
new neurons in the injured retina (Ooto et al., 2004) and in the neural crest-derived 
carotid body (Pardal et al., 2007) of adult mammals. The findings reported here support 
the idea that also the mature ENS harbours glial cells that carry out a dual role, 
supporting neuronal functions and participating in neurogenesis. The neurogenic 
potential of enteric glia is likely to remain dormant under the constraints of the adult 
ENS niche, however as our data indicates, such potential can be activated in specific 
conditions that are associated with the acute loss of enteric neurons.  
Neuronal degeneration is a common feature of a number of gastrointestinal 
disorders, such as inflammatory bowel disease (IBD) and post-enteritis irritable bowel 
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syndrome. Interestingly, early histopathological studies reported that neuronal 
degeneration is often accompanied by other abnormalities, including ganglia and nerve 
bundles of increased size (hypertrophy) and/or number (hyperplasia), as well as changes 
to glial cells (hyperplasia) (Davis et al., 1955; Nadorra et al., 1986; Siemers & Dobbins, 
1974; Storsteen et al., 1953). The link between inflammation, neuronal degeneration and 
neurogenesis is further supported by increasing evidence pointing to mutual interaction 
between the ENS and the gastrointestinal immune system (Ruhl et al., 2001a; Ruhl et 
al., 2001b).  
Our observations suggesting that glial cells are facultative stem cells ready to 
respond to neural injury raise a series of important questions: (1) Are the types of cells 
regenerated after damage dependent on the types of cells destroyed? (2) Do all or just a 
subset of glial cells have neurogenic potential? (3) Are the newly born neurons able to 
establish connections with previously innervated tissues and become integrated in the 
circuitry? (4) What are the signals responsible for activating the neurogenic potential of 
glial cells? Further insight onto these questions will be fundamental to better 
comprehend the plasticity and regenerative capacity of the ENS and may facilitate the 
design of novel therapeutic strategies for the treatment of conditions associated with 
congenital absence or acquired loss of enteric neurons, such as Hirschsprung’s disease 
or gut inflammation. 
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Development of a genetic strategy to 
address the role of RET in cell fate 
decisions during ENS development 
 
  Appendix 
Introduction 
 
During development, receptor tyrosine kinases (RTKs) transduce extracellular signals 
into multiple cellular responses, such as growth and cell differentiation.  
The RTK RET encoded by the c-Ret proto-oncogene, is the main signalling 
component of a receptor complex for the glial cell line-derived neurotrophic factor 
(GDNF) family ligands (GFLs) – GDNF, neurturin, artemin and persephin (Baloh et al., 
2000). As a receptor tyrosine kinase, RET possesses an extracellular cysteine-rich 
ligand-binding domain, a transmembrane domain and a cytoplasmatic segment 
containing the catalytic tyrosine kinase domain (Yarden & Ullrich, 1988). Signalling 
through the RET receptor requires binding of GFLs to GFR, a glycosyl 
phosphatidylinositol cell surface receptor which, in turn, binds to RET. This leads to the 
dimerization of the receptor and activation of the kinase domain, which results in 
autophosphorylation and phosphorylation of specific substrates that mediate intracellular 
signalling (Ullrich & Schlessinger, 1990). 
Deregulation of the RET RTK function has been shown to be oncogenic. Dominant, 
gain-of-function mutations in the c-RET locus are associated with inherited cancer 
syndromes which involve cell types of neural crest origin (familial medullary thyroid 
carcinoma -FMTC- and multiple endocrine neoplasia -MEN- 2A and 2B; Jhiang, 2000). 
In the majority of MEN2B cases, a M918T mutation causes a change of RET substrate 
specificity which results in oncogenic transformation (Santoro et al., 1995). In contrast, 
in most of MEN2A and FMTC cases mutations affect one of the cysteine residues in the 
cysteine-rich extracellular domain of c-RET leading to the formation of permanent 
disulfide-bonded homodimers and trans-auto-phosphorylation of the tyrosine kinase. 
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This results in the constitutive activation of the RET receptor independent of its ligands 
(Santoro et al., 1995).  
Besides its role in tumorigenesis, RET has been shown to be an important player in 
the development of the PNS, including the ENS. Mutations of RET in humans lead to 
absence of enteric ganglia from the distal colon (HSCR; Edery et al., 1994; Romeo et 
al., 1994), whereas mice homozygous for a targeted mutation in Ret (Ret
k-) die soon 
after birth and display complete intestinal aganglionosis (Durbec et al., 1996; 
Schuchardt et al., 1994). A similar phenotype is observed in mice in the absence of Gdnf 
or Gfrα1 (Cacalano et al., 1998; Enomoto et al., 1998; Moore et al., 1996; Sanchez et 
al., 1996), highlighting the functional interaction between these molecules and the 
crucial role of the RET/GDNF/GFR1 signalling pathway in ENS development.  
During ENS development, c-Ret is expressed in NCCs when they first reach the 
vicinity of the gut at E9-9.5 and continues to be expressed as these cells colonize the 
entire gastrointestinal tract (Durbec et al., 1996; Pachnis et al., 1993; Tsuzuki et al., 
1995). In the differentiated lineages of the ENS, Ret expression is maintained 
exclusively in the neuronal population (Young et al., 2003).  
Early in vitro and in vivo studies have implicated Ret in numerous aspects of ENS 
development. Detailed analysis of Ret-deficient embryos revealed that ENS progenitors 
undergo apoptosis before reaching the midgut, thus suggesting a role for this gene in the 
early survival of ENS progenitors (Durbec et al., 1996). Moreover, GDNF activation of 
RET via GFRα1 has been shown to be required for the migration and proliferation of 
ENS progenitors (Gianino et al., 2003; Natarajan et al., 1999; Taraviras et al., 1999). 
Interestingly, a recent report has suggested that the physiological role of the RET 
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signalling pathway is regulated spatiotemporally (Uesaka et al., 2007). Mice in which 
Gfrα1 gene function is conditionally disrupted during midgestation (E11.5-13.5) display 
reduced proliferation in the ENS but not cell death. Thus, whereas at early stages of 
development RET signalling is required for the survival of ENS progenitors (Durbec et 
al., 1996), at E11.5-13.5 this pathway plays a crucial role in cell proliferation but not 
cell survival. Impairment of RET signalling at late stages of development has also been 
addressed by conditionally ablating Gfrα1 or c-Ret. At these stages, Gfrα1 is expressed 
in both enteric neurons and glia whereas c-Ret is expressed in eNCSCs and neurons. The 
glial cell population does not express c-Ret and, so it is not affected by the loss of Gfrα1 
(Enomoto et al., 2004). In contrast, enteric neurons in the colon undergo cell death in 
the absence of Gfrα1 or c-Ret, thus suggesting that RET signalling is required for the 
survival of enteric neurons in the colon (Uesaka et al., 2007; Uesaka et al., 2008). 
However, the effects of abrogating the RET signalling pathway in ENS progenitors and 
how that affects cell commitment and differentiation was not addressed in this study. 
Evidence supporting a potential association between signalling of the RET RTK in 
eNCSCs and their commitment and differentiation into specific cellular phenotypes 
came from an in vitro study by Chalazonitis and colleagues (Chalazonitis et al., 1998). 
p75
+ cells from the gut of E16 rat embryos were cultured in the presence or absence of 
GDNF. This approach showed that in the presence of GDNF, p75
+ cells preferentially 
adopt a neuronal rather than a glial fate. Whether GDNF exerts an instructive effect on 
eNCSCs to follow the neuronal lineage is still unclear. A role for RET in cell fate 
decisions was further demonstrated by the study of the monoisoformic Ret mutants (de 
Graaff et al., 2001). In mammals, c-Ret encodes
 for two isoforms, RET9 and RET51, 
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which are generated by alternative splicing and differ only in their carboxy-terminal 
sequences (Tahira et al., 1990). RET isoforms have distinct signalling properties; 
whereas RET9 isoform is sufficient to support normal embryonic and postnatal 
development, the RET51 isoform is not. Mice mutants that express only the RET51 
isoform (Ret
51/51) display absence of enteric ganglia in the colon, a phenotype that 
reproduces that of human aganglionosis (de Graaff et al., 2001). Further analysis of 
these mutants showed that they exhibit differentiation defects as the fraction of enteric 
neurons in the gut of the Ret
51/51 mutants is significantly reduced relative to wild-type 
littermates (Dipa Natarajan, personal communication). Moreover, clonal cultures of 
enteric multipotential progenitors isolated from Ret
51/51 mutants contain a reduced 
number of enteric neurons (Dipa Natarajan, personal communication).  Despite these 
studies, the role of RET signalling on cell commitment and differentiation is still poorly 
understood.  
Here, we wished to explore the role of RET in cell fate decisions and test the 
hypothesis that sustained expression of c-RET is sufficient to divert differentiation of 
ENS progenitors away from the glial lineage and towards the neuronal cell fate in vivo.    
Results 
 
Generation of R26
RET9 and R26
RET9(MEN2A) constructs 
 
To elucidate the role of RET signalling in cell fate decisions during ENS development, 
we wished to generate novel transgenic lines in which a wild-type (c-RET9) or a 
mutated form of the RET9 isoform (Ret9-MEN2A) is knocked-in the ROSA26 (R26) 
locus (R26
RET9 and
 R26
RET9(MEN2A), respectively). 
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As a first step towards the generation of R26
RET9 and
 R26
RET9(MEN2A) mouse lines, we 
constructed a RET9-IRES-GFP cassette. The RET9/RET9
MEN2A cDNA (3.2 Kb) could 
not be isolated from the vector pcDNA3 due to the lack of appropriate restriction 
enzyme sites. For that reason, RET9/RET9
MEN2A cDNA was reconstructed using a three-
step strategy. First, fragments FA (161 bp) and FB (153 bp) were amplified by PCR 
using the RET9 cDNA as a template. Primers were designed to insert KpnI and XhoI 
restriction sites at the ends of FA and XhoI and HindIII sites at the ends of FB (Fig.7.1 
A-i, ii; see Chapter II). FA was subcloned into the pBlueScript KS (pBS KS) vector 
previously double-digested with KpnI/XhoI. Similarly, FB was subcloned into 
XhoI/HindIII digested pBS KS+FA construct, thus generating pBS KS+FA+FB. 
Secondly, a 3 Kb fragment of RET9 cDNA with and without MEN2A mutation (FC) was 
released by XhoI digestion and cloned into XhoI digested pBS KS+FA+FB. Because this 
is a non-directional cloning step, colony lifts and hybridization were used to perform a 
screen for positive transformed colonies using FC as a probe. Then, DNA from the 
selected colonies was analysed following restriction digestion with KpnI to identify 
colonies carrying the FC in the right orientation. All the positive colonies selected (50 
for RET9 FC and 36 for RET9
MEN2A FC) carried FC in the wrong orientation. In an effort 
to overcome this, we designed a new cloning strategy: RET9/RET9
MEN2A cDNA harbours 
two unique restriction enzyme sites (AatII and NsiI), which were used to release a 3 Kb 
fragment (FC’). This fragment was then subcloned into pBS KS+FA+FB previously 
digested with AatII and NsiI thereby generating pBS KS+FA+FB+FC (Fig.7.1 A-iii; see 
Chapter II). Finally, NheI digestion of pBS KS+FA+FB+FC released the coding sequence 
of Ret9 and Ret9
MEN2A (3.2 Kb fragment) which was then inserted at a unique NheI site 
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of the pBigT plasmid (kindly provided by S. Srinivas, University of Oxford, UK; 
Srinivas et al., 2001). In this construct, a cassette containing the neomycin-coding gene 
under the control of the promoter for phosphoglycerate kinase (PGKneobpA) flanked by 
loxP sites lays 5’ to a RET9/RET9
MEN2A coding sequence to prevent translation until 
Cre-mediated excision of the neo cassette. 3’ to RET9/RET9
MEN2A coding sequence lays 
an IRES-GFP reporter construct to monitor expression of the transgene in vivo (Fig.7.1 
A-iv; see Chapter II). Once again, colony lifts and hybridization were used to perform a 
screen for positive transformed colonies using FC as a probe. DNA of the selected 
colonies was then digested with different restriction enzymes to assess for correct 
orientation of the cloned fragment. Restriction analysis revealed a wrong restriction 
pattern for all the colonies tested due to rearrangements of the pBigT vector. More 
specifically, we identified the loss of an 870 bp fragment from the PGK cassette of the 
pBigT vector following subcloning of RET9/RET9
MEN2A coding sequence. In an effort 
to overcome this unexpected rearrangement, pBigT-RET9 and pBigT-RET9
(MEN2A) 
constructs were again subcloned into a non-rearranged pBigT vector and transformed 
into HB101 bacteria, grown at 28ºC. 
Once generated, the RET9-IRES-GFP and the RET9
MEN2A-IRES-GFP cassettes were 
digested with PacI/AscI restriction enzymes and inserted into an AscI/PacI digested 
vector pROSA26PA (a kind gift from S. Srinivas, University of Oxford, UK; Srinivas et 
al., 2001). This plasmid contains genomic R26 sequences for homologous 
recombination and a diphtheria toxin gene for negative selection in ES cells (Fig.7.1 B- 
ii; see Chapter II). Appendix 
Figure A1 Generation of the R26
RET9 and R26
RET9(MEN2A) constructs. 
 
 (A) Map of the RET9/RET9
MEN2A cDNA indicating the relative locations of the AatII 
and NsiI restriction sites (i). Maps of FC’ and the PCR-amplified FA and FB, including 
the relative location of the added KpnI+NheI and HindIII+NheI restriction sites (ii). 
RET9/RET9
MEN2A were isolated by NheI digestion and then subcloned into pBigT:IRES-
GFP vector (iii). Schematic representation of the pBigT:IRES-GFP vector indicating the 
adenovirus splice acceptor sequence (SA; blue) followed by a loxP site (red), neo 
expression cassette (PGK-neo tpA; orange), another loxP site (red), the NheI restriction 
site where RET9/RET9
MEN2A were subcloned into, the IRES-GFP cassette and the 
bovine growth hormone polyadenylation sequence (IRESGFP bPA; light blue) and the 
restriction sites PacI and AscI (iv). (B) Map of the pBigT:RET9:IRESGFP plasmid (i). 
Schematic of the pROSA26A vector showing the location of the 5’ and 3’ homology 
sequences for homologous recombination and the diphtheria toxin gene (PGK-DTA) for 
negative selection in ES cells (ii). Wild-type R26 locus with the relative location of the 
BglI restriction sites and the location of the probe (iii). Structure of the targeted locus 
before (iv) and after (v) Cre-mediated excision of the loxP-flanked cassette.
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Both the targeting vectors were linearized with SfiI. We started by electroporating 
the targeting vector paROSA-RET9
MEN2A-IRES-GFP into E14G2A embryonic stem 
(ES) cells (kindly provided by A. Smith, Institute for Stem Cell Research, UK). 
Following G418 selection, 332 G418-resistant clones were picked. PCR analysis of the 
clones showed that 2 G418-resistant clones had correctly undergone homologous 
recombination (Fig.A1 B-iv; 7.2 A). This result was further verified by Southern blot 
analysis of EcoRI digested DNA from the ES clones using a 5’ external probe (692 bp 
fragment generated by PCR - kind gift of A. Smith, Institute for Stem Cell Research, 
UK; Fig.A1 B-iii,iv). The endogenous gene was detected as a 13 Kb band whilst the 
transgene was detected as 4.3 Kb band confirming correct targeting of the R26 locus in 
both clones (FigA2 B). 
 
GFP expression in targeted ES cell clones 
 
To determine whether the GFP reporter in the R26
RET9MEN2A construct could be activated 
appropriately, the correctly targeted ES cell clones were electroporated with a plasmid 
encoding Cre recombinase under the control of the CAGGS promoter. Cre-mediated 
recombination leads to excision of the transcriptional terminator cassette and, 
consequently, expression of RET9
MEN2A and GFP (Fig.A1 B-v). Cells were monitored 
for GFP expression by immunostaining, which showed strong GFP expression 
exclusively in transfected ES cells (Fig.A3).  
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Figure A2 Targeting of the R26 locus. 
 
(A) ES cell clones were analysed by PCR using the set of primers F1-PS/R1-PS 
(amplify a 1.2 Kb diagnostic fragment of the targeted R26 locus) and F1-PS/R2 (amplify 
a 1.4 Kb of the wild-type locus). The relative location of the primers is shown in Fig. 7.1 
B. Sample 2 represents an ES cell clone carrying the targeted allele (identified by the 
diagnostic 1.2 Kb fragment) and the wild-type allele (1.4 Kb fragment). Genomic DNA 
from R26ReYFP transgenics and wild-type mice were used as positive [C(+)] and 
negative (wt) controls, respectively. As expected, lanes corresponding to the negative 
control and water were blank when the set of primers that recognizes the targeted locus 
were used. The molecular weights in kilobases are shown on the left. (B) Southern blot 
of DNA from 9 ES cell lines digested with EcoRI and hybridized with the probe 
indicated in Fig7.1 B. The 13 Kb band is the wild-type and the 4.3 Kb band represents 
the targeted allele. ES cell clones 1 and 3-9 are wild-type, while clone 2 is heterozygous 
for the targeted allele. Genomic DNA from R26ReYFP transgenics and wild-type mice 
were used as positive [C(+)] and negative (wt) controls, respectively.The expected 
fragment sizes are indicated on the left. 
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Figure A3 GFP is expressed in targeted ES cell clones 
 
(A-B) A correctly targeted ES cell clone was transiently transfected with a plasmid 
encoding Cre recombinase under the control of the CAGGS promoter. Immunostaining 
for GFP (green) revealed expression of this protein in the transfected ES cell clone (A) 
but not in the control (not transfected; B ). Nuclei were labelled with DAPI. x400 
magnification. 
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Generation of R26
RET9(MEN2A) transgenics 
 
The correctly targeted ES cell clones were microinjected into (C57BL/6) blastocysts and 
these were transferred into the uterus of pseudopregnant female 
[(CBA/CA_XC57BL/10)_F1] mice to produce chimeric mice. Twenty-one chimeras (19 
males, 2 females) were generated, mated to F1 animals and the offspring examined for 
germ line transmission of ES cell DNA, as determined by the presence of agouti coat 
colour, indicating the successful transmission of ES cell DNA through the germ line. 
PCR analysis of tail DNA from the first 19 agouti pups has revealed no positive animals.  
 
Discussion 
 
In the ENS, progenitor cells divide during embryogenesis and postnatal stages but, at 
specific times throughout this period, some stop dividing to differentiate first into 
neurons, and later, into neurons and glia. Little is known about the mechanisms that 
regulate the timing and choice of differentiation in the ENS. Studies focusing mainly 
upon the developing CNS have shown that changes in signal availability are involved in 
cell type specification (Lillien, 1995; Miller & Gauthier, 2007). In addition, differences 
among progenitor cells in their competence to respond to extrinsic signals may also 
contribute to cell fate decisions. In the embryonic forebrain, for example, asymmetric 
distribution of the RTK EGFR during mitosis generates progenitors with different 
differentiation responses to the ligand EGF (Sun et al., 2005). Similarly, a difference in 
the levels of expression of EGFR has also been implicated in biasing cell type choice in 
the mouse retina (Lillien, 1995). Thus, modulation of cell-surface receptor levels is one 
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of the molecular mechanisms that determine differences in responsiveness to 
extracellular cues and influences cell fate decisions.  
The RTK RET has been identified as a crucial player in many aspects of ENS 
development, namely in cell survival, migration and proliferation (Durbec et al., 1996; 
Natarajan et al., 2002; Taraviras et al., 1999). Whether at certain stages of development 
RET signalling also plays a role on cell commitment and differentiation is unclear. We 
wished to explore whether sustained expression of RET biases ENS progenitor cells to 
follow a neuronal fate at the expense of the glial lineage. To this end, we report here a 
strategy to attain persistent expression of RET in a spatiotemporal controlled manner, i.e 
in specific cell-types, at defined developmental stages.  
To express RET ubiquitously and independently from the endogenous Ret locus, we 
targeted the R26 locus. R26 has been widely used for expression of various genes in a 
ubiquitous manner (Friedrich & Soriano, 1991; Soriano, 1999). Modification of the R26 
locus was carried out using established homologous recombination techniques in ES 
cells, thereby knocking-in the locus the coding sequence of the short isoform of the 
human c-RET gene (RET9). The RET9 isoform was chosen based on previous reports 
demonstrating that unlike RET51, RET9 is necessary and sufficient for normal 
development of the ENS (de Graaff et al., 2001; Uesaka et al., 2008). Besides wild-type 
RET9, a mutated form of RET9 – RET9
MEN2A - was also used. The MEN2A form of c-
RET9 harbours a single base-pair missense mutation that converts a cysteine residue into 
arginine (C634R mutation). Such a mutation results in the disruption of an 
intramolecular disulphide bond leading to ligand-independent dimerisation and 
constitutive activation of RET proteins. Thus, unlike the wild-type form of RET9, 
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activation of RET9
MEN2A does not rely on the availability of GFLs at different stages of 
development (Santoro et al., 1995).  
Transgenic mice expressing RET with the common MEN2A point mutation C634R 
have been used to study the biological effect of MEN2A mutations in thyroid C-cell 
tumorigenesis (Michiels et al., 1997; Reynolds et al., 2001). In thyroid C-cells, 
expression of RET9
MEN2A  but not wild-type RET9 has been shown to result in the 
development of medullary thyroid carcinoma, a malignant tumour arising from thyroid 
C cells, in 8-12 month old mice. In our study, RET9 and RET9
MEN2A are expressed under 
the control of the ubiquitously expressed R26 locus. However, expression of 
RET9/RET9
MEN2A depends upon Cre-mediated excision of a loxP-flanked transcriptional 
terminator sequence (tpA). Thus, persistent expression of RET can be restricted to the 
specific cell types depending on the Cre lines used. For the purposes of this study 
R26
RET9/R26
RET9(MEN2A)  transgenic mice will be crossed with the inducible Cre line 
Sox10iCreER
T2. In the progeny of this cross, expression of RET9/RET9
MEN2A will be 
restricted to Sox10-expressing cells and dependent on 4-OHT administration. Given that 
Sox10 is expressed in thyroid C-cells (Deal et al., 2006), development of C-cell 
neoplasia in Sox10iCreER
T2; R26
RET9(MEN2A)GFP double transgenics cannot be ruled out. 
Nevertheless, this approach provides a valuable tool to attain persistent expression of 
RET in vivo, in a temporally and spatially controlled manner and assess its effect on 
ENS differentiation during development. In particular, it can be used to examine 
whether persistent expression of RET in Sox10-expressing progenitor cells prevents 
them from following a glial fate. For this purpose, analysis of SER93; 
R26
RET9/R26
RET9(MEN2A) double transgenics
 may be particularly informative. We have 
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established a regime for 4-OHT administration that allows targeting of single or small 
populations of Sox10-expressing cells in the gut of SER93 transgenic animals (Chapter 
IV). By crossing SER93 and  R26
RET9/R26
RET9(MEN2A) transgenics we aim to generate 
genetic mosaics in which expression of RET9 or the constitutively active RET9
MEN2A is 
restricted to a small population of Sox10-expressing cells in a wild-type background. 
The effect of persistently expressing RET in Sox10
+ progenitor cells can then be 
determined by tracing the fate of the targeted progenitors (GFP-labelled) clonally in 
vivo. Identification of the cell types present in each cell cluster will reveal the 
developmental potential of targeted progenitors. In light of our hypothesis, we predict 
that most multi-cell clusters derived from Sox10-expressing progenitors that persistently 
express RET9/RET9
(MEN2A) will be mainly composed of neurons. Further analysis of 
these clusters for the presence of different neuronal subtypes will also be carried out. So 
far, little is known about the mechanisms that control the differentiation and subtype 
identity of enteric neurons. RET is known to be expressed in differentiated enteric 
neurons (Young et al., 2003). However, expression of RET in the different enteric 
neuron subtypes and how this expression may be modulated during development has 
never been addressed. Therefore, the question as to whether RET signalling is involved 
in differentiation or maintenance of specific neuron subtypes remains unclear. The 
approach presented here can provide valuable insight onto the potential role of the RET 
signalling pathway in the generation of enteric neuron diversity.  
Another unresolved question in stem cell biology is to what extent the differentiation 
programme is hardwired or reversible. This issue has received increased attention 
recently as the therapeutic value of inducing changes in cell identity and generating 
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patient-specific cell types has become apparent (Jaenisch & Young, 2008). Our findings 
that glial cells can generate eNCSCs in vitro and give rise to neurons under certain 
conditions raises the question as to how hardwired the glial identity actually is. During 
development, expression of Ret is downregulated as cells differentiate into glia (Young 
et al., 2003). Whether downregulation of Ret expression is necessary for the 
maintenance of “glial identity” is unknown. The effect of persistently expressing RET in 
GFAP
+ glial cells in which Ret expression is normally downregulated can be addressed 
by following the fate of GFAP
+ cells in vivo in the gut of hGFAPCreER
T2; 
R26
RET9/R26
RET9(MEN2A) double transgenics.  
In summary, the genetic system described here aims at attaining persistent 
expression of RET in vivo in a spatiotemporally controlled manner. Analysis of this 
mouse model should give insight into the mechanisms underlying cell-fate decisions 
during ENS organogenesis, in particular, the role of RET in the enteric neurogenic-
gliogenic switch.  
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